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Summary 
 
Serovars of Salmonella enterica subspecies enterica are generally pathogenic to humans 
and other mammals. In this study, I examined the population structure of one of the most 
common serovars of this subspecies isolated from humans and food animals, serovar 
Newport, using a multilocus sequence typing scheme. This scheme was also used to 
analyze isolates of this subspecies from chronic human carriers and reptiles to determine 
whether isolates from these sources represent distinct populations than those from other 
hosts. 
Multilocus sequence typing has extensively been used to study evolution and population 
structure of a wide range of organisms. 400-600 bp fragments of 7 housekeeping genes 
were sequenced and every unique sequence of each gene fragment was given a distinct 
allele number. Each unique combination of alleles was assigned a distinct sequence type 
number. The data were used in further analyses. 
Three lineages, namely Newport-I, Newport-II and Newport-III were identified within 
serovar Newport which were associated to European humans, animals and humans in North 
America, respectively. Multidrug resistance phenotypes were most common in Newport-II 
whereas most isolates in Newport-III were pan-susceptible. When compared to other 
serovars, the numbers of lineages within Newport were higher than for Enteritidis, 
Kentucky and Typhimurium but lower than for Paratyphi B. Therefore, serovars of S. 
enterica subspecies enterica vary greatly in their population structures. 
The sequence types observed for isolates from chronic human carriers were generally the 
most common among human-clinical and animal isolates. Most isolates from non-carrier 
humans plus animals were genetically identical to the carried isolates within most serovars. 
Genetic diversity was also comparable between isolates from these sources. These results 
suggest that salmonellae from chronic human carriers belong to the same population as 
isolates from non-carrier humans and animals. 
For most serovars, most isolates from reptiles were genetically identical to those from 
humans or other warm blooded animals. However, in serovars Bovismorbificans, Decatur, 
Miami and Oranienburg, most reptile isolates were genetically distinct from isolates from 
other hosts. Only few reptile isolates were tested from Bovismorbificans, Decatur and 
Miami and only few non-reptile isolates were tested from Oranienburg, and in larger 
numbers of such isolates would be needed to determine whether these differences are 
statistically significant. 
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Zusammenfassung 
 
Serovare von Salmonella enterica subspecies enterica sind im allgemeinen pathogen für 
Mensch und andere Säugetiere. In dieser Arbeit habe ich anhand eines “Multilocus 
Sequences Typing” Typisierungsschemas die Populationsstruktur einer der am häufigsten 
auftretenden Serovaren dieser Subspecies, das aus Menschen und Schlachttieren isolierte 
Serovar Newport charakterisiert. Dieses Schema wurde auch für die Charakterisierung von 
Isolaten derselben Subspecies aus humanen Dauerträgern und Reptilien verwandt, um zu 
bestimmen, ob Isolate aus diesen Quellen sich in ihrer Populationstruktur von denjenigen 
unterscheiden, die aus anderen Quellen isoliert wurden. 
Multilocus Sequences Typing ist eine weitgehend für die Untersuchung der Evolution und 
Populationsstruktur von einen breiten Spektrum von Organismen verwendete Technik. 400 
- 600 bp lange Fragmente von 7 Haushaltsgenen wurden sequenziert, und jede einzelne 
Sequenz jedes einzelnen Gens wurde eine Allelnummer zugeordnet. Jede einzelne 
Allelkombination wurde einem Sequenztyp zugeordnet. Die so gewonnenen Daten wurden 
weiter analysiert. 
Drei “Lineages”, Newport-I, Newport-II und Newport-III, wurden innerhalb dieses 
Serovars identifiziert, die jeweils aus Menschen in Europa, Tieren und Menschen in 
Nordamerika isoliert wurden. Der Multiresistenz-Phänotyp wurde häufiger in Newport II 
gefunden, während die meisten Newport III Isolate pan-sensitiv waren. Verglichen mit 
anderen Serovaren war die Anzahl von “Lineages” innerhalb Newport höher als bei 
Enteritidis, Kentucky und Typhimurium, aber niedriger als bei Paratyphi B. Das heisst, die 
Serovare von S. enterica subspecies enterica variieren stark in ihrer Populationsstruktur. 
Die Sequenztypen in Isolaten aus humanen Dauerträgern waren im allgemeinen am 
häufigsten in Isolaten von klinischen Patienten und Tieren vorhanden. In der Mehrheit der 
Serovaren waren die meisten Isolate aus Patienten und Tieren genetisch identisch mit 
solchen, die aus gesunden Trägern isoliert wurden. Die genetische Variabilität war 
zwischen Isolaten aus diesen Quellen vergleichbar. Diese Ergebnissen deuten daraufhin, 
dass Salmonellen aus Dauerträgern sowie Isolate aus Patienten und Tieren derselben 
Population angehören. 
Die meisten Serovare aus Reptilienisolaten waren genetisch identisch mit denen von 
Menschen und warmblütigen Tieren. In den Serovaren Bovismorbificans, Decatur, Miami 
und Oranienburg hingegen waren die meisten Isolate aus Reptilien genetisch anders als 
Isolate aus anderen Wirten. Allerdings wurden nur wenige Isolate der Serovaren 
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Bovismorbificans, Decatur und Miami aus Reptilien und nur wenige Isolate der Serovaren 
Oranienburg aus anderen Quellen getestet; eine grössere Anzahl von Isolaten müsste daher 
untersucht werden, um festzustellen ob diese genetischen Unterschiede statistich signifikant 
sind oder nicht. 
 
Keywords: Salmonella enterica, population structure, serovar, Newport, chronic human 
carrier, reptile, mutation, recombination. 
 
Schlagwörter: Salmonella enterica, Populationsstruktur, Serovar, Newport, humanen 
Dauerträgern, Reptilien, Mutation, Rekombination. 
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1. Introduction 
Salmonellae are facultatively anaerobic, gram-negative rod shaped bacteria that belong to 
the family Enterobacteriacae (Chart, 2003). They are one of the major causes of morbidity 
among humans (Herikstad et al., 2002; Mead et al., 1999). Salmonella infection in humans 
may result in self limiting diarrhoea to life threatening systemic diseases (Chart, 2003). 
Based on the description of the clinical symptoms, typhoid fever and dysentery found to be 
responsible for the mass deaths in Jamestown, Virginia during the English colonization 
between 1607 and 1624 (Earle, 1979). Alexander the Great (356-323 BC) and Prince Albert 
the Consort of Queen Victoria (1819-1861), two famous historical figures, also died of 
typhoid fever1 (Knights, 1969; Cunha, 2004). The typhoid epidemic has been responsible 
for high mortality rate among the American soldiers during the Spanish-American war in 
1898 (Cirillo, 2000). The bacilli were first isolated in 1885 from pigs and named after 
Daniel Elmer Salmon, one of the discoverer (Clark, 1959). 
1.1 Classification and Nomenclature 
Salmonella is a member of the family Enterobacteriaceae of the class γ- proteobacteria in 
the kingdom Bacteria (Euzéby, 2007). 
 
Kingdom Bacteria 
Phylum Proteobacteria 
Class  γ-proteobacteria 
Order  Enterobacteriales 
Family  Enterobacteriaceae 
Genus  Salmonella 
 
The nomenclature of Salmonella had been very unstable and undergone dramatic changes 
in the last few decades (Euzeby, 1999; Brenner et al., 2000; Ezaki et al., 2000a; Ezaki et 
al., 2000b; Yabuuchi and Ezaki, 2000; Heyndrickx et al., 2005; Tindall et al., 2005).  
 
 
1Various studies argued for other diseases to be the cause of deaths of Alexander the Great as well as Prince 
Albert because similar symptoms are also observed for various non-typhoidal diseases (Marr and Calisher, 
2003; Williams and Arnott, 2004; Paulley, 1993). 
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S. choleraesuis, S. typhi and S. enteritidis had been considered three species within the 
genus Salmonella until 1973 when results from DNA-DNA hybridization experiments led 
to the proposal that S. choleraesuis be the type and only Salmonella species (Crosa et al., 
1973). Subsequently, in 1999, Euzeby recommended changing this name to S. enterica and 
subdividing the species into six subspecies namely enterica, salamae, arizonae, diarizonae, 
houtenae and indica (Euzeby, 1999). These subspecies are also designated by roman 
numbers I, II, IIIa, IIIb, IV and VI, respectively. The proposal to grant the status of a 
species to S. bongori (Reeves et al., 1989) which was earlier considered as subspecies V, 
was also accepted (Euzeby, 1999). 
In 2004, S. subterranea was published as a new species, isolated from a low pH subsurface 
sediment contaminated with nitrite and Uranium-VI (Shelobolina et al., 2004). This isolate 
showed 96.4% homology with S. bongori in 16S ribosomal DNA sequences. Currently, the 
genus Salmonella consists of three species namely S. enterica, S. bongori and S. 
subterranea and S. enterica is further divided into six subspecies. 
1.2 Classical schemes for Salmonella typing 
Two classical methods are routinely used for subtyping of S. enterica, namely serotyping 
and phage-typing. 
1.2.1 Serotyping 
Serotyping scheme was proposed by Kauffmann and White in 1957 for antigenic 
classification of S. enterica. The outer membrane of Gram-negative bacteria including S. 
enterica contain two sets of immunogenic antigens, one being long-chain 
lipopolysaccharides (LPS), also referred to as somatic or O antigens and the second being 
flagellar protein subunits, also called H antigens (Chart, 2003). In addition, the surface 
polysaccharide antigen Vi (virulence antigen) is expressed by serovars Typhi, Paratyphi C 
and occasionally by serovar Dublin (Selander et al., 1990b; Selander et al., 1992; 
Cheminay and Hensel, 2008). LPS molecules consists of three regions: (i) a hydrophobic 
lipid A residue, (ii) the core oligosaccharide region and (iii) the hydrophilic O- 
polysaccharide or O-chain region (Raetz and Whitfield, 2002). The O-chain region consists 
of 20-40 repeating units of 2-8 monosaccharides. Differences in sugar composition and the 
degree of branching are the source of variation among O-antigens (Raetz and Whitfield, 
2002). 
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Most of S. enterica isolates are equipped with two genes, namely fliC and fljB, that encode 
H1 (Phase 1) and H2 (Phase 2) flagellar antigens, respectively (Iino et al., 1988). These 
genes were formerly known as H1 and H2, respectively. Only one of these genes is 
expressed at any one time and changes in expression are regulated by a phase switch 
(Silverman et al., 1979; Simon et al., 1980). This switch is an invertible DNA sequence 
adjacent to the fljB gene which contains a promoter region required for transcription. In one 
orientation fljB is co-expressed with fljA (formerly known as rh1) whose product represses 
the expression of fliC. In the other orientation, only fliC is expressed (Simon et al., 1980). 
However, both antigens can be simultaneously expressed by a bacterial culture where a 
fraction of cells expresses one antigen and the rest express the other antigen. 
S. enterica cultures are tested against a panel of antisera to identify O and H antigens and 
the agglutination profiles are used to assign the isolates to serovars. A cell suspension is 
mixed and incubated with an antiserum and a reaction is scored positive on the formation of 
visible clumps (The National Food Institute, 2008). Bacterial cultures are grown on a non-
selective agar medium to test O antigens and semisolid agar medium to test H antigens. 
Various kits containing omni-, poly- and mono-valent antisera are commercially available. 
Each unique combination of O and H antigens (antigenic formula) is assigned a serovar 
designation which is usually the name of the geographic location where the strain was first 
isolated (Brenner et al., 2000). However, naming of the serovars for subspecies other than 
enterica is no longer practised. O-antigens are denoted by numbers, H1 antigens by lower 
case letters and H2 by both number and letters (Popoff, 2001). The three types of antigens 
are separated by colons while multiple antigenic determinants within an antigen type are 
separated by commas. Salmonella serovars containing common somatic antigens are often 
assigned to a sero-group or O group, e.g., serovar Typhimurium belongs to sero-group O:4 
that contain all the serovars with O-antigens 4 and 12 (Popoff, 2001). 
Example: the antigenic formula for S. enterica subsp. enterica (henceforth referred to as 
subspecies enterica) serovar Typhimurium is 1,4,[5],12:i:1,2. An underlined somatic 
antigen indicates that the determinant is caused by the lysogenization of a bacteriophage 
and factors in square brackets indicate that the expression of these determinants is variable. 
Some antigenic determinants are weakly agglutinable and are written in brackets ‘( )’ 
(Popoff, 2001). 1,4,[5],12 in this formula are the somatic antigens that are expressed by 
isolates of serovar Typhimurium while i and 1,2 are the H1 and H2 antigens, respectively. 
This scheme has identified more than 2500 serovars to date, 1500 in subspecies enterica 
and remainder in other S. enterica subspecies plus S. bongori (Popoff et al., 2004). 
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1.2.2 Phage typing 
Phage typing has been practised for identification and classification of Salmonella from 
1920s, prior to the introduction of serotyping and was extensively used for subtyping of 
typhoid and paratyphoid bacilli (Felix, 1951; Gershman, 1976). It has also been used for 
typing of other serovars such as Anatum (Gershman, 1974), Enteritidis (Gershman, 1976), 
Heidelberg and Typhimurium (Ibrahim, 1969). Phage typing is based on the selective 
ability of bacteriophages to infect certain S. enterica strains and isolates within a serovar 
are differentiated into various subtypes based on the patterns of their lysis by a series of 
bacteriophages (Schmieger, 1999). The susceptibility of a bacterial isolate to particular 
bacteriophages depends on the presence of appropriate phage receptors on the cell surface. 
The numbers, sizes and transparencies of plaques are compared to known phage patterns to 
define the phage type (Hickman-Brenner et al., 1991). Salmonella isolates that do not react 
to any of the typing phages are called non-typeable (NT) and if a lysis pattern does not 
correspond to any of the recognized phage types, it is defined as RDNC (React but does not 
conform). 
Phage typing has been used for routine strain characterization and epidemiological 
investigations for various S. enterica serovars. Ten of the Typhi outbreaks were 
characterized to have caused by phage type E1 between 1960-1999 in the U.S.A. (Olsen et 
al., 2003). Host restricted subtypes of certain serovars have also been identified by phage 
typing, e.g., Typhimurium phage types DT2 and DT99 are restricted to pigeons (Rabsch et 
al., 2002). Phage typing has also been used to differentiate salmonellae of various sero-
groups (Gershman and Markowsky, 1983). 
 
1.3 Host range 
Salmonellae are capable to infect a variety of hosts ranging from cold-blooded reptiles 
through warm-blooded animals and humans. Most serovars of subspecies enterica can also 
infect a wide spectrum of hosts and are referred to as unrestricted or generalist salmonellae, 
e.g. Tyhimurium and Enteritidis (Uzzau et al., 2000). In contrast, serovars that are specific 
for particular hosts and are only rarely isolated from other sources are called host-adapted 
salmonellae (Kingsley and Baumler, 2000). Serovars Choleraesuis and Dublin are adapted 
to pigs and cattle, respectively, and human cases of Choleraesuis and Dublin infections are 
often linked to the consumption of contaminated meat products (Kingsley and Baumler, 
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2000). Still other serovars are exclusively associated with a single host and are called host-
restricted serovars, e.g., Typhi can infect only humans and higher primates (Kingsley and 
Baumler, 2000; Uzzau et al., 2000). 
Numerous insertions, deletions and genomic rearrangements have been identified in host-
adapted and host-restricted serovars (Wu et al., 2005; Helm et al., 2004). Genomic 
rearrangements at rrn operons have been observed in Typhi (human-restricted) (Liu et al., 
2006) and Typhimurium phage type DT2 (pigeon-restricted) (Helm et al., 2004). Various 
insertions, deletions and genomic rearrangements have been found in Gallinarum and 
Pullorum, two fowl-restricted variants of serovar Enteritidis (Liu et al., 2002; Wu et al., 
2005). Several genomic insertions have been observed in the human-restricted serovars 
Typhi and Paratyphi A that are usually absent in other serovars and might potentially 
contribute to the increased virulence of these serovars to humans (McClelland et al., 2004). 
Host adaptation in Typhi and Paratyphi A has also been accompanied by genome 
degradation of regions that are apparently not required for infection and survival in humans 
(McClelland et al., 2004). Some host-adapted and host-restricted serovars are auxotrophs, 
e.g., Typhi, Gallinarum, Paratyphi A, and depend on their hosts for specific nutrients 
(amino acids and vitamins) (Uzzau et al., 2000). The auxotrophies may reflect genomic 
rearrangements that have resulted in the loss of function of genes involved in the 
biosynthesis of particular nutrients. 
 
1.4 Asymptomatic carriers 
Non-typhoidal Salmonella infection usually results in self limiting diarrhoea (Chart, 2003). 
After clinical recovery, patients often excrete salmonellae for 12 days to 5 weeks (Sirinavin 
et al., 2004). Approximately 1% of such patients become chronic asymptomatic carriers 
and excrete salmonellae for years (D'Aoust, 1991). The frequency of chronic asymptomatic 
carriers after infection of serovar Typhi is slightly higher and 1-5% of infections result in 
long-term colonization of the bacilli in the hepatobiliary system (Gupta et al., 2006). “Mr. 
N the milker” and Mary Mallon (“Typhoid Mary”) are two widely known chronic human 
carriers of serovar Typhi (Hasian, 2000; Mortimer, 1999). In addition to infect the healthy 
population, chronic typhoid and paratyphoid carriers themselves are at a high risk of 
developing cancer of the gall bladder (Caygill et al., 1994). Therefore, a treatment with 
antibiotics or cholecystectomy has been recommended for them, both for eradication of 
 6
chronic carriage as well as to reduce the cancer mortality in chronic carriers (Caygill et al., 
1994). 
Salmonella not only persist asymptomatically among humans but also in reptiles and other 
warm-blooded animals, especially dairy and food animals (Cobbold et al., 2006; McCain 
and Powell, 1990; Sadeyen et al., 2006; Ebani et al., 2005). They colonize lymph nodes 
and internal organs and are shed continuously or intermittently with the faeces (McCain 
and Powell, 1990; Nielsen et al., 2004; Perron et al., 2007). A reservoir of Salmonella is 
maintained in the caeca by avian Salmonella carriers (Duchet-Suchaux et al., 1995). 
However, transient colonization of salmonellae has also been observed in avian liver and 
spleen (Duchet-Suchaux et al., 1995). Reptiles are probably the largest reservoir of all 
Salmonella subspecies (Briones et al., 2004; Ebani et al., 2005), where they colonize the 
intestinal tract as commensals (Baumler et al., 1998) and are regularly shed with the 
excrement (Geue and Loschner, 2002; Briones et al., 2004; Ebani et al., 2005). 
 
1.5 Epidemiology 
Salmonellosis claims thousands of lives every year and is a global problem (World Health 
Organization, 2005). Despite advanced medical science and improved hygiene, Salmonella 
constitutes a major threat to humans and animals, both in developing and developed 
countries. Approximately 1.4 million human cases of nontyphoidal salmonellosis occur 
annually in the U.S.A. resulting in 400 deaths (Voetsch et al., 2004), and approximately 
200,000 human infections claim ~140 lives per year in Europe (van Lier and Havelaar, 
2007). Infants, children, pregnant women, elderly people and immunocompromised 
patients are at  high risk (Mermin et al., 1997; Hemsworth and Pizer, 2006; Milstone et al., 
2006; Pasmans et al., 2007). The faecal-oral route is the primary means of Salmonella 
transmission (Herikstad et al., 2002; Mead et al., 1999). Transmission is one of the major 
challenges for the animal and food processing industries because outbreaks in humans are 
often linked to the consumption of contaminated meat and food products (World Health 
Organization, 2005; Voetsch et al., 2004). Some of the outbreaks of particular serovars of 
subspecies enterica that occurred in the last two years are listed in Table 1.1. 
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Table 1.1 Salmonella outbreaks occurred in 2006 and 2007. 
Serovar Country Year Source Reference 
Paratyphi B var Java 
 
Sweden, Denmark, 
U.K. 
2007 
 
Baby spinach1 
 
(Denny et al., 2007) 
 
Senftenberg U.K. 2007 Fresh basil (Pezzoli et al., 2007) 
Stanley Sweden 2007 Alfalfa sprouts (Werner et al., 2007) 
Typhimurium 
 
U.S.A. 
 2007 
Milk and 
cheese 
(Centers for Disease Control and 
Prevention, 2007b) 
Weltevreden Scandinavia 2007 Alfalfa sprouts (Emberland et al., 2007) 
Othmarschen South Korea 2007 Catered food (Kim et al., 2007) 
Enteritidis Hungary 2007 Cooked food (Krisztalovics et al., 2007) 
Kedougou Norway 2006 Salami (Emberland et al., 2006) 
Bareilly and Virchow Sweden 2006 Cooked food (de Jong et al., 2007) 
Enteritidis phage type 13a United Kingdom 2006 Eggs (Morgan et al., 2007) 
monophasic 4,[5],12:i:- Luxembourg 2006 Pork1 (Mossong et al., 2007) 
Oranienburg 
 
U.S.A. and Canada 
 
2006 
 
Fruit salad 
 
(Centers for Disease Control and 
Prevention, 2007a) 
Kottbus Spain 2006 Bottled water (Palmera-Suarez et al., 2007) 
Newport, Braenderup and 
Typhimurium 
U.S.A. 
 
2005-
2006 
Tomatoes 
 
(Centers for Disease control and 
Prevention, 2007) 
1Source suspected but was not confirmed 
 
 
Although salmonellosis in humans is often associated with food, numerous cases of reptile-
associated salmonellosis have also been reported in Europe (Geue and Loschner, 2002; 
Willis et al., 2002), Asia (Mahajan et al., 2003; Nakadai et al., 2005), the U.S.A. (Centers 
for Disease Control and Prevention, 2007c), Australia (Thomas et al., 2001) and Canada 
(Woodward et al., 1997). Of the 1.4 million annual cases of Salmonella infection in the 
United States, 6% are acquired from reptiles (Mermin et al., 2004; Voetsch et al., 2004). 
A large proportion of Salmonella infections in humans are caused by serovars belonging to 
subspecies enterica. In the U.S.A. in 2005, the top ten serovars that infected humans were 
Typhimurium, Enteritidis, Newport, Heidelberg, Javiana, 4,[5],12:i:-, Montevideo, 
Muenchen, Saintpaul and Braenderup, all of which belong to subspecies enterica (Centers 
for Disease Control and Prevention, 2006). Enteritidis, Typhimurium, Virchow, Hadar, 
Infantis, Newport, Saintpaul, Typhi, Agona and Stanley were the most prevalent serovars in 
Europe in the years 2000-2006 (European Centre for Disease Prevention and Control, 
2008) and again all belong to subspecies enterica. 
1.6 Other typing schemes for Salmonella 
Serotyping has widely been used for strain identification and routine diagnostics within 
Salmonella but the technique has limitations. The LPS antigens of some of Salmonella 
 8
serovars are cross-reactive with other genus of Enterobacteriaceae, especially Escherichia 
coli, which can lead to false results (Rundlof et al., 1998; Navarro et al., 2007). Serotyping 
groups isolates based on antigenic profiles and does not discriminate within serovars 
between host-restricted strains and others, e.g., within Typhimurium phage types DT2 and 
DT99 are avian-restricted whereas DT104 and DT204 are of broad host range. 
Phage typing can discriminate between closely related strains but its discriminatory abilities 
are limited by the available typing phages and some isolates may not be typeable with this 
technique. Phage typing requires the maintenance of multiple bacteriophages that are 
usually accessible only to reference laboratories (Foley et al., 2007). Furthermore, the 
interpretations of the results require considerable experience. One important aspect of 
phage typing is the long-term reliability of the bacteriophages stocks. Yet, variation among 
archived phage cultures has been observed over time that could possibly be due to host 
specific modifications or recombination with residing prophages in the propagation strains 
(Schmieger, 1999; Rabsch et al., 2004). The phage type of individual strains can also 
change over time possibly due to the loss of prophages, recombination within prophages, 
mutations leading to changes in phage receptors at the cell surface and mutations in 
restriction-modification systems (Rabsch et al., 2004). 
An ideal typing method should be user friendly, easy to interpret, reproducible, economic 
and portable between laboratories. Both serotyping and phage typing are time consuming, 
require considerable technical expertise for interpretation and sometimes show poor 
reproducibility between different laboratories. Various other techniques have been used for 
Salmonella typing to overcome some of these problems, some of which are briefly 
described below: 
1.6.1 Antimicrobial susceptibility typing 
Antimicrobial therapy is often used to treat systemic salmonellosis. Fluoroquinolones have 
been commonly used to treat adults and third generation cephalosporins for children 
(Dunne et al., 2000). A variety of antimicrobial drugs including tetracyclines, penicillins 
and quinolones have traditionally been used for prophylactic and therapeutic purposes or as 
growth supplements for food-animal stocks (Angulo et al., 2004; Fabrega et al., 2008). As 
a consequence, resistance to multiple antimicrobials including fluoroquinolones and 
expanded-spectrum cephalosporins has emerged among salmonellae that counteract 
medical treatment of life threatening invasive Salmonella infections (Gay et al., 2006; 
Angulo et al., 2000; Threlfall et al., 2000). 
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Antimicrobial resistance to a particular drug can be caused by point mutations in the 
chromosomal DNA and/or by the acquisition of mobile genetic elements such as plasmids, 
transposons and integrons (Miko et al., 2005). Resistance to nalidixic acid and reduced 
susceptibility to fluoroquinolones can be mediated by one or more point mutations in the 
quinolone resistance determining region of the chromosomal gyrA gene (Fabrega et al., 
2008). Acquisition of resistance to broad-spectrum cephalosporins is associated with 
plasmid-borne ampC genes which encode β-lactamases that hydrolyze the β-lactam ring of 
these antibiotics (Winokur et al., 2000; Carattoli et al., 2002). 
Resistance of S. enterica to various antibiotics has increased dramatically in the last two 
decades (Threlfall et al., 2000). The widespread dissemination of multi-drug resistant 
(MDR) strains has made it necessary to determine antimicrobial susceptibility patterns in 
order to take proper prophylactic measures (Threlfall et al., 2000). Salmonella isolates are 
tested against a panel of antibiotics either by the disc diffusion or broth micro-dilution 
methods, following standard protocols as recommended by the Clinical and Laboratory 
Standards Institute, U.S.A. (CLSI, formerly known as NCCLS; homepage http://clsi.org/). 
In the disc diffusion method, discs containing known amounts of antimicrobials are placed 
on the agar surface of non-selective media inoculated with the bacterial suspension. A zone 
appears around the disc after the incubation due to growth inhibition by the antimicrobial 
that diffuses into the medium from the discs. The width of the inhibition zones are used to 
classify the isolates as being susceptible, intermediate or resistant to an antimicrobial agent 
according to the break points as suggested by the CLSI (NCCLS, 2002). For the broth-
microdilution method, bacterial suspensions are mixed with non-selective broth and 
dispensed to the wells of a microtiter plate containing different amounts of various 
lyophilized antimicrobial agents. After incubation, the plates are screened for bacterial 
growth, which indicate the minimum inhibitory concentration (MIC in µg/ml) (NCCLS, 
2002). 
The list of antimicrobials that are tested varies from country to country based on prevalence 
patterns of individual antimicrobial resistances. The antimicrobials suggested for testing by 
CLSI include amikacin, ampicillin, amoxicillin-clavulanic acid, cefoxitin, ceftriaxone, 
ceftiofur, cephalothin, cifrofloxacin, chloramphenicol, gentamicin, kanamycin, nalidixic 
acid, streptomycin, sulfamethoxazole, tetracycline, and trimethoprim-sulfamethoxazole 
(NCCLS, 2002). 
Antimicrobial susceptibility typing has been useful for Salmonella surveillance studies. It 
has been widely used to study the emergence and spread of antimicrobial resistance in 
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various Salmonella serovars (Threlfall et al., 2003; Thorsteinsdottir et al., 2007). However, 
antimicrobial sensitivity reflects phenotypic expression and does not allow inferring the 
genetic descent of isolates because similar phenotypic patterns do not necessarily indicate a 
common genetic ancestry (Achtman, 2002). Resistance to a particular antimicrobial by an 
isolate can result by the acquisition of a mobile element from another isolate of a different 
serovar, e.g., resistance to extended spectrum cephalosporins is plasmid borne and can be 
horizontally disseminated between different serovars by conjugation (Dunne et al., 2000; 
Carattoli et al., 2002). 
 
1.6.2 Plasmid profiling 
Plasmids are extra-chromosomal DNA molecules that can encode extra-chromosomal 
virulence and/or antimicrobial resistance (Baker et al., 2007; Hopkins et al., 2008; Carattoli 
et al., 2002). Plasmid profiling was introduced to investigate the epidemiology of 
nosocomial Gram-negative bacilli (Schaberg et al., 1981). Bacterial isolates are examined 
for the presence, number and size of plasmids harboured by them as indicated by the 
patterns of plasmid DNAs after size separation through electrophoresis on an agarose gel. 
Alternatively, plasmids can be digested with restriction enzymes before separation for 
additional resolution (Nauerby et al., 2000). 
The simplicity of agarose gel electrophoresis and the speed of this method have made it one 
of the favourite methods for studying short term epidemiology. Plasmid profiling has been 
used for intra-serovar differentiation and the source identification of Salmonella outbreaks 
(Taylor et al., 1982; Threlfall et al., 1989; Threlfall et al., 1992). However, not all 
Salmonella isolates carry plasmids and plasmid free strains can not be typed by this method 
(Foley et al., 2007). Furthermore, plasmids are unstable genetic markers that can be gained 
or lost. Therefore, plasmid profiling is not suitable for evolutionary studies. Different 
degrees of supercoiling which produce multiple bands can confound the analysis (Foley et 
al., 2007). And although restriction based plasmid profiling can resolve among isolates 
with one or similar numbers of plasmids, the lack of the restriction sites for particular 
enzymes in some plasmids may render them untypeable. 
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1.6.3 Ribotyping 
For ribotyping, genomic DNA is digested with restriction enzymes, separated by gel 
electrophoresis and hybridized to DNA probes for rRNA genes (Wachsmuth et al., 1991). 
Although rRNA genes are highly conserved, they are flanked by variable regions which 
allows discrimination between strains (Bouchet et al., 2008). This approach has been used 
in many epidemiological studies of various subspecies enterica serovars (Esteban et al., 
1993; Liebana, 2002). The method is highly reproducible and can be automated (Foley et 
al., 2007). Multiple restriction enzymes can be used to increase the discriminatory ability of 
the method. 
The method has limited discrimination for some serovars due to a limited number of rRNA 
genes (Foley et al., 2007). 
1.6.4 IS200 typing 
IS200 was identified as a Salmonella specific insertion element that is approximately 700 
bp in size (Lam and Roth, 1983). IS200 typing of Salmonella has been used since 1991 to 
identify evolutionary lineages within phage types of various subspecies enterica serovars 
(Stanley et al., 1991; Liebana, 2002). IS200 typing is based on the copy number and 
location of this insertion element in the Salmonella genome. Genomic DNA is digested 
with one restriction enzyme and the copy number of this insertion element is estimated after 
southern blotting and hybridization to radiolabelled probes (Helmuth and Schroeter, 1994). 
Laborious hybridization has been replaced by IS200-PCR, in which IS200 insertions are 
amplified using outward-facing primers complementary to the ends of IS200 (Millemann et 
al., 2000). The amplified PCR products are separated by agarose gel electrophoresis and the 
patterns are defined based on the size and number of bands. The method is simpler, rapid 
and cheaper than restriction-hybridization based IS200 typing. IS200 typing has been useful 
for epidemiological studies (Liebana, 2002). However, this method can not be used for 
serovars that lack IS200 element, e.g. Hadar (Millemann et al., 2000). 
Restriction–hybridization based methods like IS200 typing and ribotyping depend on the 
restriction enzymes that are used as well as the gene probes. Unfortunately, there is a 
current lack of consensus between different laboratories on which restriction enzymes and 
probes should be used (Threlfall and Peters, 2001; Liebana, 2002). Furthermore, the 
discriminatory power of these methods varies with serovar, preventing their use as a 
general tool for all Salmonella serovars. 
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1.6.5 Pulse field gel electrophoresis (PFGE) 
PFGE was developed to separate DNA molecules of 30-2000 Kb on agarose gels for 
molecular karyotyping of Saccharomyces cerevisiae (Schwartz and Cantor, 1984). In 
PFGE, lysis of bacterial cells and restriction digestion of genomic DNA are carried out 
within agarose plugs in order to prevent shearing and the fragments are separated by 
counter-clamped homogenous electric field gel electrophoresis (Centres for Disease Control 
and Prevention, 2007). This method was introduced to analyze both sporadic and outbreak 
isolates of subspecies enterica serovar Typhi (Thong et al., 1994). PFGE has since been 
extensively used for the detection and investigation of Salmonella outbreaks. Due to the 
high discrimination of strains in comparison to traditional methods like phage typing and 
other restriction based methods, PFGE had become the gold standard for epidemiological 
studies of Salmonella by 2001 (Threlfall and Peters, 2001). A molecular database of PFGE 
profiles of various Salmonella serovars is maintained by Centres for Diseases Control and 
Prevention (CDC), USA that is accessible to epidemiologists and scientists who are the part 
of the PFGE based network PulseNet (Gerner-Smidt et al., 2006). PulseNet has established 
a common protocol for the rapid production of standardized and electronically readable 
fragment patterns. 
PFGE is labour and time intensive and needs expertise in performing the procedure and 
interpreting the results (Foley et al., 2007). Some strains may appear identical following 
analysis with one restriction enzyme; therefore, multiple PFGE runs are required using 
different restriction enzymes for better resolution (Nauerby et al., 2000). 
1.6.6 Random amplified polymorphic DNA (RAPD)  
RAPD is a PCR based method where arbitrary sets of random primers that can bind to the 
genome at multiple sites are used for the amplification. Amplicons of variable size are 
amplified based on the proximity of pairs of such sites and the fragments are separated by 
agarose gel electrophoresis (Hilton et al., 1997; Shangkuan and Lin, 1998). RAPD is easy 
to use, low cost and provides rapid output. The method has been used for strain 
discrimination in various subspecies enterica serovars, including Typhi (Shangkuan and 
Lin, 1998; Liebana, 2002; Yan et al., 2003). 
Low stringency conditions are used for PCR amplification in RAPD and hence, minor 
quantitative differences in PCR components can noticeably alter the banding patterns 
introducing batch to batch variation (Foley et al., 2007). Therefore, the major problem with 
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this method have been the identification of artefacts and a lack of reproducibility (Liebana, 
2002). 
1.6.7 Amplified fragment length polymorphism (AFLP) 
AFLP was introduced as a high resolution combination of restriction digestion and PCR 
amplification (Vos et al., 1995). Genomic DNA is digested by a set of restriction enzymes, 
usually including both a frequent cutter and a rare cutter. The fragments are ligated to DNA 
linkers in order to allow selective amplification with common primers. After amplification, 
the fragments are resolved by high resolution gel electrophoresis. Florescent labelled 
primers can be used for selective amplification and the fragments can be separated by 
automated capillary electrophoresis (Foley et al., 2007). The technique offers high 
reproducibility and resolution and no prior knowledge of DNA sequences is required for 
amplification (Vos et al., 1995; Foley et al., 2007). AFLP has been used as a high 
resolution fingerprinting method for epidemiological studies of Salmonella (Aarts et al., 
1998; Gebreyes and Altier, 2002; Torpdahl and Ahrens, 2004; Torpdahl et al., 2005; 
Gebreyes et al., 2006; Romani et al., 2007). 
Although AFLP provides high level of resolution for inter- and intra-serovar differentiation, 
genetic changes due to nucleotide substitutions will be undetected unless they occur at a 
restriction site (Foley et al., 2007). The sensitivity of the method also depends on the set of 
restriction enzyme used and the lack of a common protocol often leads to variable results. 
1.6.8 Multi-locus variable number of tandem repeats analysis (MLVA) 
Variable number of tandem repeats (VNTR) are a class of repetitive DNA that are variable 
in length and numbers between individual strains (Van Belkum, 1999). These elements are 
both ubiquitous and heterogeneous among prokaryotic species (Van Belkum et al., 1998; 
Van Belkum, 1999), making them a favourite target to study inter-strain polymorphism 
within a species. The availability of genome sequences and computer programs that can 
identify VNTRs have made this method very popular (Ramisse et al., 2004). VNTRs can be 
amplified in a multiplex PCR using florescent labelled primers and can be separated by 
capillary electrophoresis (Lindstedt et al., 2003; Lindstedt et al., 2004). This approach has 
been used for intra-serovar strain differentiation for various Salmonella serovars (Liu et al., 
2003; Lindstedt et al., 2003; Lindstedt et al., 2004; Ramisse et al., 2004; Cho et al., 2007; 
Hopkins et al., 2007). MLVA typing offers reproducibility and high discriminatory power 
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that is comparable to PFGE. The technique is easy to perform and analysis of the results is 
relatively simple (Lindstedt et al., 2004). 
MLVA is particularly useful for outbreak investigations and can distinguish between the 
strains of distinct outbreaks that are associated with a single phage and/or PFGE type 
(Hopkins et al., 2007). Although VNTR profiles were found to be stable during an 
outbreak, small changes have been observed due to insertion or deletion of repeats at 
various loci (Hopkins et al., 2007). VNTRs can evolve very rapidly, resulting in the 
emergence of multiple profiles during an outbreak that can sometimes lead to erroneous 
conclusions. 
1.6.9 DNA-microarrays for Salmonella typing 
Whole genome hybridization to multiple probes has been used to compare the gene content 
among Salmonella isolates at both inter- and intra-serovar levels (Porwollik et al., 2002; 
Boyd et al., 2003; Chan et al., 2003; Porwollik and McClelland, 2003; McClelland et al., 
2004; Porwollik et al., 2004). In subsequently recent analyses, the technique has been based 
on oligonucleotide probes of 20-40 bps that can detect genes encoding antibiotic resistance, 
pathogenicity, fimbriae, phage-associated genes, flagellae (H-antigens) and 
lipopolysacharides (O-antigens) (Malorny et al., 2007; Yoshida et al., 2007; Majtan et al., 
2007). This technique has been suggested as a powerful tool for strain characterization and 
epidemiological studies. A high level of accuracy has been validated by gene specific PCRs 
and other phenotypic methods (Malorny et al., 2007; Majtan et al., 2007). However, 
uncertainties and discordance in results have also been noticed for a small fraction of data 
points (Malorny et al., 2007; Yoshida et al., 2007; Majtan et al., 2007). 
The approach sounds promising for the reliable characterization of strains in comparison to 
other existing techniques. However, current analyses have described only small sample 
sizes from selected serovars. Therefore, the approach still should be validated by testing 
more diverse sets of larger sample size. Furthermore, the technique is expensive and time 
and labour intensive. 
 
In summary, serotyping is the first step of strain identification and primary characterization 
that is followed by other phenotypic methods like phage typing and antimicrobial 
susceptibility typing. Various genotyping techniques are then employed to further 
discriminate strains, such as plasmid profiling, ribotyping, IS200 typing, RAPD, PFGE, 
AFLP and MLVA. These typing methods are particularly useful for outbreak 
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characterization and have variable strengths and limitations. A method should have high 
discriminatory power and reproducibility for strain discrimination and outbreak 
characterization. Multiple methods are usually required to sufficiently discriminate between 
the isolates of a serovar (Foley et al., 2007) because strains that are indistinguishable by 
one method can sometimes be differentiated using others. A typing method should be 
chosen carefully based on the serovar that has to be analyzed. Although the results of 
ribotyping are highly reproducible, only few rRNA genes exist per genome, resulting in 
limited resolution for some serovars (Foley et al., 2007). Methods such as plasmid profiling 
and IS200 typing cannot be used for serovars that lack plasmids and insertion element 
(Millemann et al., 2000; Foley et al., 2007). RAPD offers slightly higher resolution but 
reproducibility has been a major issue (Liebana, 2002). AFLP, MLVA and PFGE provide 
the highest resolution but it is very difficult to currently state which one is best. The 
discriminatory powers of these methods depend on the serovar or phage type (Foley et al., 
2007). However, the powers of these methods can be improved ad hoc by using additional 
restriction enzymes in PFGE and including more loci in MLVA analysis (Foley et al., 
2007). 
1.7 Population genetics approaches 
Several methods such as PFGE, AFLP and MLVA have been used to detect microvariation 
within bacterial populations and outbreak studies (also known as short term or local 
epidemiology). However, these methods may not be suitable to study the relatedness 
amongst the strains from different geographic regions (also called global epidemiology) 
(Maiden et al., 1998). In contrast, techniques that identify neutral variation may be 
preferable for studying the evolution and population structure of a bacterial population 
(Maiden et al., 1998), because rapidly evolving variation usually indicate diversifying 
selection and might not reflect true strain relatedness. 
1.7.1 Multilocus enzyme electrophoresis (MLEE) 
MLEE was a standard method in eukaryotic population genetics that was adapted to study 
evolutionary relationship among different bacterial populations. MLEE identifies slowly 
accumulating variation in metabolic enzymes that is likely to be selectively neutral 
(Selander et al., 1986). In MLEE, metabolic enzymes are subjected to electrophoretic 
separation followed by selective enzyme staining (Selander et al., 1986). The mobilities of 
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enzymes from different isolates are compared and electromorphs (allozymes or mobility 
variants) of each enzyme are assigned allele numbers. An absence of enzyme activity is 
scored as a null allele. Each distinctive combination of alleles is assigned a numeric 
electrophoretic type (ET). 
MLEE depends on differences in electrophoretic mobility that depend on the net 
electrostatic charge which can change with the amino acid sequence. Only changes in 
charged amino acids alter electrophoretic mobility. The data is analyzed by phylogenetic 
and statistical methods to study genetic relatedness among the isolates of a species. MLEE 
was used to study evolution and population structure of various Salmonella serovars in 
1980s and 1990s predominantly by Selander’s group (Beltran et al., 1988; Boyd et al., 
1996; Selander et al., 1992). In 1988, Beltran et al. analyzed isolates of eight most common 
serovars of subspecies enterica and observed strong linkage disequilibrium among the 
enzyme loci, indicating a clonal population structure for the subspecies (Beltran et al., 
1988). Single predominant clones were observed for Choleraesuis, Dublin, Heidelberg and 
Typhimurium whereas multiple evolutionary lineages were reported for serovars Derby, 
Enteritidis, Infantis, and Newport. Isolates of serovar Typhi were genetically 
indistinguishable to each other but distinct from other enterica serovars (Reeves et al., 
1989; Selander et al., 1990b). Three lineages were observed for serovar Paratyphi B, one of 
which contained isolates of diverse biochemical subtypes and was globally distributed 
(Selander et al., 1990a). Isolates of serovars Paratyphi A and Sendai were genetically 
closely related. Serovars Paratyphi C and Panama were monophyletic, i.e. all isolates were 
members of a single predominant clone for each of these serovars (Selander et al., 1990b). 
Multiple evolutionary lineages were observed within serovars Typhisuis and Decatur. Most 
isolates of serovar Dublin were closely related to serovar Enteritidis (Selander et al., 1992). 
However, five atypical isolates of serovar Dublin were more close to isolates of Paratyphi 
B and Agona than other Dublin isolates. 
Each of the S. enterica subspecies was found to represent a distinct group of isolates 
(Reeves et al., 1989). S. bongori that was formerly considered to be a subspecies of S. 
enterica represented a distinct biological species (Reeves et al., 1989). S. enterica was 
proposed to have a clonal population structure due to strong linkage disequilibrium between 
the loci. And the acquisition of genes encoding antigenic determinants by lateral gene 
transfer and recombination was suggested to be the source of occurrence of multiple 
lineages within a serovar (Beltran et al., 1988). 
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Three Salmonella reference collections (SARA, SARB and SARC) were set up based on 
strain characterization by MLEE. SARA, a collection of 72 isolates of serovars 
Typhimurium, Saintpaul, Heidelberg, Paratyphi B and Muenchen, was set up in 1991 that 
represented the full range of genotypic variation in these serovars at that time (Beltran et 
al., 1991). Another collection, SARB, represented the genetic and phenotypic variation 
within all of subspecies enterica. A total of 72 isolates of 37 subspecies enterica serovars 
were chosen to represent 71 distinct ETs (Boyd et al., 1993). Sixteen Salmonella isolates 
that were characterized by MLEE and nucleotide sequencing of five housekeeping and 
seven invasion genes were designated as SARC (Boyd et al., 1996). This collection 
included two representatives from S. bongori and each of the S. enterica subspecies with 
two additional isolates from a biotype of subspecies diarizonae. 
MLEE can distinguish between the subspecies of S. enterica as well as the serovars within 
subspecies enterica. However, the resolution may not be sufficient for short-term 
epidemiology. PFGE has much higher discriminatory powers than MLEE to resolve 
between the strains of a highly uniform serovar like Typhi and would be more appropriate 
for outbreak investigations (Thong et al., 1994). MLEE is based on the loci that are likely 
to be selectively neural and is more suitable for evolutionary studies. However, major 
disadvantages that are associated with MLEE include a lack of reproducibility between 
different laboratories, the need to include standards for all known variants of each enzyme 
locus in every analysis and a lack of globally accessible web-based databases. Finally, 
MLEE cannot detect amino acid polymorphism that does not result in changed charge or 
synonymous sequence changes which are the most frequent source of genetic 
polymorphism. 
1.7.2 Multilocus sequence typing (MLST) 
MLST was developed in 1998 to apply the proven concept of MLEE to DNA sequences, 
i.e. the detection of slowly accumulated sequence variation at selectively neutral loci 
(Maiden et al., 1998). The alleles are directly identified from the nucleotide sequence of the 
fragments (400-600 bp) of housekeeping genes rather than by comparing the 
electrophoretic mobility of metabolic enzymes (Maiden et al., 1998). In an MLST scheme, 
housekeeping genes are selected that are scattered around the bacterial genome. One 
fragment of each housekeeping gene is amplified and sequenced. Every unique sequence is 
given a distinct allele number and each unique combination of alleles is assigned a distinct 
sequence type (ST) number (Maiden et al., 1998). 
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Many drawbacks of MLEE were overcome by MLST. The results are highly reproducible 
and the data are archived in the form of the Web based databases in order to enable easy 
exchange of the information. MLST can be automated for high-throughput. The alleles 
identified by MLST would be far more in numbers in comparison to MLEE because only 
five percent of total genetic changes alter electrophoretic properties of metabolic enzymes 
(Maiden, 2006). The availability of complete genome sequences has been useful for 
designing MLST schemes with rationally chosen genes. The reduction of sequencing costs 
has also facilitated this approach. The approach has extensively been used for a wide range 
of pathogenic and non-pathogenic organisms and led to an improved understanding of the 
evolution and population biology of these organisms (Maiden, 2006). The wide acceptance 
of this approach has resulted in more than 48 MLST schemes for various organisms 
(http://web.mpiib-berlin.mpg.de/mlst/, http://pubmlst.org/ and http://www.mlst.net/). 
Three MLST schemes have been proposed to study the evolutionary relatedness among 
salmonellae. Kotetishvili et al. proposed an MLST scheme in 2002 for Salmonella typing 
that was based on four genes: 16S RNA, phosphomannomutase (manB), glutamine 
synthetase (glnA) and the 1,2-propanediol utilization factor (pduF) (Kotetishvili et al., 
2002). The scheme was designed for the epidemiological investigation of Salmonella 
outbreaks and was found to be more discriminative than PFGE (Kotetishvili et al., 2002). 
Both clinical and environmental Salmonella isolates were analyzed by this scheme and 
various genes were found to be evolving at different rates via different evolutionary 
mechanisms, including recombination (Kotetishvili et al., 2002). However, typing only four 
genes may limit the future use of this scheme for large numbers of isolates. After testing 
twelve loci for meningococcus, seven were chosen to provide sufficient resolution and 
reliable conclusions (Maiden, 2006). Most of MLST schemes are based on 6 to 10 loci 
(Maiden, 2006). 
Another MLST scheme involved the sequencing of five housekeeping namely panB 
(ketopentoate hydroxymethyltransferase), icd (isocitrate dehydrogenase), manB 
(phosphomannomutase), mdh (malate dehydrogenase) and aceK  (isocitrate dehydrogenase 
kinase/phsophatase) and two virulence genes fimA (fimbrial gene A) and spaN (surface 
antigen) (Sukhnanand et al., 2005). Serovar specific STs were observed for various 
subspecies enterica isolates. However, this scheme may have limited implications in 
evolutionary studies of Salmonella because it includes two virulence genes that may be 
under positive selection, making it more suitable for outbreak characterization. The authors 
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also proposed an even more limited three gene subtyping scheme based on manB, fimA and 
mdh for serovar prediction and limited subtype discrimination. 
To study the evolution and population structure of serovar Typhi, a global collection of 
isolates was analyzed by sequencing fragments of seven housekeeping genes, aroC 
(chorismate synthase), dnaN (DNA polymerase III beta subunit), hemD (uroporphyrinogen 
III cosynthase), hisD (histidinol dehydrogenase), purE (phosporibosylaminoimidazole 
carboxylase), sucA (α-ketoglutarate dehydrogense) and thrA (aspartokinase and homoserine 
dehydrogenase) (Kidgell et al., 2002). All the Typhi isolates were genetically uniform, 
suggesting that they descended from a common ancestor 15,000-150,000 years ago 
(Kidgell et al., 2002). The genome of Typhi strain CT18 was used for selecting the seven 
housekeeping genes that are scattered around the genome and they encode the metabolic 
enzymes that are unlikely to be under diversifying selection (Kidgell et al., 2002). 
The scheme fits the requirement of a standard MLST scheme and was later adapted to all 
Salmonella (Torpdahl et al., 2005). Subspecies enterica isolates from humans and 
veterinary sources were analyzed by this scheme and the results were compared to those of 
PFGE and AFLP. Although a consistency was observed among the genetic trees on the data 
generated by the three methods, PFGE and AFLP were found to be more discriminatory 
(Torpdahl et al., 2005). Similar conclusion was reached when isolates of serovar Newport 
were analyzed by this MLST scheme, PFGE and antimicrobial susceptibility typing, 
indicating that this scheme may have limited implications for epidemiological 
investigations (Harbottle et al., 2006). MLST data has also been used to infer the evolution 
and speciation in Salmonella (Falush et al., 2006). Recombination was found to be 
significant within subspecies enterica. However, genetic exchanges between subspecies 
enterica and other subspecies as well as S. bongori has been rare (Falush et al., 2006). 
Although sequential splitting of all the subspecies from a common ancestor was not 
completely discerned, they seem to have diverged by multiple speciation events and 
correspond to genetically distinct biological groups (Falush et al., 2006). This scheme has 
been widely accepted by many members of the Salmonella community (Torpdahl et al., 
2005; Harbottle et al., 2006; Falush et al., 2006), resulting in > 2350 Salmonella strains and 
> 500 STs on the Salmonella MLST website (http://web.mpiib-
berlin.mpg.de/mlst/dbs/Senterica). 
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1.8 Population structure 
In a bacterial population, clones are defined as groups of genetically indistinguishable 
isolates that are asexually descended from a common ancestor (Spratt, 2004). Most of the 
genetic variation in these groups is introduced by mutation events rather than 
recombination, resulting in a low recombination-mutation rate ratio (Hanage et al., 2006; 
Turner et al., 2007). The population structure of most of bacterial species was thought to be 
clonal (Achtman et al., 1983; Selander et al., 1987) until 1993 when Maynard-Smith et al. 
showed that they could vary from strictly clonal to highly sexual (Maynard Smith et al., 
1993). S. enterica was thought to have a clonal population structure as demonstrated by 
high values of linkage disequilibrium on MLEE data whereas Neisseria gonorrhoeae was 
found to be highly sexual (Maynard Smith et al., 1993). Clonal population structures have 
also been reported in genetically monomorphic species like Mycobacterium tuberculosis 
(Baker et al., 2004) and subspecies enterica serovar Typhi (Roumagnac et al., 2006). These 
organisms are designated genetically monomorphic because they harbour very low levels of 
nucleotide diversity. But genetically monomorphic populations should be distinguished 
from clonal populations because it would be difficult to estimate true recombination rates in 
a monomorphic population due to the low levels of nucleotide diversity. 
A clonal population structure was deduced for S. enterica by researchers in 1980s and 
1990s based on MLEE where each distinct serovar evolved from a single or a few 
predominant clones (Selander et al., 1990b; Beltran et al., 1988; Selander et al., 1994; 
Reeves et al., 1989). However, recent studies demonstrated that homologous recombination 
has been the major source of variation among the housekeeping genes within subspecies 
enterica (Brown et al., 2003; Octavia and Lan, 2006; Falush et al., 2006). The phylogenetic 
trees based on nucleotide sequences found to be incongruent for some of housekeeping 
genes (Brown et al., 2003; Octavia and Lan, 2006). A mosaic pattern of ancestry and 
substantial allele sharing between different clades of the phylogenetic tree of subspecies 
enterica indicated significant recombination within this subspecies (Falush et al., 2006). 
Homologous recombination led to the similarity of gene content and nucleotide divergence 
in a quarter of genome of Typhi and Paratyphi A, two subspecies enterica serovars (Didelot 
et al., 2007). Therefore, due to significant levels of detectable recombination, phylogenetic 
approaches may not be suitable to study evolutionary relatedness within subspecies 
enterica. 
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Homologous recombination and lateral gene transfer played the key role in the evolution of 
Salmonella genome (Porwollik et al., 2002; Porwollik and McClelland, 2003; Porwollik et 
al., 2004). Almost a quarter of the Typhimurium genome seems to have acquired by lateral 
gene transfer after the divergence from Escherichia coli. However, most of these 
acquisitions confer virulence and host specificity (Porwollik and McClelland, 2003). 
Although recombination found to be significant within subspecies enterica, genetic 
exchange between enterica and other subspecies is rare (Falush et al., 2006). The studies 
based on the nucleotide sequences of six housekeeping genes on SARC collection also 
demonstrated recombination to be rare between subspecies enterica and other subspecies 
(Nelson et al., 1991; Nelson and Selander, 1992; Boyd et al., 1994; Nelson and Selander, 
1994; Wang et al., 1997; Nelson et al., 1997). However, phylogenetic incongruence has 
been observed for some of the housekeeping genes using more sophisticated analyses 
(Brown et al., 2002). Recombination and lateral gene transfer is the major source of 
variation among genes coding for lipopolysaccharide and flagellar antigens in Salmonella 
and is also responsible for the occurrence of multiple distinct lineages within a serovar (Li 
et al., 1994; Selander et al., 1994; Xiang et al., 1994). 
1.9 Research goals 
S. enterica subsp. enterica serovar Newport (henceforth referred to as Newport) has 
emerged as one of the major human and animal pathogen in recent years. However, limited 
efforts have been made to study the population structure of this serovar (Beltran et al., 
1988; Sukhnanand et al., 2005; Harbottle et al., 2006). Newport was found to have evolved 
in two lineages by a MLEE study, one associated to humans and the second to animals 
(Beltran et al., 1988). Similarly, two distinct populations were identified for Newport by 
studies based on two different MLST schemes (Sukhnanand et al., 2005). However, these 
conclusions were based on a small number of isolates. Therefore, I analyzed 384 Newport 
isolates to study the evolution and population structure of serovar Newport, as the first 
objective of my thesis. 
1-5% of the patients with Salmonella infection become chronic carriers (D'Aoust, 1991; 
Gupta et al., 2006). Asymptomatic Salmonella carriers are a potential threat to the healthy 
community, especially those associated with food handling (Ollinger-Snyder and 
Matthews, 1996; Gupta et al., 2006). It has not yet been determined whether salmonellae 
from chronic human carriers are the same as those isolated from non-carrier hosts. For the 
second objective of my thesis, I analyzed 47 isolates from human carriers and compared the 
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MLST data with that of 1015 isolates from non-carrier humans and animals of the same 
serovars. 
Host associated subtypes have been identified for various subspecies enterica serovars 
(Alcaine et al., 2006; Cho et al., 2007; Rabsch et al., 2002). Although reptiles are one of 
the largest sources of Salmonella, they have been overlooked because most of these studies 
focused on isolates from humans and domesticated animals. I analyzed 137 subspecies 
enterica isolates belonging to 23 serovars that were isolated from reptiles for the third 
objective of my thesis. MLST data was compared with that of isolates from humans and 
non-human warm blooded animals of the same serovars to study whether the clonal 
diversity in subspecies enterica is associated with host categories. 
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2. Materials 
2.1 Equipments and consumables 
The names and addresses of the companies, list of chemicals, enzymes and kits, other 
consumables and equipments used in this study are summarized in Tables 2.1-2.4. 
Table 2.1. Names and addresses of companies 
Company Address 
ABgene Epsom, United Kingdom 
AccuMed International Limited East Grinstead, UK 
Alcatel Annecy, France 
Applied Biosystems Foster City, California, USA 
Bender and Hobinag Zurich, Switzerland 
BioRad Laboratories Richmond, California, USA 
Calbiochem San Diego, California, USA 
Carl Roth GmbH Karlsruhe, Germany 
Corning Incorporated  New York, U.S.A 
Difco Laboratories Detroit, Michigan, USA 
Eppendorf Hamburg, Germany 
Fermentas Burlington, Ontario, Canada 
Genomed GmbH Loehne, Germany 
GFL Burgwedel, Germany 
Heraeus Instruments Hanau, Germany 
IKA-WERK GmbH & Co. KG Staufen, Germany 
INFROS HT Bottmingen, Switzerland 
Invitrogen Carlsbad, California, USA 
Jouan SA St. Herblain, France 
LEGACI Refrigeration Systems Asheville, North Carolina, USA 
Merck Darmstadt, Germany 
Mettler Waagen GmbH Gissen, Germany 
Molecular Devices Sunnyvale, California, USA 
MPIMG Berlin, Germany 
Nunc Roskilde, Denmark  
Oxoid Cambridge, UK 
Pharmacia Biotech Uppsala, Sweden 
Sartorius AG Goettingen, Germany 
SIGMA-ALDRICH Chemie GmbH Steinheim, Germany 
Trek Diagnostics Systems Limited West Sussex, UK 
USB corporation Cleveland, Ohio, USA 
Table 2.2. List of reagents, kits and enzymes 
Chemicals/Kits/enzymes Catalogue no. Company 
Acetic acid 1.00063.2500 Merck 
Antimicrobial discs Amikacin CT0107B Oxoid 
Antimicrobial discs Cephalothin CT0010B Oxoid 
Antimicrobial discs Cefoxitin CT0119B Oxoid 
Antimicrobial discs Ceftriaxone CT0417B Oxoid 
Agarose R0491 Fermentas 
Bacto- yeast extract 0127-01-7 Difco Laboratories 
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Table 2.2 continued… 
Kits/Reagents/enzymes Catalogue no. Company 
Bacto-Tryptone 0123-01 Difco Laboratories 
Bacto-Agar 0140-01 Difco Laboratories 
Big dye terminator v 3.1 kit 4337958 Applied Biosystems 
Bromophenol blue 1.01895.0010 Merck 
Di-sodium hydrogem phosphate 1.06580.1000 Merck 
DNA extraction Kit (JetFlex) 600500 Genomed GmbH 
DNA polymerase  MPIMG 
EDTA 1.08418 Merck 
Ethidium bromide 331565 Calbiochem 
Ethyl alcohol 1.00983.2511 Merck 
Exonuclease I 70073X USB 
Hi Di formamide 4311320 Applied Biosystems 
Iso-propanol 9866-1 Carl Roth GmbH 
Magnesium chloride 5833 Merck 
Microtitre plates with antimicrobials NLMV1A Trek Diagnostics Systems Ltd. 
Molecular weight marker 10787-018 Invitrogen 
Mono-potassium phosphate 1.04873.1000 Merck 
Müller-Hinton agar CM0337 Oxoid 
Müller-Hinton broth CM0405 Oxoid 
Potassium chloride 4936-1000 Merck 
Shrimp Alkaline Phosphatase 70092Y USB 
Skimmed milk 0032-01-1 Difco Laboratories 
Sodium acetate 6268 Merck 
Sodium chloride 1.06404.5000 Merck 
Sodium hydroxide 1.06495.1000 Merck 
Sucrose 7653 Merck 
Tris 1.08382.1000 Merck 
Trizma base T-1503 SIGMA-ALDRICH Chemie GmbH 
Trizma hydrochloride T-3253 SIGMA-ALDRICH Chemie GmbH 
Table 2.3 Other consumables 
Other consumables Catalogue no. Company 
Glass beads (Ф=2.8-3.3 mm) A557.1 Carl Roth GmbH 
Pasteur pipettes A4522.1 Carl Roth GmbH 
Cryo-tubes (1.8 ml) 375418 Nunc GmbH & Co. 
96-well propylene microplates Costar-6551 Corning Incorporation 
96-well PCR plate AB-0600 ABgene 
96-deep well plate (2 ml) Costar-3960 Corning Incorporation 
Plate sealing film AB-0558 ABgene 
Table 2.4. Equipments 
Equipment Model Company 
Centrifuge 5810R Eppendorf 
Centrifuge 5415D Eppendorf 
Deep freezer (-80°C) Ultima II LEGACI Refrigeration Systems 
DNA analyzer ABI PRISM 3730 Applied Biosystems 
Electrophoresis unit  MPIMG workshop 
(Power supply & gel chambers)  
Gel documentation system Gel Doc 2000 BioRad Laboratories 
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Table 2.4 continued … 
Equipment Model Company 
Incubation oven B6120 Heraeus Instruments 
Incubation shaker RS-T INFROS HT 
Laminar airflow Herasafe Plus HS15 Heraeus Instruments 
Laminar airflow Herasafe HS12 Heraeus Instruments 
Magnetic Stirrer IKAMEG RET-G IKA-WERK GmbH & Co. KG 
Sensititre autoinoculator INO2 Trek Diagnostics Systems Ltd. 
SensiTouch system  AccuMed International Ltd. 
Spectrophotometer SpectraMax 190 Molecular Devices 
Spectrophotometer GeneQuant Pharmacia Biotech 
Thermocycler MJ Research PTC225 BioRad Laboratories 
Vaccume centrifuge RC10.22 Jouan SA 
Vaccume pump PASCAL 2005SD ALCATEL 
Vortex K550GE Bender and Hobinag 
Waterbath 1001 GFL 
Weighing machine BP2100S Sartorius AG 
Weighing machine PE360 Mettler Waagen GmbH 
2.2 Bacterial strains 
Salmonella isolates analyzed for various research goals are summarized in Tables 2.5-2.8. 
2.3 Oligonucleotides 
List of the primers that were used for the amplification and sequencing of gene fragments 
are mentioned in Table 2.9. 
2.4 Media and solutions 
LB medium 
10 g Bacto-tryptone, 5 g yeast extract and 10 g NaCl were dissolved in 900 ml of distilled 
water. The pH was adjusted to 7.0 using 1 M NaOH. Final volume was adjusted to 1 litre 
using distilled water. The medium was sterilized by autoclaving. 
LB agar was prepared by adding 15 g of bacto-agar to above preparation before adjusting 
the final volume to 1 litre while for semisolid LB agar only 7 g of bacto-agar was used. 
 
10X PCR buffer 
500 mM KCl, 100 mM Tris (pH 8.3 at 25°C), 15 mM MgCl2 and 0.01% gelatine 
 
5X sequencing buffer 
400 mM Tris (pH 9.0 at 25°C) and 10 mM MgCl2 
 26
Table 2.5. List of Newport isolates 
Z No. DNANo. StrainID Subspecies Serotype Host Source Country ST Year Continent 
10934 4277 73-2008 I Newport Human W. Rabsch Germany 166 1973 Europe 
10936 4278 74-25 I Newport Human W. Rabsch Germany 45 1974 Europe 
10938 4279 74-101 I Newport Human W. Rabsch Germany 45 1974 Europe 
10940 4280 74-123 I Newport Human W. Rabsch Germany 31 1974 Europe 
10942 4281 74-141 I Newport Human W. Rabsch Germany 45 1974 Europe 
10944 4282 74-205 I Newport Human W. Rabsch Germany 118 1974 Europe 
10946 4283 74-431 I Newport Human W. Rabsch Germany 166 1974 Europe 
10948 4284 74-435 I Newport Human W. Rabsch Germany 166 1974 Europe 
10950 4285 74-165b I Newport Human W. Rabsch Germany 166 1974 Europe 
10952 4286 74-187 I Newport Human W. Rabsch Germany 166 1974 Europe 
10954 4287 75-588 I Newport Human W. Rabsch Germany 118 1975 Europe 
10956 4288 75-589 I Newport Human W. Rabsch Germany 118 1975 Europe 
10958 4289 75-702 I Newport Human W. Rabsch Germany 45 1975 Europe 
10960 4290 75-1231 I Newport Human W. Rabsch Germany 46 1975 Europe 
10962 4291 75-1261 I Newport Human W. Rabsch Germany 31 1975 Europe 
10964 4292 76-19 I Newport Human W. Rabsch Germany 45 1976 Europe 
10966 4293 76-1725 I Newport Human W. Rabsch Germany 45 1976 Europe 
10968 4294 76-1726 I Newport Human W. Rabsch Germany 46 1976 Europe 
10970 4295 76-1758 I Newport Human W. Rabsch Germany 31 1976 Europe 
10972 4296 76-1779 I Newport Human W. Rabsch Germany 46 1976 Europe 
10974 4297 76-1795 I Newport Human W. Rabsch Germany 46 1976 Europe 
10976 4298 76-1821 I Newport Human W. Rabsch Germany 46 1976 Europe 
10978 4299 76-1896 I Newport Human W. Rabsch Germany 46 1976 Europe 
10980 4300 74-445 I Newport Human W. Rabsch Germany 46 1974 Europe 
10982 4301 76-2016 I Newport Human W. Rabsch Germany 46 1976 Europe 
10984 4302 76-2063 I Newport Human W. Rabsch Germany 46 1976 Europe 
10986 4331 99-8496 I Newport Human W. Rabsch Germany 158 1999 Europe 
10988 4304 00 5187 I Newport Human W. Rabsch Germany 167 2000 Europe 
10990 4305 00 6045 I Newport Human W. Rabsch Germany 156 2000 Europe 
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Table 2.5 continued… 
Z No. DNANo. StrainID Subspecies Serotype Host Source Country ST Year Continent 
10992 4306 00 6775 I Newport Human W. Rabsch Germany 118 2000 Europe 
10994 4307 01-3000 I Newport Human W. Rabsch Germany 45 2001 Europe 
10996 4308 01-6102 I Newport Human W. Rabsch Germany 46 2001 Europe 
10998 4309 02-1789 I Newport Chicken W. Rabsch Germany 31 2002 Europe 
11000 4310 02-5961 I Newport Human W. Rabsch Germany 163 2002 Europe 
11002 4311 02-6778 I Newport Human W. Rabsch Germany 167 2002 Europe 
11004 4312 02-9281 I Newport Poultry W. Rabsch Germany 166 2002 Europe 
11006 4313 02-9460 I Newport Human W. Rabsch Germany 166 2002 Europe 
11008 4332 02-10269 I Newport Human W. Rabsch Germany 166 2002 Europe 
11010 4333 03-558 I Newport Meat W. Rabsch Germany 166 2003 Europe 
11012 4334 03-788 I Newport Animalfeed W. Rabsch Germany 157 2003 Europe 
11014 4335 03-2193 I Newport Human W. Rabsch Germany 166 2003 Europe 
11016 4336 03-4162 I Newport Human W. Rabsch Germany 118 2003 Europe 
11018 4319 03-7424 I Newport Food W. Rabsch Germany 165 2003 Europe 
11020 4320 03-7713 I Newport food W. Rabsch Germany 46 2003 Europe 
11022 4321 03-8520 I Newport Human W. Rabsch Germany 118 2003 Europe 
11024 4322 04-127 I Newport Human W. Rabsch Germany 45 2004 Europe 
11026 4323 04-5845 I Newport Fertilizer W. Rabsch Germany 166 2004 Europe 
11028 4324 04-7663 I Newport Human W. Rabsch Germany 166 2004 Europe 
11030 4325 05-914 I Newport Human W. Rabsch Germany 31 2005 Europe 
11032 4326 05-1812 I Newport Human W. Rabsch United Kingdom 164 2005 Europe 
11306 4207 SARB36 I Newport Human F. Boyd USA 5  North America 
11308 4208 SARB37 I Newport Human F. Boyd Mexico 31  North America 
11310 4209 SARB38 I Newport Snake F. Boyd USA 46 1987 North America 
11484 4489 98-00280 I Newport Snake R. Helmuth Germany 45 1997 Europe 
11486 4490 98-00499 I Newport Reptile R. Helmuth Germany 45 1998 Europe 
11488 4491 98-02541 I Newport TigerPython R. Helmuth Germany 46 1998 Europe 
11490 4492 98-02865 I Newport Snake R. Helmuth Germany 118 1998 Europe 
11492 4493 98-02915 I Newport Tortoise R. Helmuth Germany 118 1998 Europe 
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Table 2.5 continued… 
Z No. DNANo. StrainID Subspecies Serotype Host Source Country ST Year Continent 
11494 4494 01-00182 I Newport CornSnake R. Helmuth Germany 118 2000 Europe 
11496 4495 01-00350 I Newport GarterSnake R. Helmuth Germany 118 2001 Europe 
11498 4496 01-02029 I Newport Turtle R. Helmuth Germany 118 2001 Europe 
11500 4497 01-03113 I Newport Python R. Helmuth Germany 46 2001 Europe 
11502 4498 02-00184 I Newport Blood Python R. Helmuth Germany 46 2002 Europe 
11504 4499 02-01825 I Newport Snake R. Helmuth Germany 118 2002 Europe 
11506 4500 03-01771-2 I Newport Colubrid Snake R. Helmuth Germany 118 2003 Europe 
11508 4501 04-00451 I Newport Snake R. Helmuth Germany 46 2004 Europe 
11510 4502 04-02663 I Newport Reticulated Python R. Helmuth Germany 45 2004 Europe 
11512 4503 05-00763 I Newport Snake R. Helmuth Germany 45 2005 Europe 
11514 4504 05-00842 I Newport Snake R. Helmuth Germany 118 2005 Europe 
11516 4505 05-01286 I Newport Gecko R. Helmuth Germany 45 2005 Europe 
11518 4506 05-01730 I Newport Reptile R. Helmuth Germany 184 2005 Europe 
11520 4507 05-01897 I Newport King Snake R. Helmuth Germany 118 2005 Europe 
11522 4508 05-01994 I Newport Snake R. Helmuth Germany 118 2005 Europe 
11785 4652 00 7093 I Newport Human F-X. Weill France 45 2000 Europe 
11787 4653 00 7325 I Newport Human F-X. Weill France 45 2000 Europe 
11789 4654 00 3525 I Newport Human F-X. Weill France 45 2000 Europe 
11791 4655 00 3767 I Newport Human F-X. Weill France 45 2000 Europe 
11793 4656 02 7891 I Newport Human F-X. Weill France 45 2002 Europe 
11795 4657 00 3784 I Newport Human F-X. Weill France 45 2000 Europe 
11797 4658 00 4165 I Newport Human F-X. Weill France 45 2000 Europe 
11799 4659 00 5089 I Newport Human F-X. Weill France 45 2000 Europe 
11801 4660 01 2288 I Newport Human F-X. Weill France 45 2001 Europe 
11803 4661 04 9597 I Newport Human F-X. Weill France 45 2004 Europe 
11805 4662 03 8748 I Newport Human F-X. Weill France 118 2003 Europe 
11807 4663 03 3184 I Newport Human F-X. Weill France 45 2003 Europe 
11809 4664 03 3349 I Newport Human F-X. Weill France 45 2003 Europe 
11811 4665 03 5145 I Newport Human F-X. Weill France 45 2003 Europe 
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Table 2.5 continued… 
Z No. DNANo. StrainID Subspecies Serotype Host Source Country ST Year Continent 
11813 4666 03 6521 I Newport Human F-X. Weill France 45 2003 Europe 
11815 4667 03 7338 I Newport Human F-X. Weill France 45 2003 Europe 
11817 4668 03 9969 I Newport Human F-X. Weill France 45 2003 Europe 
11819 4669 05 2439 I Newport Human F-X. Weill France 166 2005 Europe 
11821 4670 00 6147 I Newport Human F-X. Weill France 166 2000 Europe 
11823 4671 00 4093 I Newport Human F-X. Weill France 156 2000 Europe 
11825 4672 00 8034 I Newport Human F-X. Weill France 166 2000 Europe 
11827 4673 01 9032 I Newport Human F-X. Weill France 166 2001 Europe 
11829 4674 04 1701 I Newport Human F-X. Weill France 132 2004 Europe 
11831 4675 00 0448 I Newport Human F-X. Weill France 166 2000 Europe 
11833 4676 04 8765 I Newport Human F-X. Weill France 166 2004 Europe 
11835 4677 01 2174 I Newport Human F-X. Weill France 156 2001 Europe 
11837 4678 01 5348 I Newport Human F-X. Weill France 156 2001 Europe 
11839 4679 04 3489 I Newport Human F-X. Weill France 156 2004 Europe 
11841 4680 03 5595 I Newport Human F-X. Weill France 156 2003 Europe 
11843 4681 03 3813 I Newport Human F-X. Weill France 31 2003 Europe 
11845 4682 03 6344 I Newport Human F-X. Weill France 46 2003 Europe 
11847 4683 03 7463 I Newport Human F-X. Weill France 46 2003 Europe 
11849 4684 04 1198 I Newport Human F-X. Weill France 31 2004 Europe 
11851 4685 04 1534 I Newport Human F-X. Weill France 45 2004 Europe 
11853 4686 04 2006 I Newport Human F-X. Weill France 45 2004 Europe 
11855 4687 04 2417 I Newport Human F-X. Weill France 46 2004 Europe 
11857 4688 04 2487 I Newport Human F-X. Weill France 166 2004 Europe 
11859 4689 04 3976 I Newport Human F-X. Weill France 45 2004 Europe 
11861 4690 04 4849 I Newport Human F-X. Weill France 118 2004 Europe 
11863 4691 00 2611 I Newport Human F-X. Weill France 45 2000 Europe 
11867 4693 408 I Newport Human F-X. Weill Madagascar 31 1948 Africa 
11869 4694 FW4-51 I Newport Human F-X. Weill France 118 1951 Europe 
11871 4695 FW8-52 I Newport Human F-X. Weill Madagascar 31 1948 Africa 
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Table 2.5 continued… 
Z No. DNANo. StrainID Subspecies Serotype Host Source Country ST Year Continent 
11873 4696 FW50-3 I Newport Human F-X. Weill Vietnam 31 1946 Asia 
11875 4697 Barcelone/34 I Newport Pig F-X. Weill Spain 46 1953 Europe 
11877 4698 FW23-56 I Newport Human F-X. Weill Vietnam 46 1956 Asia 
11879 4699 FW10-56 I Newport Snake F-X. Weill Vietnam 46 1952 Asia 
11881 4700 FW16-56 I Newport Gecko F-X. Weill Vietnam 46 1952 Asia 
11883 4701 FW18-56 I Newport Gecko F-X. Weill Vietnam 46 1952 Asia 
11885 4702 FW24-56 I Newport Human F-X. Weill Tunisia 46 1956 Africa 
11887 4703 FW13-56 I Newport Human F-X. Weill Vietnam 46 1952 Asia 
11889 4704 404 I Newport Pig F-X. Weill Madagascar 31 1944 Africa 
11891 4705 411 I Newport Rat F-X. Weill Madagascar 31 1948 Africa 
11893 4706 FW6-52 I Newport Human F-X. Weill Congo 31 1952 Africa 
11895 4707 FW8-56 I Newport Turtle F-X. Weill Vietnam 46 1956 Asia 
11897 4708 FW9-57 I Newport Human F-X. Weill Belgium 46 1957 Europe 
11899 4709 FW2-58 I Newport Turtle F-X. Weill Morocco 211 1958 Africa 
11901 4710 FW6-58 I Newport Turtle F-X. Weill Morocco 46 1958 Africa 
11903 4711 FW7-58 I Newport Human F-X. Weill France 118 1958 Europe 
11905 4712 FW12-58 I Newport Human F-X. Weill Algeria 118 1958 Africa 
11907 4713 FW1-59 I Newport Human F-X. Weill France 46 1959 Europe 
11909 4714 FW3-59 I Newport Human F-X. Weill Ethiopia 31 1959 Africa 
11911 4715 FW6-60 I Newport Human F-X. Weill Tunisia 118 1956 Africa 
11913 4716 FW7-61 I Newport Chameleon F-X. Weill Madagascar 46 1957 Africa 
11915 4717 FW18-61 I Newport Human F-X. Weill France 118 1957 Europe 
11917 4718 FW3-64 I Newport Food F-X. Weill France 46 1964 Europe 
11919 4719 FW5-64 I Newport Human F-X. Weill France 31 1964 Europe 
11921 4720 FW9-64 I Newport Food F-X. Weill France 118 1960 Europe 
11923 4721 FW39-64 I Newport Horse F-X. Weill France 166 1960 Europe 
11925 4722 FW8-65 I Newport Human F-X. Weill France 166 1965 Europe 
11927 4723 FW26-65 I Newport Food F-X. Weill France 118 1961 Europe 
11929 4724 FW33-65 I Newport Human F-X. Weill Romania 166 1965 Europe 
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Table 2.5 continued… 
Z No. DNANo. StrainID Subspecies Serotype Host Source Country ST Year Continent 
11931 4725 FW9-66 I Newport Lion F-X. Weill Venezuela 45 1962 South America 
11933 4726 FW10-66 I Newport Chicken F-X. Weill Venezuela 45 1962 South America 
11935 4727 FW19-66 I Newport Human F-X. Weill Thailand 46 1966 Asia 
11937 4728 FW20-66 I Newport Human F-X. Weill Greece 31 1962 Europe 
11939 4729 FW8-67 I Newport Pig F-X. Weill Brazil 31 1962 South America 
11941 4730 50K I Newport Human F-X. Weill France 31 1918 Europe 
11943 4731 FW15-65 I Newport Human F-X. Weill Madagascar 46 1965 Africa 
12441 4974 SGSC4157 I Newport  S. Porwollik  375   
12443 4975 SGSC4910 I Newport  S. Porwollik  45   
12445 4976 SGSC4911 I Newport  S. Porwollik  5   
12167 4840 3240    I Newport  Human carrier R. Curtiss Germany 166 1985 Europe  
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Table 2.6. List of isolates from human carriers 
Z No. DNA No. Strain ID Subspecies Serotype Host Source Country  ST Year Continent 
12139 4826 3225    I Virchow  Human carrier R. Curtiss Germany 16 1985 Europe  
12141 4827 3226    I Infantis Human carrier R. Curtiss Germany 32 1985 Europe  
12143 4828 3228    I Bovismorbificans Human carrier R. Curtiss Germany 142 1985 Europe  
12145 4829 3229    I Anatum Human carrier R. Curtiss Germany 64 1985 Europe  
12147 4830 3230    I Hadar  Human carrier R. Curtiss Germany 33 1985 Europe  
12149 4831 3231    I Infantis Human carrier R. Curtiss Germany 32 1985 Europe  
12151 4832 3232    I Anatum Human carrier R. Curtiss Germany 64 1985 Europe  
12153 4833 3233    I Bovismorbificans Human carrier R. Curtiss Germany 142 1985 Europe  
12155 4834 3234    I Paratyphi B var Java Human carrier R. Curtiss Germany 88 1985 Europe  
12161 4837 3237    I Enteritidis  Human carrier R. Curtiss Germany 11 1985 Europe  
12163 4838 3238    I Manhattan  Human carrier R. Curtiss Germany 18 1985 Europe  
12165 4839 3239    I Ohio Human carrier R. Curtiss Germany 329 1985 Europe  
12169 4841 3241    I Manhattan  Human carrier R. Curtiss Germany 18 1985 Europe  
12171 4842 3242    I Heidelberg Human carrier R. Curtiss Germany 15 1985 Europe  
12173 4843 3187    I Typhimurium  Human carrier R. Curtiss Germany 19 1985 Europe  
12175 4844 3188    I Typhimurium  Human carrier R. Curtiss Germany 19 1985 Europe  
12177 4845 3189    I Typhimurium  Human carrier R. Curtiss Germany 19 1985 Europe  
12179 4846 3190    I Typhimurium  Human carrier R. Curtiss Germany 19 1985 Europe  
12181 4847 3192    I Typhimurium  Human carrier R. Curtiss Germany 19 1985 Europe  
12183 4848 3193    I Typhimurium  Human carrier R. Curtiss Germany 19 1985 Europe  
12185 4849 3194    I Typhimurium  Human carrier R. Curtiss Germany 19 1985 Europe  
12187 4850 3195    I Typhimurium  Human carrier R. Curtiss Germany 19 1985 Europe  
12189 4851 3196    I Typhimurium  Human carrier R. Curtiss Germany 19 1985 Europe  
12191 4852 3197    I Typhimurium  Human carrier R. Curtiss Germany 19 1985 Europe  
12193 4853 3198    I Typhimurium  Human carrier R. Curtiss Germany 19 1985 Europe  
12195 4854 3199    I Typhimurium  Human carrier R. Curtiss Germany 19 1985 Europe  
12197 4855 3200    I Typhimurium  Human carrier R. Curtiss Germany 19 1985 Europe  
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Table 2.6 continued… 
Z No. DNA No. Strain ID  Subspecies Serotype Host Source Country  ST Year Continent 
12199 4856 3201    I Agona  Human carrier R. Curtiss Germany 13 1985 Europe  
12203 4858 3203    I Anatum Human carrier R. Curtiss Germany 64 1985 Europe  
12205 4859 3204    I Braenderup Human carrier R. Curtiss Germany 22 1985 Europe  
12207 4860 3205    I Brandenburg  Human carrier R. Curtiss Germany 20 1985 Europe  
12209 4861 3206    I Bredeney Human carrier R. Curtiss Germany 241 1985 Europe  
12213 4863 3208    I Derby  Human carrier R. Curtiss Germany 39 1985 Europe  
12215 4864 3209    I Hadar Human carrier R. Curtiss Germany 33 1985 Europe  
12217 4865 3210    I Hadar  Human carrier R. Curtiss Germany 368 1985 Europe  
12221 4867 3212    I Heidelberg Human carrier R. Curtiss Germany 15 1985 Europe  
12223 4868 3213    I Infantis Human carrier R. Curtiss Germany 32 1985 Europe  
12225 4869 3214    I Infantis Human carrier R. Curtiss Germany 32 1985 Europe  
12231 4872 3217    I Montevideo Human carrier R. Curtiss Germany 138 1985 Europe  
12233 4873 3218    I Ohio Human carrier R. Curtiss Germany 329 1985 Europe  
12235 4874 3219    I Ohio Human carrier R. Curtiss Germany 329 1985 Europe  
12237 4875 3220    I Panama Human carrier R. Curtiss Germany 48 1985 Europe  
12239 4876 3221    I Panama Human carrier R. Curtiss Germany 48 1985 Europe  
12241 4877 3222    I Schwarzengrund Human carrier R. Curtiss Germany 96 1985 Europe  
12243 4878 3223    I Thompson Human carrier R. Curtiss Germany 26 1985 Europe  
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Table 2.7. List of isolates from reptiles 
Z No. DNA No. Strain ID  Subspecies Serotype Host Source Country  ST Year Continent 
11404 4449 02-00302   I Braenderup Snake  R. Helmuth  Germany  22 2001 Europe  
11406 4450 03-00124   I Braenderup Gecko  R. Helmuth  Germany  22 2002 Europe  
11408 4451 03-01323   I Braenderup Snake  R. Helmuth  Germany  22 2003 Europe  
11410 4452 05-00728   I Braenderup Snake  R. Helmuth  Germany  194 2005 Europe  
11412 4453 05-02388   I Braenderup Monitor Lizard R. Helmuth  Germany  22 2005 Europe  
11414 4454 99-02017-2 I Dublin Agame  R. Helmuth  Germany  74 1999 Europe  
11416 4455 03-03818   I Dublin Snake  R. Helmuth  Germany  180 2003 Europe  
11418 4456 99-03574   I Enteritidis  Snake  R. Helmuth  Germany  11 1999 Europe  
11420 4457 00-00610   I Enteritidis  Snake  R. Helmuth  Germany  11 2000 Europe  
11422 4458 01-00493-2 I Enteritidis  Reptile  R. Helmuth  Germany  168 2001 Europe  
11424 4459 02-02908-2 I Enteritidis  Snake  R. Helmuth  Germany  172 2002 Europe  
11426 4460 02-03265   I Enteritidis  Monitor Lizard R. Helmuth  Germany  11 2002 Europe  
11428 4461 03-01771-1 I Enteritidis  Colubrid Snake R. Helmuth  Germany  11 2003 Europe  
11430 4462 04-01507   I Enteritidis  Snake  R. Helmuth  Germany  11 2004 Europe  
11432 4463 05-00489   I Enteritidis  Reptile  R. Helmuth  Germany  180 2005 Europe  
11434 4464 98-00123   I Javiana z28 neg. Tortoise R. Helmuth  Germany  175 1997 Europe  
11436 4465 02-02216   I Javiana  Boa Constrictor  R. Helmuth  Germany  24 2002 Europe  
11438 4466 02-02877   I Javiana z28 neg. Reptile  R. Helmuth  Germany  175 2002 Europe  
11440 4467 03-00119   I Javiana  Snake  R. Helmuth  Germany  24 2002 Europe  
11442 4468 02-02256   I Miami  Reptile  R. Helmuth  Germany  171 2002 Europe  
11444 4469 03-01890   I Miami  Tortoise R. Helmuth  Germany  171 2003 Europe  
11446 4470 98-03021   I Montevideo Reptile  R. Helmuth  Germany  4 1998 Europe  
11448 4471 98-03023   I Montevideo Reptile  R. Helmuth  Germany  4 1998 Europe  
11450 4472 98-04046   I Montevideo Chameleon  R. Helmuth  Germany  195 1998 Europe  
11452 4473 99-00173   I Montevideo Monitor Lizard R. Helmuth  Germany  4 1999 Europe  
11454 4474 98-00489   I Muenchen Snake  R. Helmuth  Germany  112 1998 Europe  
11456 4475 98-00490   I Muenchen Snake  R. Helmuth  Germany  112 1998 Europe  
11458 4476 98-01002   I Muenchen Snake  R. Helmuth  Germany  112 1998 Europe  
11460 4477 98-01780   I Muenchen Metallic Iguana  R. Helmuth  Germany  112 1998 Europe  
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Table 2.7 continued… 
Z No. DNA No. Strain ID  Subspecies Serotype Host Source Country  ST Year Continent 
11462 4478 98-04248   I Muenchen Tortoise R. Helmuth  Germany  112 1998 Europe  
11464 4479 99-04404   I Muenchen Boa Constrictor  R. Helmuth  Germany  112 1999 Europe  
11466 4480 01-01300   I Muenchen Snake  R. Helmuth  Germany  170 2001 Europe  
11468 4481 01-03079   I Muenchen Snake  R. Helmuth  Germany  112 2001 Europe  
11470 4482 03-00146   I Muenchen Snake  R. Helmuth  Germany  112 2002 Europe  
11472 4483 03-01321   I Muenchen Red Throat Anolis  R. Helmuth  Germany  112 2003 Europe  
11474 4484 03-02124   I Muenchen Rainbow Boa  R. Helmuth  Germany  112 2003 Europe  
11476 4485 04-00724   I Muenchen Reptile  R. Helmuth  Germany  176 2004 Europe  
11478 4486 04-01589   I Muenchen Snake  R. Helmuth  Germany  177 2004 Europe  
11480 4487 04-03008-1 I Muenchen Snake  R. Helmuth  Germany  178 2004 Europe  
11482 4488 04-03596   I Muenchen Reptile  R. Helmuth  Germany  173 2004 Europe  
11524 4509 98-00501   I Oranienburg  Reptile  R. Helmuth  Germany  174 1998 Europe  
11526 4510 98-01003   I Oranienburg  Tortoise R. Helmuth  Germany  23 1998 Europe  
11528 4511 98-03150   I Oranienburg  Lizard R. Helmuth  Germany  47 1998 Europe  
11530 4512 99-01511   I Oranienburg  Shingleback Lizard R. Helmuth  Germany  174 1999 Europe  
11532 4513 99-03694   I Oranienburg  Snake  R. Helmuth  Germany  174 1999 Europe  
11534 4514 00-02036   I Oranienburg  Monitor Lizard R. Helmuth  Germany  23 2000 Europe  
11536 4515 00-02043   I Oranienburg  Malachite Iguana R. Helmuth  Germany  23 2000 Europe  
11538 4516 01-00348   I Oranienburg  King Python  R. Helmuth  Germany  23 2001 Europe  
11540 4517 01-01279   I Oranienburg  Gecko  R. Helmuth  Germany  23 2001 Europe  
11542 4518 01-01632   I Oranienburg  Reptile  R. Helmuth  Germany  169 2001 Europe  
11544 4519 02-00025   I Oranienburg  Boa Constrictor  R. Helmuth  Germany  179 2002 Europe  
11546 4520 02-03361   I Oranienburg  Bearded Agame  R. Helmuth  Germany  47 2002 Europe  
11548 4521 02-04555   I Oranienburg  Snake  R. Helmuth  Germany  179 2002 Europe  
11550 4522 02-04558   I Oranienburg  Snake  R. Helmuth  Germany  174 2002 Europe  
11552 4523 02-04559   I Oranienburg  Snake  R. Helmuth  Germany  174 2002 Europe  
11554 4524 02-04561   I Oranienburg  Snake  R. Helmuth  Germany  174 2002 Europe  
11556 4525 02-04562   I Oranienburg  Snake  R. Helmuth  Germany  174 2002 Europe  
11558 4526 02-04563   I Oranienburg  Snake  R. Helmuth  Germany  174 2002 Europe  
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Table 2.7 continued 
Z No. DNA No. Strain ID  Subspecies Serotype Host Source Country  ST Year Continent 
11560 4527 02-04570   I Oranienburg  Snake  R. Helmuth  Germany  174 2002 Europe  
11562 4528 04-00454   I Oranienburg  Snake  R. Helmuth  Germany  179 2004 Europe  
11564 4529 04-01588   I Oranienburg  Snake  R. Helmuth  Germany  174 2004 Europe  
11566 4530 04-03447   I Oranienburg  Snake  R. Helmuth  Germany  23 2004 Europe  
11568 4531 04-03465   I Oranienburg  Snake  R. Helmuth  Germany  179 2004 Europe  
11570 4532 05-00368   I Oranienburg  Snake  R. Helmuth  Germany  23 2005 Europe  
11572 4533 05-00373   I Oranienburg  Snake  R. Helmuth  Germany  174 2005 Europe  
11574 4534 05-00844   I Oranienburg  Snake  R. Helmuth  Germany  179 2005 Europe  
11576 4535 05-01895   I Oranienburg  Tortoise R. Helmuth  Germany  23 2005 Europe  
11578 4536 05-02633   I Oranienburg  Snake  R. Helmuth  Germany  179 2005 Europe  
11580 4537 05-02834   I Oranienburg  Snake  R. Helmuth  Germany  179 2005 Europe  
11582 4538 05-02969   I Oranienburg  Snake  R. Helmuth  Germany  174 2005 Europe  
11584 4539 99-00287   I Panama Snake  R. Helmuth  Germany  48 1999 Europe  
11586 4540 99-01236   I Panama Snake  R. Helmuth  Germany  48 1999 Europe  
11588 4541 02-04627   I Panama Corn Snake R. Helmuth  Germany  48 2002 Europe  
11590 4542 04-00740   I Panama Snake  R. Helmuth  Germany  48 2004 Europe  
11592 4543 04-00939   I Panama Snake  R. Helmuth  Germany  48 2004 Europe  
11594 4544 00-02650   I Paratyphi B  Snake  R. Helmuth  Germany  88 2000 Europe  
11596 4545 00-03806   I Paratyphi B  Python R. Helmuth  Germany  88 2000 Europe  
11598 4546 02-00729   I Paratyphi B  Tortoise R. Helmuth  Germany  43 2002 Europe  
11600 4547 02-04564   I Paratyphi B  Snake  R. Helmuth  Germany  88 2002 Europe  
11602 4548 02-04565   I Paratyphi B  Snake  R. Helmuth  Germany  88 2002 Europe  
11604 4549 02-04626   I Paratyphi B  Corn Snake R. Helmuth  Germany  88 2002 Europe  
11606 4550 04-01793   I Paratyphi B  Snake  R. Helmuth  Germany  88 2004 Europe  
11608 4551 05-01473   I Paratyphi B  Snake  R. Helmuth  Germany  88 2005 Europe  
11610 4552 02-01364   I Saintpaul  Tortoise R. Helmuth  Germany  27 2002 Europe  
11612 4553 05-02659   I Saintpaul  Crocodile  R. Helmuth  Germany  50 2005 Europe  
11614 4554 04-00456   I Senftenberg  Snake  R. Helmuth  Germany  14 2004 Europe  
11616 4555 04-03354   I Senftenberg  Snake  R. Helmuth  Germany  14 2004 Europe  
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Table 2.7 continued… 
Z No. DNA No. Strain ID          Subspecies Serotype Host Source Country  ST Year Continent 
11618 4556 04-03461   I Senftenberg  Lizard R. Helmuth  Germany  14 2004 Europe  
11620 4557 01-01318   I Stanley  Reptile  R. Helmuth  Germany  182 2001 Europe  
11622 4558 01-00185   I Thompson Turtle R. Helmuth  Germany  26 2001 Europe  
11624 4559 03-02125   I Thompson Tortoise R. Helmuth  Germany  26 2003 Europe  
11626 4560 03-02126   I Thompson Tortoise R. Helmuth  Germany  26 2003 Europe  
11628 4561 98-02312   I Typhimurium  Reptile  R. Helmuth  Germany  19 1998 Europe  
11630 4562 98-04017   I Typhimurium  Python R. Helmuth  Germany  19 1998 Europe  
11632 4563 99-03089   I Typhimurium  Tortoise R. Helmuth  Germany  19 1999 Europe  
11634 4564 01-00493-1 I Typhimurium  Gecko  R. Helmuth  Germany  34 2001 Europe  
11636 4565 04-00449   I Typhimurium  Snake  R. Helmuth  Germany  19 2004 Europe  
11638 4566 99-01235   I Virchow  Turtle R. Helmuth  Germany  197 1999 Europe  
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11642 4568 00-03509   I Virchow  Lizard R. Helmuth  Germany  181 2000 Europe  
11644 4569 98-00485   I Anatum Snake  R. Helmuth  Germany  64 1998 Europe  
11646 4570 99-01212   I Anatum Reptile  R. Helmuth  Germany  64 1999 Europe  
11648 4571 98-01679   I Infantis Snake  R. Helmuth  Germany  32 1998 Europe  
11650 4572 00-01231   I Infantis Snake  R. Helmuth  Germany  32 2000 Europe  
11652 4573 98-02313   I Decatur Reptile  R. Helmuth  Germany  186 1998 Europe  
11654 4574 02-04382   I Bovismorbificans Snake  R. Helmuth  Germany  150 2002 Europe  
11656 4575 04-00762   I Bovismorbificans Reptile  R. Helmuth  Germany  150 2004 Europe  
11658 4576 01-01676   I Brandenburg  Iguana R. Helmuth  Germany  65 2001 Europe  
11664 4579 99-00032   I Hadar  Snake  R. Helmuth  Germany  33 1999 Europe  
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Table 2.8. Other Salmonella isolates analyzed in this study 
Z No. DNA No. Strain ID Subspecies Serotype Host Source Country ST Year Continent Phage type 
11666 4580 00-03100 I Enteritidis Hedgehog R. Helmuth Germany 11 2000 Europe  
11668 4581 02-04192 I Enteritidis Hedgehog R. Helmuth Germany 11 2002 Europe  
11670 4582 04-03542 I Enteritidis Hedgehog R. Helmuth Germany 183 2004 Europe  
11672 4583 05-02531 I Enteritidis Hedgehog R. Helmuth Germany 11 2005 Europe  
11674 4584 99-02302 I Enteritidis Hedgehog R. Helmuth Germany 183 1999 Europe PT11 
11676 4585 00-03508 I Enteritidis Hedgehog R. Helmuth Germany 183 2000 Europe PT11 
11678 4586 02-00390 I Enteritidis Hedgehog R. Helmuth Germany 183 2002 Europe PT11 
11680 4587 03-00641 I Enteritidis Hedgehog R. Helmuth Germany 183 2002 Europe PT11 
11682 4588 04-00150 I Enteritidis Hedgehog R. Helmuth Germany 183 2003 Europe PT11 
11684 4589 98-00886 I Senftenberg Animal Feed R. Helmuth Germany 185 1998 Europe  
11686 4590 98-04320 I Senftenberg Animal meal R. Helmuth Germany 196 1998 Europe  
11688 4591 99-00016 I Senftenberg Dog/Cat Food R. Helmuth Germany 14 1998 Europe  
11690 4592 99-01195 I Senftenberg Cereal R. Helmuth Germany 185 1999 Europe  
11692 4593 99-04145-1 I Senftenberg Animal Feed R. Helmuth Germany 185 1999 Europe  
11694 4594 00-00378 I Senftenberg Soya R. Helmuth Germany 14 2000 Europe  
11696 4595 00-00822 I Senftenberg Animal meal R. Helmuth Germany 185 2000 Europe  
11698 4596 00-03768 I Senftenberg Animal Feed R. Helmuth Germany 192 2000 Europe  
11700 4597 01-00576 I Senftenberg Fish meal R. Helmuth Germany 14 2001 Europe  
11702 4598 01-02488 I Senftenberg Fish meal R. Helmuth Germany 14 2001 Europe  
11704 4599 02-00253 I Senftenberg Animal Feed R. Helmuth Germany 185 2002 Europe  
11706 4600 03-00172 I Senftenberg Animal Feed R. Helmuth Germany 185 2002 Europe  
11708 4601 03-02853 I Senftenberg Dog/Cat Food R. Helmuth Germany 14 2003 Europe  
11710 4602 03-02877 I Senftenberg Fish Meal R. Helmuth Germany 14 2003 Europe  
11712 4603 04-00548 I Senftenberg Animal Feed R. Helmuth Germany 185 2004 Europe  
11714 4604 04-00997 I Senftenberg Soya R. Helmuth Germany 14 2004 Europe  
11716 4605 04-01228 I Senftenberg Animal Feed R. Helmuth Germany 210 2004 Europe  
11718 4606 04-03902 I Senftenberg Fish meal R. Helmuth Germany 14 2004 Europe  
11720 4607 05-00522 I Senftenberg Animal Feed R. Helmuth Germany 185 2005 Europe  
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Table 2.8 continued… 
Z No. DNA No. Strain ID Subspecies Serotype Host Source Country ST Year Continent Phage type 
11722 4608 05-01371 I Senftenberg Animal Feed R. Helmuth Germany 14 2005 Europe  
11724 4609 RKI04-07579 I Kentucky Human W. Rabsch Senegal 198 2004 Africa  
11726 4610 RKI04-07898 I Kentucky Human W. Rabsch Senegal 198 2004 Africa  
11728 4611 RKI04-07904 I Kentucky Human W. Rabsch Senegal 198 2004 Africa  
11730 4612 RKI05-02137 I Kentucky Falcon W. Rabsch United Arab Emirates 198 2005 Asia  
11732 4613 RKI05-02142 I Kentucky Cheetah W. Rabsch United Arab Emirates 198 2005 Asia  
11734 4614 RKI05-02154 I Kentucky Jaguar W. Rabsch United Arab Emirates 198 2005 Asia  
11971 4742 R1 I Typhimurium Bovine H. L A-Polymenis Germany 19 1990 Europe DT104 
11973 4743 R2 I Typhimurium Bovine H. L A-Polymenis Germany 19 1994 Europe DT104 
11975 4744 R3 I Typhimurium Bovine H. L A-Polymenis Germany 19 1996 Europe DT104 
11977 4745 R4 I Typhimurium Bovine H. L A-Polymenis Germany 19 1996 Europe DT104 
11979 4746 R5 I Typhimurium Bovine H. L A-Polymenis Germany 19 1997 Europe DT104 
11981 4747 R6 I Typhimurium Bovine H. L A-Polymenis Germany 19 1997 Europe DT104 
11983 4748 R7 I Typhimurium Bovine H. L A-Polymenis Germany 19 1997 Europe DT104 
11985 4749 R8 I Typhimurium Bovine H. L A-Polymenis Germany 19 1997 Europe DT104 
11987 4750 R9 I Typhimurium Bovine H. L A-Polymenis Germany 19 1998 Europe DT104 
11989 4751 R10 I Typhimurium Bovine H. L A-Polymenis Germany 19 1998 Europe DT104 
11991 4752 R11 I Typhimurium Bovine H. L A-Polymenis Germany 19 1997 Europe DT104 
11993 4753 R12 I Typhimurium Bovine H. L A-Polymenis Germany 19 1999 Europe DT104 
11995 4754 R13 I Typhimurium Bovine H. L A-Polymenis Germany 128 1999 Europe DT104 
11999 4756 R15 I Typhimurium Pigeon H. L A-Polymenis Germany 128 1992 Europe DT2 
12003 4758 R17 I Typhimurium Pigeon H. L A-Polymenis Germany 128 1994 Europe DT2 
12005 4759 R18 I Typhimurium Pigeon H. L A-Polymenis Germany 128 1996 Europe DT2 
12007 4760 R19 I Typhimurium Pigeon H. L A-Polymenis Germany 128 2000 Europe DT2 
12009 4761 R20 I Typhimurium Pigeon H. L A-Polymenis Germany 128 2001 Europe DT2 
12011 4762 R21 I Typhimurium Human H. L A-Polymenis Germany 19 1974 Europe DT204 
12013 4763 R22 I Typhimurium Bovine H. L A-Polymenis Germany 19 1975 Europe DT204 
12015 4764 R23 I Typhimurium Bovine H. L A-Polymenis Germany 19 1979 Europe DT204 
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Table 2.8 continued… 
Z No. DNA No. Strain ID Subspecies Serotype Host Source Country ST Year Continent Phage type 
12017 4765 R24 I Typhimurium Bovine H. L A-Polymenis Germany 19 1990 Europe DT204 
12019 4766 R25 I Typhimurium Bovine H. L A-Polymenis Germany 19 1996 Europe DT204 
12021 4767 R26 I Typhimurium Bovine H. L A-Polymenis Germany 19 2000 Europe DT204 
12023 4768 R27 I Typhimurium Bovine H. L A-Polymenis Germany 19 2000 Europe DT204 
12025 4769 R28 I Typhimurium Bovine H. L A-Polymenis Germany 19 1994 Europe DT204c 
12027 4770 R29 I Typhimurium Bovine H. L A-Polymenis Germany 19 1994 Europe DT204c 
12029 4771 R30 I Typhimurium Bovine H. L A-Polymenis Germany 19 1997 Europe DT204c 
12031 4772 R31 I Typhimurium Bovine H. L A-Polymenis Germany 19 1997 Europe DT204c 
12033 4773 R32 I Typhimurium Bovine H. L A-Polymenis Germany 19 1997 Europe DT204c 
12035 4774 R33 I Typhimurium Pigeon H. L A-Polymenis Germany 19 1988 Europe DT99 
12037 4775 R34 I Typhimurium Pigeon H. L A-Polymenis Germany 19 1992 Europe DT99 
12039 4776 R35 I Typhimurium Pigeon H. L A-Polymenis Germany 19 1994 Europe DT99 
12041 4777 R36 I Typhimurium Pigeon H. L A-Polymenis Germany 19 1994 Europe DT99 
12043 4778 R37 I Typhimurium Pigeon H. L A-Polymenis Germany 19 1996 Europe DT99 
12045 4779 R38 I Typhimurium Pigeon H. L A-Polymenis Germany 19 2000 Europe DT99 
12047 4780 R39 I Typhimurium Pigeon H. L A-Polymenis Germany 19 2000 Europe DT99 
12049 4781 R40 I Typhimurium Bovine H. L A-Polymenis Germany 19 1991 Europe DT49 
12051 4782 R41 I Typhimurium Bovine H. L A-Polymenis Germany 19 1994 Europe DT49 
12053 4783 R42 I Typhimurium Bovine H. L A-Polymenis Germany 19 1996 Europe DT49 
12055 4784 R43 I Typhimurium Bovine H. L A-Polymenis Germany 19 1996 Europe DT49 
12057 4785 R44 I Typhimurium Bovine H. L A-Polymenis Germany 19 1988 Europe DT193 
12059 4786 R45 I Typhimurium Bovine H. L A-Polymenis Germany 19 1996 Europe DT193 
12061 4787 R46 I Typhimurium Bovine H. L A-Polymenis Germany 19 1997 Europe DT193 
12063 4788 R47 I Typhimurium Bovine H. L A-Polymenis Germany 19 1988 Europe DT15A 
12065 4789 R48 I Typhimurium Bovine H. L A-Polymenis Germany 323 1988 Europe DT1 
12067 4790 R49 I Typhimurium Bovine H. L A-Polymenis Germany 323 1989 Europe DT1 
12069 4791 R50 I Typhimurium Bovine H. L A-Polymenis Germany 19 1988 Europe DT10 
12073 4793 R52 I Typhimurium Bovine H. L A-Polymenis Germany 376 1988 Europe DT17 
12075 4794 R53 I Typhimurium Bovine H. L A-Polymenis Germany 19 1989 Europe DT17 
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Table 2.8 continued… 
Z No. DNA No. Strain ID Subspecies Serotype Host Source Country ST Year Continent Phage type 
12077 4795 R54 I Typhimurium Bovine H. L A-Polymenis Germany 19 1990 Europe DT17 
12079 4796 R55 I Typhimurium Bovine H. L A-Polymenis Germany 19 1988 Europe DT12 
12081 4797 R56 I Typhimurium Bovine H. L A-Polymenis Germany 332 1992 Europe DT12 
12083 4798 R57 I Typhimurium Bovine H. L A-Polymenis Germany 332 1990 Europe DT66 
12085 4799 R58 I Typhimurium Bovine H. L A-Polymenis Germany 19 1991 Europe DT66 
12087 4800 R59 I Typhimurium Bovine H. L A-Polymenis Germany 19 1994 Europe DT66 
12089 4801 R60 I Typhimurium Bovine H. L A-Polymenis Germany 19 1996 Europe DT66 
12091 4802 R61 I Typhimurium Bovine H. L A-Polymenis Germany 19 1991 Europe DT22 
12093 4803 R62 I Typhimurium Bovine H. L A-Polymenis Germany 34 1996 Europe DT7 
12095 4804 R63 I Typhimurium Bovine H. L A-Polymenis Germany 19 1991 Europe DT41 
12097 4805 R64 I Typhimurium Bovine H. L A-Polymenis Germany 19 1996 Europe DT106 
12099 4806 R65 I Typhimurium Bovine H. L A-Polymenis Germany 19 1992 Europe DT12A 
12101 4807 H04 I Typhimurium Pigeon H. L A-Polymenis Germany 19 1996 Europe DT99 
12103 4808 H05 I Typhimurium Pigeon H. L A-Polymenis Germany 128 2000 Europe DT99 
12105 4809 H06 I Typhimurium Pigeon H. L A-Polymenis Germany 19 2000 Europe DT99 
12107 4810 H07 I Typhimurium Pigeon H. L A-Polymenis Germany 19 2001 Europe DT99 
12109 4811 H08 I Typhimurium Pigeon H. L A-Polymenis Germany 128 1999 Europe DT2 
12111 4812 H09 I Typhimurium Pigeon H. L A-Polymenis Germany 128 2000 Europe DT2 
12113 4813 H10 I Typhimurium Pigeon H. L A-Polymenis Germany 128 2001 Europe DT2 
12115 4814 STM213/94 I Typhimurium Pigeon W. Rabsch Germany 128 1994 Europe DT2 
12117 4815 STM2350/94 I Typhimurium Bovine W. Rabsch Germany 19 1994 Europe DT4 
12119 4816 STM3246/94 I Typhimurium Bovine W. Rabsch Germany 98 1994 Europe DT36 
12121 4817 STM6669/96 I Typhimurium Bovine W. Rabsch Germany 19 1996 Europe DT68 
12123 4818 STM3244/94 I Typhimurium Bovine W. Rabsch Germany 19 1994 Europe DT120 
12125 4819 STM499/94 I Typhimurium Animal feed W. Rabsch Germany 19 1994 Europe DT120 
12127 4820 STM1663/89 I Typhimurium Bovine W. Rabsch Germany 19 1989 Europe DT120 
12129 4821 STM3115/94 I Typhimurium Bovine W. Rabsch Germany 19 1994 Europe DT143 
12131 4822 STM1371/94 I Typhimurium Bovine W. Rabsch Germany 19 1994 Europe DT170 
12133 4823 STM2204/89 I Typhimurium Bovine W. Rabsch Germany 19 1989 Europe  
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Table 2.8 continued… 
Z No. DNA No. Strain ID Subspecies Serotype Host Source Country ST Year Continent Phage type 
12135 4824 STM261/91 I Typhimurium Bovine W. Rabsch Germany 19 1991 Europe  
12257 4883 MZ0876 I Gallinarum  S. Porwollik  331 None   
12259 4884 CDC1983-167 I Pullorum  S. Porwollik  92    
12261 4885 SGSC4770SC-B67 I Choleraesuis Human S. Porwollik Taiwan 66  Asia  
12265 4886 MZ0526 I Hadar  S. Porwollik  330 None   
12267 4887 S-1241 I Paratyphi B var Java  S. Porwollik  372    
12277 4892 ccc28 I Agona Milk S. Porwollik Ireland 13 2002 Europe  
12291 4899 ATCC 700720 I Typhimurium  S. Porwollik  19 1948  LT2 
12293 4900 MZ0523 I Javiana  S. Porwollik  371    
12295 4901 S-407 I Oranienburg  S. Porwollik  320    
12297 4902 MZ0530 I Oranienburg  S. Porwollik  320 None   
12301 4904 MZ0552 I Cubana  S. Porwollik  324    
12303 4905 125109 I Enteritidis  S. Porwollik  11   PT4 
12313 4910 SS44 I Abortusovis Sheep S. Porwollik Italy 202 1980 Europe  
12315 4911 MZ0680 I Abortusovis  S. Porwollik France 373 1980 Europe  
12327 4917 SGSC3820 I Enteritidis Chicken S. Porwollik  11    
12403 4955 74-1035 I Sendai Human S. Porwollik U.S.A. 85  North 
America 
 
12407 4957 RKS4594 I Paratyphi C  S. Porwollik  114    
12409 4958 MZ0955 I Paratyphi B  S. Porwollik  325 None   
12411 4959 01-05481 I Bovismorbificans  S. Porwollik Germany 142  Europe PT13 
12413 4960 05-0774 I Bovismorbificans  S. Porwollik Germany 142  Europe PT24 
12415 4961 M1166 I Typhimurium  S. Porwollik  19    
12417 4962 L14 I Typhimurium  S. Porwollik  19    
12419 4963 A36 I Typhimurium  S. Porwollik Germany 19  Europe  
12421 4964 MZ1292 I Muenster Human S. Porwollik  321 None   
12423 4965 MZ1293 I Virchow Human S. Porwollik  326 None   
12425 4966 04-0258 I Muenster Human S. Porwollik  374    
12427 4967 MZ1295 I Virchow Human S. Porwollik  333 None   
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Table 2.8 continued… 
Z No. DNA No. Strain ID Subspecies Serotype Host Source Country ST Year Continent Phage type 
12429 4968 SL1344 I Typhimurium  S. Porwollik United Kingdom 19  Europe  
12433 4970 SGSC4902 I Paratyphi A  S. Porwollik  85    
12435 4971 SGSC4903 I Typhimurium  S. Porwollik  19    
12437 4972 SGSC4905 I Infantis  S. Porwollik  32    
12439 4973 MZ1302 I Hadar  S. Porwollik  327 None   
12447 4977 SGSC4912 I Schwarzengrund  S. Porwollik  322    
12449 4978 SGSC4913 I   S. Porwollik  19    
12451 4979 SGSC4914 I Kentucky  S. Porwollik  152    
12453 4980 SGSC4915 I Heidelberg  S. Porwollik  15    
12455 4981 SGSC4916 I Dublin  S. Porwollik  10    
12457 4982 SGSC4917 I Javiana  S. Porwollik  24    
12459 4983 SGSC4918 I Kentucky  S. Porwollik  152    
12461 4984 MZ1313 I Schwarzengrund  S. Porwollik  322 None   
12463 4985 SGSC4920 I Saintpaul  S. Porwollik  50    
12465 4986 SGSC4921 I Saintpaul  S. Porwollik  95    
12157 4835 3235    I Rough (4,12:d:-) Human carrier R. Curtiss Germany 279 1985 Europe   
12159 4836 3236    I Tennessee  Human carrier R. Curtiss Germany 319 1985 Europe   
12201 4857 3202    I Albany Human carrier R. Curtiss Germany 292 1985 Europe   
12211 4862 3207    I Cerro var. Siegburg  Human carrier R. Curtiss Germany 367 1985 Europe   
12219 4866 3211    I Give Human carrier R. Curtiss Germany 369 1985 Europe   
12227 4870 3215    I London Human carrier R. Curtiss Germany 155 1985 Europe   
12229 4871 3216    I London Human carrier R. Curtiss Germany 155 1985 Europe   
12137 4825 3224    I Vejle  Human carrier R. Curtiss Germany 370 1985 Europe   
 
Note: These isolates were analyzed and MLST data were submitted to the Salmonella MLST website (http://web.mpiib-berlin.mpg.de/mlst/dbs/Senterica). The data of 
relevant isolates were used in comparative analyses for different objectives of this study. 
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Table 2.9. Primers for the amplification and sequencing of MLST gene fragments 
O- number Gene name Primer direction Oligonucleotide sequence 
Amplification    
2181 aroC Forward CCTGGCACCTCGCGCTATAC 
2182 aroC Reverse CCACACACGGATCGTGGCG 
2173 dnaN Forward ATGAAATTTACCGTTGAACGTGA 
6586 dnaN Reverse AATTTCTCATTCGAGAGGATTGC 
2169 hemD Forward ATGAGTATTCTGATCACCCG 
6584 hemD Reverse TTATTGTAATGCGCGCAACAG 
6080 hisD Forward GAAACGTTCCATTCCGCGCAGAC 
6081 hisD Reverse CTGAACGGTCATCCGTTTCTG 
6589 purE Forward ATGTCTTCCCGCAATAATCC 
2178 purE Reverse TCATAGCGTCCCCCGCGGATC 
6593 sucA Forward CCTTTGCCAGCGGCAAAGAGAC 
2190 sucA Reverse CGCATTGACGTGGAAAATCGG 
6078 thrA Forward GTCACGGTGATCGATCCGGT 
6079 thrA Reverse CACGATATTGATATTAGCCCG 
Sequencing    
2184 aroC Reverse CATATGCGCCACAATGTGTTG 
6587 dnaN Forward CCGATTCTCGGTAACCTGCT 
6588 dnaN Reverse CCATCCACCAGCTTCGAGGT 
6585 hemD Forward CCACTGATTGAATTTGTCGC 
2172 hemD Reverse GTTGTCGGCGTTATCAGCGAC 
6076 hisD Forward GTCGGTCTGTATATTCCCGG 
6077 hisD Reverse GGTAATCGCATCCACCAAATC 
2179 purE Forward CGCATTATTCCGGCGCGTGT 
2180 purE Reverse CGCGGATCGGGATTTTCCAG 
2191 sucA Forward AGCACCGAAGAGAAACGCTG 
6594 sucA Reverse GGTTGTTGATAACCGATACGTAC 
6591 thrA Forward ATCCCGGCCGATCACATGAT 
6592 thrA Reverse CTCCAGCAGCCCCTCTTTCAG 
 
 
50x TAE buffer 
2 M Tris-acetate and 50 mM EDTA (pH 8.0) 
 
20x PBS buffer 
2.8 M NaCl, 30 mM KH2PO4, 162 mM Na2HPO4.2H2O (pH 7.4) 
 
Agarose gel loading buffer 
0.25% bromophenol blue and 40% (w/v) sucrose in distilled water. 
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2.5 Glass beads for storage of bacterial isolates 
2.8-3.3 mm glass beads were washed in tap water with a commercial detergent. They were 
then soaked in 0.05 M HCl for five minutes to neutralize alkalinity. The glass beads were 
washed several times in tap water until the pH of the wash water was that of tap water. The 
beads are washed twice in distilled water and dried in an oven at 50°C. Approximately 120 
glass beads are dispensed per 10 ml loosely capped culture tubes which are sterilized by 
autoclaving at 121°C for 20 min. The cryo-vials were filled with approximately 20 
sterilized glass beads in a laminar air-flow workbench. 
2.6 Software and databases 
The computer programs used in the study are summarized in Table 2.10 and the databases 
in Table 2.11. 
Table 2.10. Computer programs 
Name Source Web address 
Access 2002 Microsoft 
office.microsoft.com/en-
us/access/default.aspx 
Bionumerics 4.5 
 
Applied Maths, Sint-Martens-
Latem, Belgium 
www.applied-maths.com 
 
ClonalFrame 1.1 
 
Didelot, X. and Falush,D., 
University of Oxford, UK 
www2.warwick.ac.uk/fac/sci/statistics/staff 
/research/didelot/clonalframe 
DnaSP 4.0 
 
 
 
Rozas,J., Librado,P., Sánchez-
DelBarrio,J.C., Messeguer, X., 
Rozas,R., Universitat de 
Barcelona, Spain 
www.ub.es/dnasp 
 
 
 
eBURST 3.0 
 
 
Spratt, B.G., Hanage, W.P., Li, B., 
Aanensen, D.M., Feil, E.J., 
Imperial College, London, U.K.  
http://eburst.mlst.net 
 
 
GenAlEx 6.0 
 
 
Peakall, R. and Smouse,P., The 
Australian National University, 
Canberra, Australia 
www.anu.edu.au/BoZo/GenAlEx 
 
 
Illustrator CS2 
 
Adobe Systems Inc., San Jose, 
California, USA 
www.adobe.com 
 
MEGA 4.0 
 
 
Tamura,K., Dudley,J., Nei,M., 
Kumar,S., Arizona State 
University, Tempe, Arizona, USA 
www.megasoftware.net/fixed_bugs.html 
 
 
Modeltest 3.7 
 
David Posada, University of Vigo, 
Spain 
http://darwin.uvigo.es/software/modeltest.html 
 
Origin 6.0 
 
 
Microcal Software Inc., 
Northhampton, Massachusetts, 
USA 
www.microcal.com 
 
 
PAML 4.0 
 
 
Yang,Z., Department of Biology, 
University College London, 
London, UK 
abacus.gene.ucl.ac.uk/software/paml.html 
 
 
PAST 1.73 
 
 
Hammer,Ø., Paleontological 
Museum, University of Oslo, Oslo, 
Norway 
folk.uio.no/ohammer/past/download.html 
 
 
Paup 4b10 
 
Sinauer Associates Inc. Publishers, 
Sunderland, Massachusetts, USA 
paup.csit.fsu.edu/ 
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Table 2.10 continued… 
Name Source Web address 
RDP 3.0 
 
Martin,D., University of Cape 
Town, Cape Town, South Africa 
darwin.uvigo.es/rdp/rdp.html 
 
Reference manager 10.0 
 
ISI ResearchSoft,  Carlsbad, 
California, USA 
www.refman.com 
 
Splitstree 4.0 
 
 
Hudson,D.H. and Bryant,D., 
Tuebingen University, Tuebingen, 
Germany 
www.splitstree.org 
 
 
STATISTICA StatSoft, In., Tulsa, U.S.A. www.statsoft.com 
UniFrac 
 
 
Lozupone,C., Hamady,M., 
Knight,R., University of Colorado 
at Boulder, Boulder, USA 
bmf2.colorado.edu/unifrac/index.psp 
 
 
 
 
Table 2.11. Databases 
Database Web address 
PubMed www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed 
Salmonella MLST web.mpiib-berlin.mpg.de/mlst/dbs/Senterica 
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3. Evolution and population structure of Newport 
3.1 Introduction 
Salmonellosis continues to be a major global public health concern due to a high number of 
human cases every year (World Health Organization, 2005). Newport has emerged as one 
of the most common serovars isolated from both humans and food animals in recent years 
(Centers for Disease Control and Prevention, 2002; Animal Disease Diagnostic Laboratory, 
2004; Poppe et al., 2006). It is the third most frequent serovar in the United States (Centers 
for Disease Control and Prevention, 2006) and one of the top 15 serovars which infects 
humans in Europe (European Centre for Disease Prevention and Control, 2008). Multidrug 
resistant Newport isolates, especially those resistant to expanded-spectrum cephalosporins 
(MDR-AmpC), have become a serious problem among food animals which are a major 
source of human infections (Zhao et al., 2001; Gupta et al., 2003; Devasia et al., 2005; 
Poppe et al., 2006; Egorova et al., 2008). Outbreaks of MDR-AmpC Newport have been 
reported in the U.S.A. and France (Centers for Disease Control and Prevention, 2002; Espie 
et al., 2005). MDR-AmpC Newport strains are resistant to ampicillin, chloramphenicol, 
streptomycin, sulphamethoxazole, tetracycline, amoxicillin/clavulanic acid, cephalothin, 
cefoxitin and ceftiofur and have a decreased susceptibility to ceftriaxone (Centers for 
Disease Control and Prevention, 2002; Devasia et al., 2005). 
The population structure of some serovars of subspecies enterica is monophyletic while 
others are polyphyletic (Beltran et al., 1988). Newport is polyphyletic according to both 
MLEE and MLST studies (Beltran et al., 1988; Sukhnanand et al., 2005; Torpdahl et al., 
2005; Harbottle et al., 2006). Two distantly related lineages were identified for Newport, 
one associated with humans and the second with domesticated animals (Beltran et al., 
1988; Sukhnanand et al., 2005). However, the population structure of Newport has not yet 
been examined in detail. I analyzed 384 Newport isolates in order to study the evolution 
and population structure of this serovar using an MLST scheme (Torpdahl et al., 2005). For 
comparative analyses, MLST data of four other serovars were also included, namely 
Enteritidis (including Gallinarum and Pullorum, avian-adapted variants), Kentucky, 
Paratyphi B (including d-tartrate positive variant Paratyphi B var. Java) and Typhimurium. 
These serovars were chosen because MLST data for more than fifty isolates are available 
from each of these serovars. 
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3.2 Methods 
3.2.1 Bacterial isolates 
149 Newport isolates were obtained from various Salmonella reference laboratories in 
Europe: 79 isolates were provided by Dr. Francois-Xavier Weill, Pasteur Institute, Paris, 
France; 50 by Dr. Wolfgang Rabsch, Robert Koch Institute, Wernigerode, Germany; and 20 
by Dr. Reiner Helmuth, National Salmonella Reference Laboratory, Federal Institute for 
Risk Assessment (BFR), Berlin, Germany. 
In addition, three isolates were obtained from Dr. Steffen Porwollik, Sidney Kimmel 
Cancer Center, San Diego, U.S.A and one isolate from Prof. Roy Curtiss III, Center for 
Infectious Diseases and Vaccinology, The Biodesign Institute, Arizona State University, 
Tempe, U.S.A. Finally, three Newport isolates from the SARB collection that had been 
tested by MLEE (SARB36, SARB37 and SARB38) (Boyd et al., 1993) were obtained from 
Dr. Fidelma Boyd, University College Cork, Ireland. 
MLST data for 135 Newport isolates was provided by Dr. Heather Harbottle, Center for 
Veterinary Medicine, U. S. Food and Drug Administration, Laurel, USA. Additional data 
were from the published literature (Harbottle et al., 2006; Torpdahl et al., 2005) and data 
for nine other isolates were from the Salmonella MLST website (http://web.mpiib-
berlin.mpg.de/mlst/dbs/Senterica). 
In all, data were available for 384 Newport isolates (Table 3.1). MLST data for serovars 
Enteritidis, Kentucky, Paratyphi B and Typhimurium were downloaded from the 
Salmonella MLST website (http://web.mpiib-berlin.mpg.de/mlst/dbs/Senterica). 
 
3.2.2 Cultivation and storage of isolates 
All bacterial isolates were streaked on LB agar plates and grown for 16-18 h at 37°C. A 
single colony was suspended in 100 μl of LB broth and spread on a fresh LB agar plate. 
After overnight growth, one third of the bacterial lawn was suspended in 1 ml of 10% 
skimmed milk. The suspension was added to a cryo-vial containing approximately 20 
sterilized glass beads and was gently mixed by pipetting, resulting in a homogenous 
suspension. Excess fluid was discarded and the vials were stored at -80°C. 
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Table 3.1. Sources of Newport isolates 
       Continent   
Year of Isolation 
(No. of isolates) Host Europe 
North 
America Othersa 
1940-1959 Human 6 4 10 
(33) b Rat   1 
 Reptile   7 
 Swine 1  1 
 Unknown  3  
1960-1979 Chicken   1 
(117) Frog legs 3   
 Equine 1 1  
 Human 30 77 2 
 Lion   1 
 Swine   1 
1980-2005 Bovine  20  
(226) Chicken 2 10  
 Food/feed 4 9  
 Human 60 75  
 Reptile 20 1  
 Swine  13  
 Turkey  9  
 Unknown 3   
Unknown Human 2 2  
(8) Swine  1  
 Unknown   3 
Total   132 225 27  
a Isolates from Africa, Asia, South America or of unknown sources. 
b One strain was isolated in 1918. 
 
3.2.3 Antimicrobial susceptibility typing 
Disc diffusion and broth microdilution methods were used for antimicrobial susceptibility 
typing of the Newport isolates as follows: 
3.2.3.1 Disc diffusion method 
Newport isolates were tested for resistance to amikacin, cephalothin, cefoxitin and 
ceftriaxone by the disc diffusion method. Bacterial cultures were streaked to LB agar plates 
and grown overnight at 37ºC. Four ml of LB-broth was inoculated with a loop full of 
bacteria from these plates and incubated at 37ºC for 18 h. 100 µl of a 1:100 dilution was 
spread on a Müller-Hinton agar plate (Oxoid, UK) and 6 mm discs containing 
antimicrobials (Oxoid, UK) were placed on the agar surface. These plates were incubated 
for 18 h at 37ºC. Zone diameters were measured and compared with break points that were 
recommended by the CLSI (NCCLS, 2002). 
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3.2.3.2 Broth microdilution method 
A total of twelve antimicrobials were tested by the broth microdilution method, namely 
ampicillin, amoxicillin-clavulanic acid, ceftiofur, chloramphenicol, ciprofloxacin, 
gentamicin, kanamycin, nalidixic acid, streptomycin, sulfamethoxazole, tetracycline and 
trimethoprim-sulfamethoxazole. Bacterial cultures were streaked on Müller-Hinton agar 
plates and incubated at 37ºC for 18 h. Bacteria from these plates were suspended in sterile 
normal saline solution (0.85% NaCl) to a turbidity of 0.5 McFarland using the Sensititer 
System (Autoinoculator INO2, Trek Diagnostic Systems Ltd., UK). 15 µl of this 
suspension was mixed with 11 ml Müller-Hinton-broth (Oxoid, UK). 100 µl of the 
inoculated broth was dispensed to each well of a microtiter plate (NLMV1A, Trek 
Diagnostic Systmes Ltd., UK) that contained lyophilized antimicrobial agents in different 
concentrations. The plates were sealed with sealing films and incubated at 37ºC for 18 h. 
The plates were read with a semi-automatic Sensitouch System (Accumed International 
Ltd., UK) in order to determine the minimum inhibitory concentration (MIC µg/ml) as per 
the CLSI guidelines (NCCLS, 2002). 
3.2.4 DNA isolation 
DNA was extracted from liquid cultures grown overnight at 37°C in LB broth using the 
JETFLEX Genomic DNA purification kit (GENOMED). Approximately 1.5 ml of LB 
broth was added to each well in a 96 deep-well plate and inoculated with one glass-bead 
from the -80°C bacterial stock. The cultures were grown overnight in a shaking incubator at 
37°C and 80-100 rpm. The plate was centrifuged at 3,220×g' for 5 min and the supernatant 
was discarded. The pellets were dissolved in 300 µl of cell lysis buffer and 10 µl of 
proteinase K (20 mg/ml) was added to each well followed by incubation at 58°C for 2 h in a 
waterbath. After incubation, 10 µl of RNase (4 mg/ml) was added to each well and the plate 
was incubated at 37°C for 10 min in an incubator. 150 µl of protein precipitation buffer and 
50 µl of pellet compactor were added to each well and mixed thoroughly to precipitate the 
cell debris. The plate was centrifuged at 3,220×g' for 15 min, vortexed and incubated on ice 
for 10 min before re-centrifugation at 3,220×g' for 15 min. 
The clear supernatant was transferred to a second 96 deep-well plate and 450 µl of iso-
propanol was added to each well. The contents were mixed by gently inverting the plate 
after sealing with a sealing film. The plate was incubated on ice for 15 min followed by 
centrifugation at 3,220×g' for 10 min. The supernatant was discarded by inverting the plate 
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on a paper towel and 500 µl of 70% ethanol (room temperature) was added to wash the 
pellet. The plate was centrifuged at 3,220×g' for 5 min and the supernatant was discarded in 
the same manner. The washing with 70% ethanol (room temperature) was repeated once 
again. The pellets were air dried and 200 µl of Tris buffer pH 8.0 (10 mM) was added to 
each of the wells. The plate was sealed with sealing film and left at 4°C overnight to 
dissolve the DNA. 
Five µl of each DNA was diluted 1:10 with Tris buffer pH 8.0 (10mM) in a microtitre plate 
and quantified using the spectrophotometer SPECTRA-MAX 190 or GeneQuant at the 
wavelengths 260 and 280 nm. One unit of absorbance of dsDNA at 260 nm is equal to 50 
ng/µl. The OD at 280 is used to check the quality of DNA. The ratio of ODs should be 
~1.8. A ratio of < 1.7 indicates contamination with protein or other reagents left due to 
improper washing and ≥ 2.0 indicates RNA contamination. DNA whose A260/A280 OD ratio 
was < 1.7 ratio was re-purified by repeating the entire procedure after adding 300 µl cell 
lysis buffer and 10 µl proteinase K (20 mg/ml). 10 µl of RNase (4 mg/ml) was added to 
DNA with A260/A280 ratio of > 2.0 followed by incubation at 37°C for 10 min in a 
waterbath. The DNA was precipitated by adding 1 volume iso-propanol and washed with 
70% ethanol (room temperature) as described. DNAs with A260/A280 ratio between 1.7-1.9 
were diluted to the concentration of 50 ng/µl with Tris buffer pH 8.0 (10 mM) and were 
stored at -20°C. 20 µl of DNA from each of these stocks was further diluted to 5 ng/µl by 
adding 180 µl Tris buffer pH 8.0 (10 mM) which was stored at 4°C and was used for PCR 
amplification. 
3.2.5 PCR amplification and sequencing 
3.2.5.1 PCR amplification 
Fragments of seven housekeeping genes were amplified as previously described (Harbottle 
et al., 2006; Torpdahl et al., 2005). The primers used for amplification are listed in Table 
2.9 of Chapter 2. The reaction mix contained 1x reaction buffer with MgCl2, 200 µM 
deoxynucleoside triphosphates (dNTPs), 10 pmol of each primer, 1U of Taq polymerase 
and 10 ng of template DNA in 15 µl of reaction volume. PCR cycling conditions were as 
follows: 
Step 1. 94°C : 5 min 
(35 cycles from step 2 to 4) 
Step 2. 94°C : 1 min 
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Step 3. 55°C : 1 min 
Step 4. 72°C : 1 min 
Step 5. 72°C : 5 min 
Step 6.   4°C : ∞ 
 
3.2.5.2 Agarose gel electrophoresis 
One gram of agarose was dissolved in 100 ml of TAE buffer in a microwave oven. The 
solution was allowed to cool to 50-60°C and 5 µl of 10 mg/ml ethidium bromide solution 
was added. The gel was poured in a 13 X 13.5 cm plate and four combs were inserted, each 
with 26 teeth. Once the gel had solidified, the combs were removed and 3 µl of each PCR 
product plus 1 µl of bromophenol blue dye were loaded. The DNA was resolved by 
electrophoresis at 5V/cm until the loading dye had reached the beginning of the second 
block. The gel documentation system BIO-RAD Gel Doc 2000 was used for visualization 
of amplified products and photography. 
3.2.5.3 Cleaning of amplified products 
Amplified products were treated with shrimp alkaline phosphatase (SAP) and exonuclease I 
(ExoI) to remove unused dNTPs and primers. 0.5 µl of ExoI (10 U/µl) and 0.5 µl of SAP (1 
U/µl) were added to 12 µl of PCR product in a 96 well plate. The plate was sealed with 
adhesive sealing film and incubated as follows: 
Step 1. 37°C : 60 min 
Step 2. 80°C : 15 min 
Step 3.   4°C : ∞ 
 
3.2.5.4 Sequencing of purified PCR products 
PCR products were diluted with sterile distilled water to a concentration of 5 ng/µl. The 
primers used for sequencing are listed in Table 2.9 of Chapter 2. Sequencing reaction mix 
contained 1.875 µl 5X sequencing buffer, 0.25 µl Big Dye Terminator v3.0 and 3 pmol of 
primer. 2.0 µl of diluted PCR product was used as template and sterile distilled water was 
added to make up the reaction volume to 10 µl. The conditions used are as follows: 
Step 1. 96°C : 2 min 
(30 cycles from step 2 to 4) 
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Step 2. 96°C : 10 sec 
Step 3. 50°C : 5 sec 
Step 4. 60°C : 2 min 
Step 5.   4°C : ∞ 
 
The sequenced products were precipitated by ethanol precipitation. 10 µl of sterile distilled 
water was added to 10 µl of sequence reaction. 7 ml absolute ethyl-alcohol was mixed with 
280 µl of 3 M sodium-acetate, pH 4.6 and 52 µl of the mix was added to each well. The 
microtitre plate was sealed with sealing film, briefly vortexed to mix the content and 
incubated at room temperature for 45 min. 
The plate was centrifuged at 2,750×g' for 1 h at 4oC and the supernatant was discarded by 
gently inverting onto a paper towel followed by an inverted spin onto a piece of Whatman 
3MM paper at 500×g' for 1 min. DNA pellets were washed twice by adding 150 µl of 70% 
ethyl-alcohol (room temperature) and centifugation at 2,750×g' for 10 min. The supernatant 
was discarded as before. Dried pellets were dissolved in 10 µl of Hi Di formamide and 
sequenced with an ABI PRISM DNA analyzer 3770 (Applied Biosystems, Foster City, 
Calif). 
 
3.2.6 MLST analyses 
Strain information that includes strain designation, subspecies, serovar, year of isolation, 
host, continent and source were stored in a Bionumerics 4.5 database (Applied Maths, Sint-
Martens-Latem, Belgium). The nucleotide sequences of gene fragments were also stored in 
the same database. They were assembled and trimmed using scripts written by Prof. Mark 
Achtman. New alleles and STs were submitted to the Salmonella MLST website for the 
assignment of allele and ST numbers after curation. Final allele and ST designations were 
assigned to the entries in the Bionumerics 4.5 database using scripts also written by Prof. 
Mark Achtman. Nucleotide sequences of gene fragments were concatenated in the order 
aroC, dnaN, hemD, hisD, purE, sucA and thrA for analyses of concatenated sequence 
alignments. Alignments of gene fragments and concatenated sequences were exported from 
Bionumerics 4.5 for further analyses. 
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3.2.7 Evolutionary analyses 
3.2.7.1 Clonal Frame 
The computer program ClonalFrame (Didelot and Falush, 2006) was used to infer clonal 
relationships among strains on the basis of multilocus sequence data. ClonalFrame is based 
on a coalescent approach which assumes that the bacteria in a sample come from a 
constant-sized population and all individuals are equally likely to reproduce. The program 
identifies potential regions within nucleotide sequences that have been imported from other 
bacteria and calculate genealogies after ignoring these imports which minimizes the effects 
of recombination. A consensus tree based on the posterior probabilities of genealogies is 
generated, depicting clonal relationships among the strains. 
Ten ClonalFrame runs were computed on unique STs from the entire dataset, each with 
100,000 iterations after 100,000 burn-in iterations. A 50% consensus tree was generated on 
the outputs of these 10 runs using the graphical user interface of the program. 
3.2.7.2 Neighbor-net 
Neighbor-net is a distance based method that constructs phylogenetic networks using 
nucleotide sequence data (Bryant and Moulton, 2004). An agglomerative process of pairing 
nodes is followed by collection of weighted splits which are converted into a phylogenetic 
network (Bryant and Moulton, 2004). The method is highly efficient for resolving 
conflicting signals in the dataset in comparison to other methods like split decomposition 
(Bryant and Moulton, 2004). 
Various DNA substitution models were tested on an alignment of unique concatenated 
sequences in PAUP 4.0 (Swofford, 1998) and the model that fits best was chosen using 
Modeltest 3.7 (Posada and Crandall, 1998). This model and parameter estimates were used 
to generate a phylogenetic network on the dataset using Neighbor-net algorithm 
implemented in SplitsTree 4.0 (Huson and Bryant, 2006). 
3.2.7.3 Minimal spanning tree (MSTREE) 
The MSTREE is a graphical tool that links the nodes by unique minimal paths in a given 
dataset i.e. total summed distance of all branches is minimized. The MST algorithm 
implemented in Bionumerics 4.5 was used to generate an MSTREE from the allelic profiles 
of all isolates. The algorithm uses an ST with highest numbers of single locus variants 
(SLVs) as a root node and derives other STs from it. STs that shared up to three alleles 
were connected by crosslinks. 
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A second MSTREE was generated from allelic profiles only for Newport isolates without 
crosslinks. 
3.2.7.4 eBURST 
eBURST is an algorithm that identifies groups of closely related sequence types from 
MLST data (Feil et al., 2004). The algorithm attempts to predict a founder for each group 
based on the abundance of STs that are linked to a particular ST at a single allelic 
difference. If two STs in a group have the same number of SLVs, then the one with the 
larger number of double locus variants (DLVs) is chosen. The output is displayed in the 
form of a radial diagram where descendent genotypes (SLVs) are linked to the predicted 
founder at the centre. Other STs within a group (except for the predicted founder) that have 
≥ 3 SLVs are predicted to be co-founders. It has been a popular method to study the 
evolutionary descent among isolates using MLST data (Enright et al., 2002; Feil et al., 
2004; Honsa et al., 2008; Feil et al., 2003). The algorithm was tested on allelic data of 
Newport isolates using eBURST 3.0 (http://eburst.mlst.net).  
3.2.7.5 Reticulate 
The concatenated sequence alignments from each group identified by the ClonalFrame 
were independently tested for reticulate evolution by the program Reticulate (Jakobsen and 
Easteal, 1996). This program calculates the compatibility between pairs of parsimony 
informative sites in a given alignment, resulting in an overall compatibility score ranging 
from 0 (no compatibility) to 1 (highly compatible). A pair of informative site is compatible 
if c = n–1 for both sites, where c is the minimum number of changes that are required to 
construct a genealogy and n is the total number of polymorphic nucleotides. If c > n–1 for 
any one or both sites, they are incompatible. Such incompatibilities generally result from 
recurrent mutations, recombination or lateral gene transfer. An overall low compatibility 
score indicate that different nucleotides followed different evolutionary paths and a 
phylogenetic tree on the concatenated sequences would not reflect true evolutionary 
relatedness. 
3.2.7.6 Pairwise homoplasy index (Фw) test of recombination 
The Фw test is a program that detects recombination on the basis of low compatibility 
between informative sites in a sequence alignment (Bruen et al., 2006). The program 
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calculates refined incompatibilities between the pairs of parsimony informative sites as per 
the following equation: 
 
i(χi, χj) = l(χi, χj) – (|χi|-1) – (|χj| -1) 
 
i(χi, χj) = refined incompatibility score for parsimony informative sites i and j 
l(χi, χj) = minimum number of mutations required to represent genealogy by any tree for 
these sites 
|χi| = number of different states at site i 
|χj| = number of different states at site j 
 
The mean of refined incompatibility is calculated for nearby sites in the diagonal for the 
first k rows of the incompatibility matrix as the pairwise homoplasy index or Фw statistics 
using the following equation [taken from Bruen et al., 2006]. 
 
k = wq 
w = width of the window in basepairs (set to 100 by default) 
q = proportion of parsimony informative sites within the alignment 
n = number of total informative sites 
k(2n-k-1)/2 = normalizing factor 
 
The significance of the observed Фw statistics is obtained by permutation test. The 
concatenated sequence alignments of ClonalFrame groups were tested for recombination by 
Фw test. 
3.2.8 Characteristics of housekeeping genes  
The average pairwise nucleotide diversity per site (π) with Jukes-Cantor correction was 
calculated for gene alignments in each group using MEGA version 4.0 (Tamura et al., 
2007). 
 
    1 
π’  =                    Σ  πij   [taken from (Page and Holmes, 1998)] 
          [n(n-1)/2]    i<j 
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π’ is the average pairwise nucleotide diversity, n is the number of sequences in the sample 
and πij is the difference between the ith and the jth sequence. π can be calculated by dividing  
π’ by the total length of the sequences. 
Assuming that substitutions at all the sites are equally likely and that the frequencies of all 
four bases are the same, Jukes and Cantor proposed that the mean number of base 
differences (d) between a pair of sequences is related to the proportion of different 
nucleotides (p) by 
 
d = - ¾ ln (1 – 4/3 p)   [taken from (Page and Holmes, 1998)] 
 
The mean of non-synonymous substitutions per non-synonymous site (Ka) and 
synonymous substitutions per synonymous site (Ks) were computed for gene alignments 
using DnaSP version 4.0 (Rozas et al., 2003). Substitutions in a protein coding sequence 
that result in amino acid changes are known as non-synonymous substitutions while those 
that does not change the amino acid are called synonymous. The Ka/Ks ratio is commonly 
used to estimate selection pressure on a protein coding sequence. A value of Ka/Ks > 1.0 
indicates diversifying selection whereas Ka/Ks = 1.0 indicates neutral evolution and Ka/Ks 
< 1.0 indicates purifying selection.  
3.3 Results 
3.3.1 Population structure of Newport and other serovars 
An alignment of unique concatenated sequences was tested by ClonalFrame to infer their 
phylogenetic relatedness. I assigned each cluster of ≥ 3 STs or a distinct ST with ≥ 10 
isolates as a group and STs that did not meet these criteria were treated as singletons. The 
STs of serovar Newport grouped into three distinct clusters that were designated Newport-I, 
Newport-II and Newport-III (Fig. 3.1). Newport-I was a group of three STs that contained 
8% of the Newport isolates (Table 3.2). Newport-II and Newport-III were more diverse and 
more common, each containing 47% of the Newport STs and 58% and 34% of the isolates, 
respectively. STs, allelic profiles and the number of isolates within each Newport group are 
summarized in Table 3.3. 
Paratyphi B (including var. Java) is a highly heterogeneous serovar because four distinct 
groups were identified among the 18 STs that were identified among 66 isolates. Kentucky 
is also a polyphyletic serovar because five STs were assigned to two groups, designated as 
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Kentucky-I and Kentucky-II. In contrast, most of the Enteritidis and Typhimurium STs 
clustered into a single group for each serovar. However, two Enteritidis STs (ST6 and 
ST77) and two Typhimurium STs (ST36 and ST207) were singletons. Each of the singleton 
STs was distant from the main groups and contained only one to two isolates. 
 
Fig. 3.1. A 50% consensus of 10 evolutionary trees generated using ClonalFrame 1.1. 
 
 
Serovars of subspecies enterica vary greatly in their population structures and can contain 
between one to four distinct groups per serovar. The degree of polyphyly within serovar 
Newport was higher than Enteritidis, Typhimurium or Kentucky but lower than Paratyphi 
B. 
Recombination has been an important source of variation among housekeeping genes 
within subspecies enterica (Brown et al., 2003; Octavia and Lan, 2006; Falush et al., 2006). 
The effects of recombination are minimized when ClonalFrame is used to deduce 
genealogies. Therefore, to test whether the structures of the groups identified by 
ClonalFrame are different when recombination is not excluded, I used the Neighbor-net 
algorithm on the alignment of unique concatenated sequences from all serovars. The 
conflicting signals introduced to nucleotide sequences by recombination or recurrent 
mutations are displayed as parallel paths in a phylogenetic network by Neighbor-net. 
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Table 3.2. Groups identified using ClonalFrame for each serovar 
 
Serotype 
No. of 
isolates 
ClonalFrame 
groups 
No. of 
STs STs 
Enteritidis1 
 
 
141 
 
 
Enteritidis 13 11, 470, 183, 366, 78, 
310, 168, 136, 460, 92, 
331, 180, 172 
 2 Singletons 2 6, 77 
Kentucky 13 Kentucky-I 1 198 
 159 Kentucky-II 4 151,152, 221, 318 
Newport 32 Newport-I 3 156, 166, 360 
 
222 
 
 
 
 
Newport-II 23 31, 132, 348, 188, 191, 
200, 346, 349, 193, 45, 
116, 121, 125, 131, 
165, 353, 355, 46, 157, 
211, 158, 201, 184 
 
130 
 
 
 
 
 
Newport-III 23 118, 189, 122, 199, 
164, 163, 345, 351, 
120, 190, 223, 167, 5, 
187, 347, 352, 354, 
115, 119, 117, 375, 
123, 350 
Paratyphi B2 16 Paratyphi B-I 1 28 
 5 Paratyphi B-II 3 42, 423, 135 
 
29 
 
Paratyphi B-III 10 86, 43, 267, 266, 265, 
264, 149, 307, 110, 325 
 16 Paratyphi B-IV 4 88, 127, 263, 372 
Typhimurium 
 
 
 
 
362 
 
 
 
 
Typhimurium 22 19, 128, 376, 209, 205, 
204, 159, 137, 429, 
313, 35, 99, 456, 153, 
213, 302, 98, 323, 332, 
328, 34, 394 
 3 Singleton 2 36, 207 
Total 1130  111   
 
1Isolates of Gallinarum and Pullorum are also included 
2Isolates of Paratyphi B var. Java are also included 
 
Neighbor-net identified similar groups to those defined by ClonalFrame, both in numbers 
and composition (Fig. 3.2). However, Neighbor-net separated three STs from Newport-II 
and one from Paratyphi B-II, which might indicate that multiple alleles in these STs were 
acquired by homologous recombination. Most STs in Enteritidis and Typhimurium were 
arranged in a radial symmetry. However, conflicting signals were resolved for multiple STs 
in the other groups as indicated by parallel paths within these groups. 
In agreement with the conclusions based on the ClonalFrame output, a serovar to serovar 
variation in population structures was also observed within subspecies enterica with 
Neighbor-net. The radial symmetry in Enteritidis and Typhimurium might indicate that 
most diversity in these groups was generated by mutations whereas parallel paths for 
multiple STs in other groups might be indicative of substantial recombination. 
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Fig. 3.2. Neighbour-net on concatenated sequence alignment following GTR+I substitution model and 
parameter estimates chosen using Modeltest 3.7 
 
 
Allele based phylogeny has been used extensively to study bacterial population structure 
and identify the groups of closely related genotypes. To compare the sequence based 
phylogeny with the groups based on shared alleles, an MSTREE was generated from the 
allelic profiles of isolates. Groups of at least 3 STs that shared six of the seven alleles with 
one another were assigned a group designation. Distinct STs with ≥ 10 isolates were also 
designated as groups whereas those with < 10 isolates were treated as singletons. STs that 
shared up to three alleles were recognized by the use of cross-linking in order to help to 
resolve relatedness between the STs of different serovars up to the level of four allelic 
differences (Fig. 3.3). 
The numbers and compositions of the groups were again consistent with the ClonalFrame 
results for each serovar. However, Newport-II was divided into two subgroups and four 
singletons STs. All singletons were linked to ST45 in one of the subgroups at a distance of 
two alleles (DLVs). One of these singletons, ST193, connected both the subgroups because 
it also shared five alleles with ST31 of the second subgroup (Fig. 3.3, box a). However, the 
structure of Newport-II was identical with the ClonalFrame output when the algorithm was 
allowed to identify groups based on sharing of five alleles instead of six (Fig. 3.3, box b). 
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Moreover, numerous cross-links between the STs from both the subgroups suggest that 
they are closely related. Similarly, two STs (ST172 and ST180) from Enteritidis, one 
(ST135) from Paratyphi B-II and two (ST123 and ST350) from Newport-III were also 
separated. These STs were also linked to the respective groups by multiple cross-links and 
lacked close associations with other groups. Therefore, the population structures of all the 
serovars were consistent with the ClonalFrame and Neighbor-net results, suggesting that 
the serovar Newport was more heterogeneous than Enteritidis, Kentucky or Typhimurium 
but lesser than Paratyphi B. 
 
 
 
Figure 3.3 An MSTREE on the allelic profiles of isolates with a crosslink distance of four alleles. Box a). the 
structure of Newport-II without cross-links and Box b). Newport-II when the groups of ≥ 3 STs that shared at 
least five of the seven alleles with at least one other ST in the group were considered. 
 
 
Cross-links were also observed between several STs of Newport-II and Newport-III, 
indicating that multiple STs between these groups share up to 4 alleles. One alternative is 
that these two groups are merging together due to frequent homologous recombination 
between the groups. A second is that they are drifting apart by recombining with other 
serovars. 
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Table 3.3. Allelic profiles in 384 Newport isolates 
Groupings ST  
No. of 
Strains aroC dnaN hemD hisD purE sucA thrA 
Newport-I 166 24 5 14 6 12 5 14 58 
 156 7 63 14 6 12 5 14 58 
 360 1 63 14 6 12 5 14 12 
Newport-II 45 109 10 7 21 14 15 12 12 
 31 43 2 2 15 14 15 20 12 
 46 36 10 7 21 12 15 12 12 
 132 9 2 57 15 14 15 20 12 
 116 6 10 7 21 14 15 39 12 
 191 2 2 2 15 14 15 20 42 
 121 1 10 7 21 14 36 12 12 
 125 1 10 7 21 14 15 53 12 
 131 1 10 56 21 14 15 12 12 
 157 1 10 61 21 12 15 12 12 
 158 1 10 62 21 67 15 12 12 
 165 1 10 7 21 14 58 12 12 
 184 1 10 64 21 14 15 12 33 
 188 1 2 7 15 14 15 39 12 
 193 1 10 2 21 14 15 20 12 
 200 1 77 2 15 14 15 20 12 
 201 1 16 7 21 14 15 12 42 
 211 1 10 7 21 12 15 12 71 
 346 1 2 2 15 14 36 20 12 
 348 1 2 2 15 14 15 39 12 
 349 1 2 2 15 43 36 20 12 
 353 1 10 7 21 43 15 12 12 
 355 1 10 7 21 14 15 7 12 
Newport-III 118 75 16 2 45 43 36 39 42 
 5 19 16 43 45 43 36 39 42 
 115 6 16 2 45 43 36 12 42 
 164 6 16 2 45 70 36 39 42 
 350 3 16 2 95 117 36 39 117 
 167 2 16 2 61 71 36 39 42 
 189 2 16 2 45 14 36 39 42 
 223 2 16 2 61 43 36 39 42 
 117 1 16 2 45 43 15 12 42 
 119 1 16 2 18 43 36 12 42 
 120 1 16 2 40 43 36 39 42 
 122 1 16 2 45 43 15 39 42 
 123 1 10 2 21 43 36 12 42 
 163 1 16 2 60 43 36 39 42 
 187 1 16 43 45 43 36 39 12 
 190 1 16 2 40 43 36 19 42 
 199 1 16 2 45 43 65 39 42 
 345 1 16 2 45 43 36 20 42 
 347 1 16 43 45 43 36 20 42 
 351 1 16 2 45 62 36 39 42 
 352 1 16 43 45 43 15 39 42 
 354 1 16 43 45 43 71 39 42 
 375 1 16 2 45 43 5 39 42 
 
Newport is particularly different to other serovars. The groups of other serovars were more 
distinct because ≥ 5 alleles were different between the STs of any two groups within those 
serovars. However, an ST of Paratyphi B-III (ST110) shared three alleles with three STs 
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(ST31, ST191 and ST346) of Newport-II. It might indicate the genetic exchange between 
the isolates of different serovars within subspecies enterica or the remnants of the common 
ancestry. These results are indicative of inter-serovar recombination within subspecies 
enterica. 
3.3.2 Properties of housekeeping genes in various groups 
The sequence diversity at selectively neutral loci is the most appropriate to study the 
evolutionary relatedness among strains (Maiden et al., 1998) whereas genes under positive 
selection might not correlate with the evolutionary history. To test the selective pressure on 
gene fragments, the Ka/Ks ratios were calculated for each fragment from all serovars. Most 
gene fragments were under strong purifying selection as indicated by a Ka/Ks ratio of << 
1.0 except for hemD (Table 3.4) (Perez-Losada et al., 2006). Although the value of Ka/Ks 
was <1.0 for the fragments of hemD indicating an absence of diversifying selection, it was 
comparatively much higher than other gene fragments. It indicates that the frequency of 
fixation of non-synonymous substitutions is higher in hemD than other gene fragments. 
Table 3.4. Average pairwise distance at non-synonymous (Ka) and synonymous (Ks) sites among gene 
fragments 
Gene fragment Ka Ks Ka/Ks 
aroC 0.00002 0.02364 0.0008 
dnaN 0.00136 0.02271 0.0599 
hemD 0.00522 0.02031 0.2570 
hisD 0.00315 0.05104 0.0617 
purE 0.00077 0.02613 0.0295 
sucA 0.00009 0.02933 0.0031 
thrA 0.00003 0.06131 0.0005 
 
To compare the genetic diversity between the groups, the mean pairwise nucleotide 
distances were calculated for gene fragments within each group. Kentucky-I and Paratyphi 
B-I were single ST groups that did not have any polymorphic sites. Only ≤4 loci were 
polymorphic in Kentucky-II, Newport-I, Paratyphi B-II, Paratyphi B-III and Paratyphi B-
IV (Table 3.5a) whereas ≥ 6 loci were polymorphic among remaining groups including 
Newport-II and III (Table 3.5b). 
The numbers of polymorphic and informative sites were highly variable between Newport 
groups. Only two loci, aroC and thrA, were polymorphic in Newport-I, each has two 
alleles. In contrast, all the seven loci were polymorphic with 2-7 alleles in Newport-II and 
Newport-III. Nucleotide diversity on concatenated sequence alignment was significantly 
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lower within Newport-I than other Newport groups. The highest π value was observed for 
Newport-II whereas Newport-III showed intermediate genetic diversity between Newport-I 
and II. 
 
 
Table 3.5a. Characteristics of gene fragments in groups with ≤ 4 polymorphic loci 
ClonalFrame 
Group 
Gene 
fragment 
Alleles 
 
Polymorphic 
sites 
Informative 
sites 
π 
 
Kentucky-II hisD 2 9 0 0.0002 ± 0.0001 
(N = 159) sucA 2 5 0 0.0001 ± 0.0001 
 thrA 2 1 0 <0.0001 ± 0.0001 
 Concatenated 4 15 0 0.0001 ± 0.0000 
Newport-I aroC 2 1 1 0.0008 ± 0.0008 
(N = 32) thrA 2 1 0 0.0001 ± 0.0001 
 Concatenated 3 2 1 0.0001 ± 0.0001 
ParatyphiB-II aroC 2 5 0 0.0040 ± 0.0016 
(N = 5) dnaN 2 5 0 0.0040 ± 0.0018 
 sucA 2 1 0 0.0008 ± 0.0007 
 thrA 3 10 0 0.0081 ± 0.0021 
 Concatenated 3 21 0 0.0025 ± 0.0005 
ParatyphiB-III aroC 5 16 7 0.0038 ± 0.0010 
(N = 29) dnaN 2 5 5 0.0030 ± 0.0014 
 purE 4 6 1 0.0022 ± 0.0012 
 thrA 2 1 1 0.0003 ± 0.0002 
 Concatenated 10 28 14 0.0013 ± 0.0004 
ParatyphiB-IV aroC 2 8 0 0.0020 ± 0.0007 
(N = 16) dnaN 2 1 1 0.0006 ± 0.0006 
 purE 2 26 0 0.0085 ± 0.0016 
 Concatenated 4 35 1 0.0014 ± 0.0002 
Note: 1. Monomorphic genes within each group were not mentioned. 
2. Kentucky-I and Paratyphi B-I, single ST groups, were also not mentioned because all gene fragments were 
monomorphic. 
 
 
Although only ≤ 4 loci were polymorphic in Newport-I and Kentucky-II while six or more 
loci were polymorphic in Enteritidis and Typhimurium, the π values were comparable 
between these groups. Similarly, nucleotide diversity was comparable between Newport-II 
and Paratyphi B-II even though all seven loci were polymorphic in Newport-II whereas 
three of the loci were monomorphic in Paratyphi B-II. The π value in Newport-III was not 
comparable to any other group because they were higher than Enteritidis, Kentucky-II and 
Typhimurium but lower than Paratyphi B-II, III and IV. Therefore, like the variation in the 
population structure, nucleotide diversity among gene fragments also varied greatly 
between the serovars as well as groups within a serovar (Table 3.5a & b). However, I did 
not observe any correlation between the two. 
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Table 3.5b. Characteristics of gene fragments in other groups 
ClonalFrame 
Group 
Gene 
fragment 
Alleles 
 
Polymorphic 
sites 
Informative 
sites 
π 
 
Enteritidis aroC 5 8 5 0.0004 ± 0.0001 
(N = 141) dnaN 1 0 0 <0.0003 ± 0.0003 
 hemD 3 3 2 0.0002 ± 0.0001 
 hisD 2 2 2 0.0001 ± 0.0001 
 purE 5 5 4 0.0006 ± 0.0003 
 sucA 2 1 1 0.0001 ± 0.0001 
 thrA 3 7 4 0.0003 ± 0.0001 
 Concatenated 13 26 18 0.0002 ± 0.0001 
Newport-II aroC 4 5 2 0.0016 ± 0.0010 
(N = 222) dnaN 7 11 6 0.0042 ± 0.0016 
 hemD 2 6 6 0.0055 ± 0.0020 
 hisD 4 11 10 0.0048 ± 0.0014 
 purE 3 6 5 0.0004 ± 0.0001 
 sucA 5 10 10 0.0042 ± 0.0017 
 thrA 4 15 8 0.0006 ± 0.0002 
 Concatenated 23 64 47 0.0031 ± 0.0005 
Newport-III aroC 2 3 0 0.0001 ± 0.0000 
(N = 130) dnaN 2 1 1 0.0006 ± 0.0006 
 hemD 7 9 8 0.0009 ± 0.0003 
 hisD 6 7 7 0.0007 ± 0.0003 
 purE 5 7 5 0.0007 ± 0.0003 
 sucA 4 10 10 0.0026 ± 0.0009 
 thrA 3 9 1 0.0003 ± 0.0001 
 Concatenated 23 46 32 0.0008 ± 0.0002 
Typhimurium aroC 3 2 2 <0.0001 ± 0.0001 
(N = 364) dnaN 2 1 1 0.0001 ± 0.0001 
 hemD 3 2 2 0.0001 ± 0.0000 
 hisD 2 1 0 <0.0001 ± 0.0001 
 purE 4 3 3 0.0013 ± 0.0008 
 sucA 9 13 3 0.0003 ± 0.0002 
 thrA 5 7 0 0.0001 ± 0.0000 
 Concatenated 23 29 10 0.0002 ± 0.0001 
 
3.3.3 Source of diversity within each group 
Parallel paths were observed in Neighbor-net possibly indicating higher frequencies of 
recombination than mutation except for Enteritidis and Typhimurium (Fig. 3.2). Therefore, 
the concatenated sequence alignment of each group was tested for recombination by 
Reticulate (Jakobsen and Easteal, 1996) and Фw test (Bruen et al., 2006). These tests are 
based on the compatibilities between informative sites in a nucleotide sequence alignment 
which is considered to be one of the most powerful methods for recombination detection 
(Bruen et al., 2006). Kentucky-I, Kentucky-II, Newport-I, Paratyphi B-I, Paratyphi B-II and 
Paratyphi B-IV were not tested due to absence or inadequate numbers of informative sites. 
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In agreement with the Neighbor-net, high compatibility scores (1.00) were observed within 
Enteritidis and Typhimurium (Table 3.6), indicating that most diversity within these groups 
might have generated by point mutations rather than recombination. Although parallel paths 
were observed in Paratyphi B-III by Neighbor-net, a high overall compatibility (0.98) was 
observed between the informative sites indicating an absence of recombination or repeated 
mutations. Similarly, a limited number of incompatibilities were observed in Newport-III as 
suggested by a compatibility score of 0.82. In contrast, the compatibility score (0.52) was 
much lower in Newport-II, suggesting that informative sites have different evolutionary 
histories in Newport-II than Newport-III. Alternatively, the high compatibility scores may 
reflect the low numbers of informative sites in all the groups except for Newport-II. 
Table 3.6. Compatibility scores and Фw probability within each ClonalFrame group 
Group Compatibility Фw 
Enteritidis 1.00 1.00 
Kentucky-I n.d. n.d. 
Kentucky-II n.d. n.d. 
Newport-I n.d. n.d. 
Newport-II 0.57 <0.001* 
Newport-III 0.82 <0.001* 
ParatyphiB-I n.d. n.d. 
ParatyphiB-II n.d. n.d. 
ParatyphiB-III 0.98 0.98 
ParatyphiB-IV n.d. n.d. 
Typhimurium 1.00 1.00 
n.d., not done; *, significant. 
 
Since a high compatibility score was observed even for the groups with multiple parallel 
paths in Neighbor-net, another statistical program, Фw test was used. The Фw test has been 
compared with many other recombination detection programs and found to be the best that 
can also distinguish recurrent mutation from recombination (Bruen et al., 2006). However, 
similar to the Reticulate results, recombination was not detected in Enteritidis, Paratyphi B-
III and Typhimurium (Table 3.6). Recombination was only detected in Newport-II and 
Newport-III (p < 0.05). 
Both the tests suggest that mutation has been the main source of diversity within 
Enteritidis, Paratyphi B-III and Typhimurium. Recombination introduced limited 
incompatibilities within Newport-III and even more incompatibilities in Newport-II. 
However, the power of these tests might be limited due to a very low nucleotide diversity 
and limited numbers of parsimony informative sites within each group. Pairwise 
compatibilities could not be calculated between gene fragments due to complete lack or 
 67
insufficient numbers of informative sites in many gene fragments within the groups. Фw 
test has also been found to have difficulties detecting recombination from the alignments 
where recombination rates were very low or nucleotide diversity was ≤ 1% (Bruen et al., 
2006). 
As an alternative, the classical approach (Feil et al., 2000) was used to assess the relative 
roles of recombination and mutation in the evolution of each group. Based on the number 
of nucleotide differences between alleles in related STs, the mutational and recombinational 
events were scored at each step of the MSTREE starting from the predicted founder of each 
group. The ST with the highest numbers of single locus variants (SLVs) was considered to 
represent the founder of each group. In cases of more than one potential founder with equal 
numbers of SLVs, the ST with the highest number of isolates was chosen. If alleles in STs 
linked to the founder differed from the founder alleles by three or more nucleotides, they 
were classified as recombinational events. If they differed by one or two nucleotides, they 
were considered to result from mutations unless they were also present in other clonal 
groups or STs of other serovars, in which case they were scored as recombinational (Feil et 
al., 1999; Feil et al., 2000; Feil et al., 2001). The same criteria were then sequentially 
applied to the descendents of each SLV. The ratio of recombinational to mutational events 
(per allele R/M) was calculated for each group. The number of polymorphic sites 
introduced by recombination was divided by number of nucleotides changed by mutation in 
each group to calculate a relative likelihood that a nucleotide will change by recombination 
than mutation (per site R/M). 
The clonal groups identified using the BURST algorithm have been extensively used to 
score mutation and recombinational events by this approach (Feil et al., 2001). I tested the 
newer version of this algorithm, eBURST 3.0, on Newport data to generate a radial diagram 
of SLVs linked to predicted founders (Fig. 3.4). The predicted founder represents the most 
likely founder genotype of the group (blue circles in Fig. 3.4). This algorithm also identifies 
co-founder or subgroup founder that is an SLV of the predicted founder which has 
diversified to generate a number of its own SLVs (yellow circles in Fig. 3.4). The structure 
of Newport groups were consistent with the MSTREE when an eBURST group was defined 
as a group of three or more STs where isolates shared at least six alleles with at least one 
other isolate in the group. However, the relatedness between the genotypes was not 
completely consistent between the eBURST diagram and the MSTREE. Newport-II was 
divided into two groups by eBURST, designated as Newport-IIa and Newport-IIb. In 
addition, ST158, ST184, ST193 and ST201 which are DLVs of ST45 in Newport-IIb were 
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separated from this subgroup. I also noted that ST193 is a DLV of ST31 in Newport-IIa 
that links both Newport-IIa and IIb in the MSTREE. Similarly, ST123 (a DLV of ST115) and 
ST350 (triple locus variant, TLV, of ST118) were also separated from Newport-III by 
eBURST. 
 
 
Figure 3.4. eBURST diagram on Newport isolates. Predicted founders are positioned centrally in each cluster 
and are shown in blue color. The subgroup founders (co-founders) are shown in yellow color. The area of 
each circle corresponds to the abundance of the isolates of the ST. 
 
 
An MSTREE of Newport isolates (Fig. 3.5) provides more information on the inter-genotype 
relationships because DLVs and TLVs are linked to the respective groups in addition to 
SLVs. Estimates of mutations and recombinational events would be more precise if these 
DLVs and TLVs were included. Therefore, I used the MSTREE to score events. 
A graphical summary of the assignments of events to mutation or recombination within 
each Newport group is shown in Fig. 3.5. Newport-I consists of a founder ST (ST156) plus 
two SLVs. The variant alleles in each of the SLVs differed from the founder alleles by one 
SNP each, but were scored as recombinational events because the same alleles were 
observed in other Newport groups and/or other serovars (Fig 3.5). The R/M ratios were > 
2.0 per allele as well as per site (Table 3.7). 
 69
 
Figure 3.5. An MSTREE of Newport isolates. STs in rectangles are the predicted founders. STs derived from 
the putative ancestors by mutational events in variant alleles are shown in white and those by recombination 
in black. The sizes of circles correspond to the number of isolates. In ST158 (marked by a * sign) of Newport-
II, one variant allele was derived by a point mutation in founder alleles while a second arose by 
recombination. 
Table 3.7. Recombinational and mutational events 
Groups 
Founder 
ST 
Mutational 
events 
Recombination 
events 
R/M per 
allele 
Polymorphic 
sites 
R/M per 
site 
Enteritidis ST11 10 4 0.4 26 1.6 
Kentucky-II ST152 1 2 2.0 15 14.0 
Newport-I ST156 0 2 >2.0 2 >2.0 
Newport-II ST45 7 20 2.9 64 8.1 
Newport-III ST118 9 16 1.8 46 4.1 
Paratyphi B-II ST42 1 4 4.0 21 5.0 
Paratyphi B-III ST86 2 7 3.5 28 13.0 
Paratyphi B-IV ST88 1 2 2.0 35 34.0 
Typhimurium ST19 16 5 0.3 29 0.7 
Note: Groups Kentucky-I and Paratyphi B-I consist of only single ST each, therefore, excluded. 
 
ST45 is the founder of Newport-II, which had eight SLVs and four DLVs. The variant 
alleles in two of the SLVs differed by a single SNP from the founder alleles and were not 
found elsewhere. They were, therefore, scored as point mutations. The variant alleles in the 
remaining SLVs were found in other Newport groups and/or other serovars. These were 
scored as recombinational events. Both variant alleles in three DLVs (STs 20, 184 and 193) 
were present elsewhere (recombination) whereas one mutational and one recombinational 
event were scored for the fourth DLV (ST158). 
In addition to the SLVs and DLVs directly descended from ST45, several STs were linked 
to the founder through an SLV (ST46) or a DLV (ST193). ST46 was the putative ancestor 
of STs 157 and 211 and the events were scored in these STs based on the differences from 
ST46. ST193 was a DLV to both ST45 as well as to ST31. ST193 was used as the ancestral 
genotype to score events in ST31 and ST31 was used to score events in its SLVs and 
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further links radiating from ST31. For Newport-II, the average per allele R/M was 2.9 and 
the per site R/M was 8.1. Of the 64 polymorphic sites that were observed among variant 
alleles, only seven were introduced by point mutations. 
The founder ST (ST118) of Newport-III had 12 SLVs which were used to score mutational 
and recombinational events, as described above. The events were also scored in ST350 
although it is a TLV to ST118; all three variant alleles were derived by point mutations. A 
total of 9 mutational and 16 recombinational events were scored in Newport-III leading to a 
per allele R/M of 1.8 and per site R/M of 4.1. Both values are slightly lower than for 
Newport-II. 
These analyses indicate that recombination has been more important than mutation for 
introducing polymorphic sites in new alleles within Newport groups. Similar observations 
were made for Kentucky-II, Paratyphi B-II, Paratyphi B-III and Paratyphi B-IV. The values 
of per allele R/M were 2.0 in Kentucky-II and Paratyphi B-IV, which are comparable to 
Newport-III. The per allele R/M were ~ 4.0 in Paratyphi B-II and Paratyphi B-III. In 
contrast, the per allele R/M in Enteritidis and Typhimurium were < 1.0, indicating that most 
new alleles arose from mutations. 
The R/M per site values indicate that an individual polymorphism is much more likely to 
arise by recombination than mutation in all groups except for Enteritidis and Typhimurium. 
The R/M per site values for the Newport groups ranged from > 2.0 to 8.1, which are higher 
than that of Enteritidis or Typhimurium but lower than Kentucky-II, Paratyphi B-III and 
Paratyphi B-IV. These results contrast to the Фw test, which only detected recombination 
within Newport-II and Newport-III. Neighbor-net, compatibility scores and the Фw test, all 
confirmed that mutations were more frequent than recombination in Enteritidis and 
Typhimurium. 
3.3.4 Properties of Newport groups 
3.3.4.1 Association with hosts 
Newport lineages that seemed to be associated with humans and animals have been 
identified by two studies (Beltran et al., 1988; Alcaine et al., 2006). 105 Newport isolates 
were grouped into two distinct clusters by MLEE analyses and the distribution of isolates 
from humans and domesticated animals was significantly different between them (Beltran 
et al., 1988). 75% of the isolates in one group were isolated from humans whereas 63% of 
isolates in the other group were from swine or other mammals. Similarly, two lineages were 
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identified when 43 Newport isolates (18 human and 25 bovine isolates) were analyzed by a 
three gene MLST scheme (Alcaine et al., 2006). All bovine isolates clustered together in a 
group with 61% of human isolates. All isolates in the second cluster were isolated from 
humans. The distribution of isolates from both the sources in the two groups was 
significantly different indicating an association between these groups and the host 
categories. I therefore tested whether the proportions of isolates from humans and non-
human hosts (avian, bovine, equine, swine and reptiles) were significantly different 
between the Newport groups by a χ2 test. Isolates from food, animal feed or water were not 
included because these sources represent vectors rather than hosts. I also excluded isolates 
lacking the host information. 
None of the three Newport groups that were identified in this study was completely specific 
to a single host. However, all 28 reptile isolates were exclusively confined to Newport-II 
and Newport-III (Table 3.8, Fig. 3.6A). The distribution of isolates from humans and non-
human hosts into the three Newport groups differed significantly (p = 0.01). This might 
reflect the existence of Newport-I, of which 27/29 isolates were from humans. The 
proportion of NhWBA isolates was higher in Newport-II (83%) than in the two other 
groups (Table 3.8). Only 15% of NhWBA and 36% of reptile isolates grouped in Newport-
III. 
Table 3.8. Distribution of isolates from various hosts among Newport groups 
Groups 
Avian 
Isolates (%)  
Human 
Isolates (%) 
NhWBA* 
Isolates (%) 
Reptiles 
Isolates (%) 
Newport-I 1 (5) 27 (16) 1 (2) 0 (0) 
Newport-II 11 (50) 44 (26) 34 (83) 18 (64) 
Newport-III 10 (45) 97 (58) 6 (15) 10 (36) 
* Non-human warm blooded animals, includes isolates from bovine, equine and swine hosts. 
Note: 25 isolates that were isolated from food, feed, fertilizer, or unknown hosts were excluded. 
 
3.3.4.2 Association with time 
All Newport isolates were isolated between 1940 and 2005, except for one that was isolated 
in 1918 from a human in France. I grouped them into three categories, i) those isolated 
prior to 1959, ii) between 1960 and 1979 and iii) since 1980 (Table 3.9). A χ2 test was 
computed on these numbers to test if the distribution of isolates among clonal groups from 
different time categories was significantly different. 
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All the isolates in Newport-I were isolated during or after the 1970s (Fig. 3.6B). However, 
the number of Newport-I isolates was low and no significant association was revealed 
between the Newport groups and time of isolation (p = 0.15). 
 
 
 
Fig. 3.6. Frequency of isolates among Newport groups from different A) hosts (excluding 25 isolates from 
food, feed or other unknown sources), B) dates (excluding 8 isolates with no information), C) continents 
(excluding 27 isolates from other geographic locations or no information) and D) antimicrobial resistance 
phenotype (excluding 20 isolates that were not tested). 
 
Table 3.9. Distribution of isolates from different time of isolation among Newport groups 
Number of isolates (%) Groups 
 ≤ 1959 1960-1979 ≥ 1980 
Newport-I 0 (0) 9 (7.7) 23 (10.2) 
Newport-II 25 (75.8) 68 (58.1) 124 (54.9) 
Newport-III 8 (24.2) 40 (34.2) 79 (35.0) 
Note: Eight isolates with unknown dates of isolation were excluded. Association between the time of isolation 
and the Newport groups was not found to be significant (p = 0.15). 
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3.3.4.3 Geographic association of Newport groups 
Most of the strains were isolated either in Europe or in North America. 31 of the 32 isolates 
in Newport-I were isolated in Europe whereas most isolates of the other groups were found 
in North America. The distribution of isolates from these continents was significantly 
different between the groups by a χ2 test (p < 0.001) (Table 3.10, Fig. 3.6C). 
Table 3.10. Distribution of isolates from Europe and North America among Newport groups 
Continent Newport-I Newport-II Newport-III 
Europe 31 (96.9) 73 (36.7) 28 (22.2) 
North America 1 (3.1) 126 (63.3) 98 (77.8) 
Note: 27 isolates that were isolated in Asia, Africa, Caribbean, South America or did not have this 
information were excluded. Distribution of isolates from Europe and North America is significantly different 
among Newport groups (p < 0 .0001). 
 
3.3.4.4 Antimicrobial susceptibility patterns and association with Newport groups 
A total of 364 Newport isolates were tested against a panel of 16 antimicrobials. 244 
isolates (67%) were pan-susceptible and the remaining isolates were resistant to at least one 
antimicrobial. The most prevalent resistances to individual antimicrobials among these 120 
isolates were to sulfamethoxazole (28%), tetracycline (26%), streptomycin (25%) and 
ampicillin (24%) followed by chloramphenicol and cephalothin (19% each), amoxicillin-
clavulanic acid and ceftiofur (16% each), cefoxitin (15%), kanamycin (8%), trimethoprim-
sulfamethoxazole (7%), ceftriaxone (5%), gentamicin (4%) and nalidixic acid (2%) (Table 
3.11). 
A total of 51 antimicrobial susceptibility patterns were observed among Newport isolates 
(Table 3.12). These patterns were simplified into phenotype categories, e.g. multi-drug 
resistant (MDR), single drug resistant (SDR) and pan-susceptible. A strain was designated 
MDR if it was resistant to at least two separate classes of antimicrobials (Weill et al., 2006) 
and isolates that were resistant to any single antimicrobial were designated as single drug 
resistant (SDR). Isolates that were resistant to extended spectrum cephalosporins (MDR-
AmpC) were further separated from MDR isolates. These isolates were resistant to 
ampicillin, chloramphenicol, streptomycin, sulphamethoxazole, tetracycline, 
amoxicillin/clavulanic acid, cephalothin, cefoxitin and ceftiofur and intermediate or full 
resistant to ceftriaxone. However, resistance to additional antimicrobials was also observed 
for many MDR-AmpC isolates (Table 3.12). 
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96 (26%) isolates were multi-drug resistant (MDR), 53 (55%) of which were characterized 
as MDR-AmpC. One human isolate that was resistant to streptomycin and intermediately 
resistant to ampicillin, chloramphenicol and tetracycline was also designated as SDR. 
Another isolate from an avian host was resistant to ampicillin and cephalothin. This isolate 
was not assigned to any category because it was the sole isolate that was resistant to two 
antimicrobials which belonged to the same class. The distribution of isolates with these 
phenotypes was tested for any association with human or non-human sources by a χ2 test. 
Isolates from food, animal feed, fertilizer and meat were excluded for the reasons 
previously mentioned. 
Table 3.11. Antimicrobial resistance among Newport isolates from different host types 
   Resistant isolates (intermediate resistant) 
Antimicrobial 
agent 
 
Resistance 
Breakpoint 
(μg/ml) 
Human 
(258) 
 
Bovine 
(20) 
 
Swine 
(16) 
 
Chicken 
(13) 
 
Turkey 
(9) 
 
Reptile 
(27) 
 
Othersa 
(21) 
 
Total 
(364) 
 
Ampicillin ≥ 32 57 (1) 16 (0) 7 (0) 4 (0) 1 (0) 0 (0) 4 (0) 89 (1) 
Amoxicillin/ 
clavulanic acid 
≥ 32/16 27 (2) 
 
16 (0) 
 
7 (0) 
 
3 (0) 
 
0 (0) 
 
0 (0) 
 
4 (0) 
 
57 (2) 
 
Ceftriaxone ≥ 64 16 (12) 1 (15) 0 (7) 0 (3) 0 (0) 0 (0) 0 (4) 17 (41) 
Cephalothin ≥ 32 37 (1) 16 (0) 7 (0) 4 (0) 0 (0) 0 (0) 4 (0) 68 (1) 
Chloramphenicol ≥ 32 39 (1) 17 (0) 6 (0) 4 (0) 0 (0) 0 (0) 4 (0) 70 (1) 
Trimethoprim/ 
sulfamethoxazole 
≥ 4/76 17 (0) 
 
3 (0) 
 
2 (0) 
 
0 (0) 
 
0 (0) 
 
0 (0) 
 
3 (0) 
 
25 (0) 
 
Cefoxitin ≥ 32 26 (1) 16 (0) 7 (0) 3 (0) 0 (0) 0 (0) 4 (0) 56 (1) 
Gentamicin ≥ 16 6 (0) 4 (0) 2(0) 1 (0) 2 (0) 0 (0) 0 (0) 15 (0) 
Kanamycin ≥ 64 14 (0) 8 (0) 3 (0) 2 (0) 1 (0) 0 (0) 0 (0) 28 (0) 
Nalidixic acid ≥ 32 7 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 1 (0) 8 (0) 
Sulfamethoxazole ≥ 512 64 (0) 18 (0) 8 (0) 4 (0) 2 (0) 1 (0) 4 (0) 101 (0) 
Streptomycin ≥ 64 57 (0) 18 (0) 8 (0) 4 (0) 1 (0) 0 (0) 4 (0) 92 (0) 
Tetracycline ≥ 16 56 (1) 19 (0) 8 (0) 5 (0) 0 (0) 0 (0) 5 (0) 93 (1) 
Ceftiofur ≥ 8 28 (0) 16 (0) 7 (0) 3 (0) 0 (0) 0 (0) 4 (0) 58 (0) 
All the isolates were sensitive to amikacin and ciprofloxacin (resistance breakpoints ≥ 32 and ≥ 4 μg/ml 
respectively). 
a Isolates from animal feed, food, fertilizer, frog legs, horse, lion, meat and rat. 
MIC values (μg/ml) for intermediate resistance to ampicillin (16), amoxicillin/clavulanic acid (16/8), 
ceftriaxone (16-32), cephalothin (16), chloramphenicol (16), cefoxitin (16), gentamicin (8), kanamycin (32), 
streptomycin (16), tetracycline (8) and ceftiofur (4) 
 
 
 75
Table 3.12: Antimicrobial resistance patterns of Newport isolates from different sources 
Number of isolates (%) Resistance profile 
 
Simple phenotype 
 Human Bovine Swine Chicken Turkey Reptile Others 
AmpAugChlStrTetTioSmxFoxCepSxtGen[Axo]Kan MDR-AmpC 0 (0) 1 (5) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
AmpAugChlStrTetTioSmxFoxCep[Axo]GenKan MDR-AmpC 0 (0) 3 (15) 1 (6.3) 1 (7.7) 0 (0) 0 (0) 0 (0) 
AmpAugChlStrTetTioSmxFoxCep[Axo]SxtKan MDR-AmpC 0 (0) 1 (5) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
AmpAugChlStrTetTioSmxFoxCepAxoGenKan MDR-AmpC 2 (0.8) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
AmpAugChlStrTetTioSmxFoxCep[Axo]Kan MDR-AmpC 1 (0.4) 0 (0) 0 (0) 1 (7.7) 0 (0) 0 (0) 0 (0) 
AmpAugChlStrTetTioSmxFoxCep[Axo]Sxt MDR-AmpC 5 (1.9) 1 (5) 1 (6.3) 0 (0) 0 (0) 0 (0) 3 (14.3) 
AmpAugChlStrTetTioSmxFoxCepAxoKan MDR-AmpC 0 (0) 1 (5) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
AmpAugChlStrTetTioSmxFoxCepAxoSxt MDR-AmpC 1 (0.4) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
AmpAugChlStrTetTioSmxFoxCepAxo MDR-AmpC 10 (3.9) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
AmpAugChlStrTetTioSmxFoxCep[Axo] MDR-AmpC 5 (1.9) 9 (45) 4 (25) 1 (7.7) 0 (0) 0 (0) 1 (4.8) 
AmpAugStrTetTioSmxFoxCep[Axo]SxtKan MDR 0 (0) 0 (0) 1 (6.3) 0 (0) 0 (0) 0 (0) 0 (0) 
AmpAugChlStrTetTioSmx[Fox]Cep[Axo] MDR 1 (0.4) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
AmpStrTetTioSmxFoxCepAxoKanNal MDR 1 (0.4) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
AmpAugStrTetTioSmxFoxCepAxo MDR 1 (0.4) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
Amp[Aug]ChlStrTetSmxKan MDR 1 (0.4) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
AmpChlStrTetSmxSxtGenNal MDR 1 (0.4) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
AmpStrTetSmx[Cep]GenKan MDR 1 (0.4) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
AmpAugChlStrTetSmxKan MDR 1 (0.4) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
AmpChlTetSmxSxtGenNal MDR 1 (0.4) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
AmpChlStrTetSmxSxtKan MDR 4 (1.6) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
AmpChlStrTetSmxSxtNal MDR 1 (0.4) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
AmpChlStrTetSmxSxt MDR 2 (0.8) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
AmpChlStrTetSmxCep MDR 1 (0.4) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
AmpStrTetSmxCepKan MDR 1 (0.4) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
AmpTioSmxCepAxoSxt MDR 1 (0.4) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
Amp[Aug]StrTetCep MDR 1 (0.4) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
AmpChlStrTetSmx MDR 1 (0.4) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
AmpStrTetSmxCep MDR 5 (1.9) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
AmpChlTetSmxNal MDR 1 (0.4) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
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Continued Table 3.12… 
Number of isolates (%) Resistance profile 
 
Simple phenotype 
 Human Bovine Swine Chicken Turkey Reptile Others 
ChlStrTetSmxKan MDR 0 (0) 1 (5) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
StrTetSmxGenKan MDR 0 (0) 0 (0) 1 (6.3) 0 (0) 0 (0) 0 (0) 0 (0) 
AmpSmxGenKan MDR 0 (0) 0 (0) 0 (0) 0 (0) 1 (11.1) 0 (0) 0 (0) 
AmpSmxSxtKan MDR 1 (0.4) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
AmpStrTetSmx MDR 1 (0.4) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
AmpStrSmxCep MDR 1 (0.4) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
ChlStrTetSmx MDR 0 (0) 0 (0) 0 (0) 1 (7.7) 0 (0) 0 (0) 0 (0) 
StrTetSmxKan MDR 0 (0) 1 (5) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
AmpStrTet MDR 1 (0.4) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
StrSmxGen MDR 1 (0.4) 0 (0) 0 (0) 0 (0) 1 (11.1) 0 (0) 0 (0) 
StrTetSmx MDR 1 (0.4) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
AmpStr MDR 1 (0.4) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
SmxKan MDR 1 (0.4) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
StrTet MDR 1 (0.4) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
Amp SDR 2 (0.8) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
Nal SDR 2 (0.8) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 1 (4.8) 
Smx SDR 9 (3.5) 0 (0) 0 (0) 0 (0) 0 (0) 1 (3.7) 0 (0) 
Str SDR 2 (0.8) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
Str [AmpChlTet] SDR 1 (0.4) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
Tet SDR 3 (1.2) 1 (5) 0 (0) 1 (7.7) 0 (0) 0 (0) 1 (4.8) 
AmpCep n.a. 0 (0) 0 (0) 0 (0) 1 (7.7) 0 (0) 0 (0) 0 (0) 
Pan-susceptible Pan 180 (69.8) 1 (5) 8 (50) 7 (53.8) 7 (77.8) 26 (96.3) 15 (71.4) 
Note: 1. An human isolate was resistant to streptomycin and intermediate resistant to ampicillin, chloramphenicol and tetracycline was also designated as SDR. 
2. The abbreviation of antimicrobials in parentheses in the cloumn “Resistance profile” indicates the intermediate resistance of the strain to that antimicrobial. 
n.a., not assigned. Because it was the only isolate that was resistant to two antimicrobials which belonged to the same class. 
Abbreviations: Amp, ampicillin; Aug, amoxicillin/clavulanic acid; Axo, ceftriaxone; Cep, cephalothin; Chl, chloramphenicol; Sxt, trimethoprim/sulfamethoxazole; Fox, 
cefoxitin; Gen, gentamicin; Kan, kanamycin; Nal, nalidixic acid; Smx, sulfamethoxazole; Str, streptomycin; Tet, tetracycline; Tio, ceftiofur. 
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The distribution of isolates with different antimicrobial phenotype was significantly 
different between human and non-human isolates (p = 0.0002). 180 human isolates (70%) 
were pan-susceptible and only 59 (23%) were MDR. 24 (41%) of human MDR isolates 
were MDR-AmpC. In contrast, 36% (32 of 89) of isolates from animal sources were MDR 
and 78% of them were MDR-AmpC. However, most data for animal isolates in this study 
was from Harbottle et al., 2006 who primarily collected isolates from clinically ill food 
animals in the U.S.A. MDR-AmpC has been a major problem among food animals in the 
United States (Zhao et al., 2001; Devasia et al., 2005). I analyzed only 36 additional 
isolates from animal sources, 27 of which were reptile in origin. Most reptile isolates (96%) 
were pan-susceptible.I also tested whether the proportions of isolates with MDR (including 
MDR-AmpC isolates), SDR and pan-susceptible phenotypes were significantly different 
between the Newport groups by χ2 test (Table 3.13). 
Table 3.13. Distribution of isolates of different resistance phenotypes among Newport groups 
Number of isolates (%)  Groups 
 MDR-AmpC MDR SDR Pan-susceptible 
Newport-I 0 (0) 12 (27.9) 5 (21.7) 12 (4.9) 
Newport-II 53 (100.0) 27 (62.8) 7 (30.4) 125 (51.2) 
Newport-III 0 (0) 4 (9.3) 11 (47.8) 107 (43.9) 
Note: 20 isolates that were not tested for antimicrobials were not included 
 
The distribution of isolates with these phenotypes was significantly different among the 
Newport groups (p < 0.0001). All MDR-AmpC isolates were in Newport-II and the highest 
proportion of other MDR isolates (63%) was also in Newport-II. Within Newport-II, the 
MDR-AmpC phenotype was restricted to STs 45 and 116 (Fig. 3.6D) which are SLVs. In 
contrast, most of the isolates in Newport-III were pan-susceptible and Newport-I contained 
equal numbers of MDR and pan-susceptible isolates. 
3.4 Discussion 
3.4.1 Newport, a polyphyletic serovar 
Previous studies have indicated that Newport is a polyphyletic serovar (Beltran et al., 1988; 
Sukhnanand et al., 2005; Torpdahl et al., 2005; Harbottle et al., 2006). But these studies 
involved smaller numbers of isolates and less powerful methods. An MLEE analysis of 105 
isolates grouped them into two distinct clusters, one associated with humans and the second 
with the domesticated animals (Beltran et al., 1988). Similarly, two lineages were identified 
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when 43 Newport isolates were analyzed by a three gene MLST scheme (Alcaine et al., 
2006). 
In this study, I defined three lineages, Newport-I, Newport-II and Newport-III, after 
analyzing 384 Newport isolates by a seven gene MLST scheme. Three different approaches 
were used on the MLST data to infer population structure of this serovar. First was 
ClonalFrame (Didelot and Falush, 2006) which deduces genealogies from multilocus 
sequence data with only minimal effects of recombination by identifying and excluding 
potentially imported stretches. Three distinct groups of Newport were identified by this 
program (Fig. 3.1). An algorithm called Neighbor-net (Bryant and Moulton, 2004) which 
accounts for recombination and resolve conflicting signals as parallel paths in a 
phylogenetic network was also applied to the multilocus sequence data. The best-fit model 
of nucleotide substitution was used in order to infer the most accurate evolutionary 
relatedness between the STs. Neighbor-net also identified three groups within Newport that 
were similar to the ClonalFrame groups in composition (Fig. 3.2). However, Neighbor-net 
separated three STs from Newport-II, possibly due to alleles that were imported from other 
serovars. 
The MSTREE application of Bionumerics 4.5 (Applied Maths, Sint-Martens-Latem, 
Belgium) was also applied to the data. It identifies groups of closely related genotypes 
based on the allelic profile of isolates and links STs at unique minimal distances. This 
application uses some of the principles of the BURST algorithm which has been widely 
used in bacterial population genetics to study evolutionary relationship using the MLST 
data (Enright et al., 2002; Feil et al., 2004; Honsa et al., 2008; Feil et al., 2003). The 
MSTREE also identified three groups of identical composition to ClonalFrame (Fig. 3.3). 
Although Newport-II was split into two subgroups and singletons, they were closely related 
when groups were defined to contain ≥ 3 STs where an ST shared a minimum of five alleles 
with at least one other ST of the group (Fig. 3.3). A close association between the STs of 
both the subgroups was also indicated by a thick net of cross-links. Two STs were 
separated from Newport-III in the MSTREE but their cross-linkage was to this group and they 
did not possess strong similarity to genotypes in other groups. 
Therefore, all the approaches indicated the existence of three distinct lineages within 
serovar Newport. However, multiple STs of Newport-II and Newport-III were connected by 
cross-links in the MSTREE. This suggests recombination but it is not clear whether these 
groups are merging through homologous recombination such as Campylobacter jejuni and 
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C. coli (Dingle et al., 2005) or drifting apart by the acquisition of additional diversity from 
other serovars. 
In the MLEE study, SARB37 (Np11) and SARB38 (Np15) belonged to one lineage while 
SARB36 (Np8) belonged to a second lineage (Beltran et al., 1988). In this study, these 
belonged to STs 31, 46 and 5, respectively. STs 31 and 46 belong to Newport-II and ST5 to 
Newport-III. Therefore, the two lineages identified by the MLEE study probably 
correspond to Newport-II and Newport-III. 
A third lineage, called Newport-I, is reported in this study but has not been previously 
described. None of the alleles in this lineage were common to the other two Newport 
lineages except that hisD12 and thrA12 were found in several STs of Newport-II as well as 
some STs from other serovars. This lineage was distinct by all three approaches that were 
used to infer evolutionary relatedness. None of the STs of this lineage was cross-linked to 
any ST of Newport-II, Newport-III or the groups of other serovars. Newport-I comprised of 
only three STs that differed from each other by one or two polymorphic nucleotide sites 
(SNPs). Nucleotide diversity in this lineage was also significantly lower than other two 
Newport groups. The variant alleles among these STs were assumed to have originated by 
recombinational events because they were found in other serovars. However, these alleles 
differed from the founder alleles only by one nucleotide and may represent homoplasies 
associated with independent point mutations. These results suggest that Newport-I 
represents a discrete lineage which has recently arisen by lateral transfer of genes encoding 
antigenic determinants (Beltran et al., 1988; Selander et al., 1994). Alternatively, the strains 
of this group are derived from a recent evolutionary bottleneck which removed most 
nucleotide diversity from this lineage. 
In contrast to these population genetic analyse based on sequence homology, a study based 
on microarray hybridization experiments proposed that Newport is monophyletic 
(Porwollik et al., 2004). A total of five Newport isolates (including SARB36, SARB37 and 
SARB38) and 74 isolates of other serovars were hybridized to PCR amplified sequences 
covering 94.5% of the Typhi genome and 96.6% of the Typhimurium LT2 genome. The 
clustering behaviour of most serovars was similar to that of MLEE data except for Newport 
and Muenchen (Porwollik et al., 2004). Newport isolates were monophyletic and shared a 
clade with isolates of serovar Muenchen. Both these serovars were polyphyletic based on 
MLEE analyses and no relationship was observed between them (Beltran et al., 1988; 
Selander et al., 1990b). Similarly, no correlation was observed between isolates of both 
serovars based on MLST analysis (unpublished data). At least five alleles were different 
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between the Newport and the Muenchen STs (data available at the Salmonella MLST 
website). The extent of sequence diversity within a serovar may not be reflected by simply 
scoring genes for presence or absence. Furthermore, phylogenetic relationship among 
strains based on the presence or absence of gene clusters may become blurred when genes 
are acquired by recombination between serovars (Porwollik et al., 2004). SARB36, 
SARB37 and SARB38 were separated into two lineages (Newport-II and Newport-III) on 
the basis of MLST in this study. I did not perform MLST with the particular strains that 
were used in the microarray experiments. Since missassignments and strain swapping of 
many strains of the SARB collection have been reported (Porwollik et al., 2004), those 
particular SARB strains should be tested by MLST in order to compare microarray 
hybridization results with MLST analyses. 
3.4.2 Association of Newport groups with hosts, time, geography and antimicrobial 
resistance phenotype 
The three Newport lineages were found to be differentially associated with human versus 
non-human hosts (avian, bovine, equine, swine and reptiles) in this study (p = 0.01). Most 
isolates of Newport-I were from humans. A higher proportion of isolates from non-human 
sources was found in Newport-II than in Newport-III whereas the proportion of human 
isolates was higher in Newport-III.  
Two Newport lineages have been reported that were associated with human and 
domesticated animals, respectively (Beltran et al., 1988; Alcaine et al., 2006). According to 
MLEE, 105 Newport isolates from humans and domesticated animals (swine or other 
mammals) were in two lineages that differed significantly in the distribution of isolates 
from these sources (Beltran et al., 1988). Similarly, according to MLST, 43 Newport 
isolates from human and bovine hosts were in two distinct clusters and the distribution of 
isolates from human and bovine sources was significantly different between the clusters 
(Alcaine et al., 2006). Consistent with these observations, in this study, most bovine (90%) 
and swine (87.5%) isolates were in group Newport-II. Furthermore, the proportions of 
human isolates were higher in two lineages, Newport-I and Newport-III than in Newport-II. 
Although isolates in Newport-I have only been isolated since the 1970s, no significant 
association existed between the time of isolation and the phylogenetic grouping (p = 0.15). 
Possibly, the distribution of isolates in the three Newport groups was independent of the 
time of isolation. Alternatively, the lack of significance reflects the low number of 
Newport-I isolates. 
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The distribution of isolates from Europe and North America varied between the Newport 
groups (p < 0.001). Newport-I is particularly prevalent in Europe. The proportions of 
isolates from North America were higher than from Europe for both Newport-II and 
Newport-III. Furthermore, the relative frequency of isolates from Europe was more than 
2fold higher in Newport-II (55%) than in Newport-III (21%). This observation suggests 
that Newport-III is more common in the U.S.A. than in Europe. 
Antimicrobial susceptibility phenotype was associated with host (p = 0.0002). The 
proportion of pan-susceptible isolates was higher among humans whereas the MDR-AmpC 
phenotype was more common among animal isolates. However, this observation is partially 
due to a high proportion of animals isolates that were isolated from food animals in the 
U.S.A. where infection of MDR-AmpC Newport has been a major problem among food 
animals (Zhao et al., 2001; Devasia et al., 2005). 
The proportion of MDR and pan-susceptible isolates was significantly different between 
the Newport groups (p < 0.0001). While 38% of Newport-II isolates were MDR, most 
Newport-III isolates were pan-susceptible. Furthermore, 83% of MDR isolates were in 
Newport-II. The MDR-AmpC phenotype was restricted to STs 45 and 116 of Newport-II in 
agreement with previous studies suggesting a single global recent origin of MDR-AmpC 
strains (Harbottle et al., 2006; Alcaine et al., 2005; Egorova et al., 2008). 
3.4.3 Newport versus other serovars 
Serovars of subspecies enterica vary in population structure (Beltran et al., 1988). Based on 
MLEE studies, Typhimurium is monophyletic whereas serovars Enteritidis and Paratyphi B 
are polyphyletic (Beltran et al., 1988; Selander et al., 1990a; Selander et al., 1990b). The 
17 ETs found within 299 Typhimurium isolates were grouped in a single cluster (Beltran et 
al., 1988). In contrast, Enteritidis was concluded to be polyphyletic by MLEE because only 
10 ETs clustered together and 4 others fell into three distantly related groups (Beltran et al., 
1988). Similarly, 14 ETs of serovar Paratyphi B fell into three groups (Selander et al., 
1990a; Selander et al., 1990b). Typhimurium was also concluded to be monophyletic 
according to MLST studies (Sukhnanand et al., 2005; Torpdahl et al., 2005). However, 
only 11 Typhimurium isolates had been analyzed in these prior MLST studies. Five isolates 
of serovar Kentucky were separated into two phylogenetically distant STs in one MLST 
study (Sukhnanand et al., 2005). 
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The results of my study are in general agreement with the MLEE and prior MLST results. 
However, the overall structure of Typhimurium was comparable to that of Enteritidis. 13 
STs of serovar Enteritidis formed a single cluster and only two other STs, each with one 
isolate, were genetically distinct (singletons) (Table 3.2). Similarly, most STs of serovar 
Typhimurium clustered together, except for two STs that were identified as singletons. Two 
groups were observed within serovar Kentucky, consistent with the previous observation 
(Sukhnanand et al., 2005). STs of Paratyphi B isolates formed four distinct groups one of 
which was a single ST containing 16 isolates. Newport differed from all these serovars 
because the 49 Newport STs fell into three distinct groups. Therefore, the population 
structure of subspecies enterica serovars varies with serovar. The degree of polyphyletism 
within serovar Newport was higher than Enteritidis, Typhimurium and Kentucky but lower 
than Paratyphi B. 
The degree of polymorphism among gene fragments also varied greatly between the 
serovars as well as between groups within each serovar (Table 3.5a and 3.5b). Various 
studies suggested that recombination has been the major source of variation among 
housekeeping genes within subspecies enterica (Brown et al., 2003; Octavia and Lan, 
2006; Falush et al., 2006). Neighbor-net also resolved conflicting signals in groups except 
for Enteritidis and Typhimurium, suggesting that multiple alleles in most groups have 
arisen by recombination. Therefore, two programs, Reticulate (Jakobsen and Easteal, 1996) 
and Фw test (Bruen et al., 2006), were employed to test whether recombination has been 
the key factor behind the current diversity within these groups. Both the programs are based 
on compatibilities between informative sites and are considered as the powerful methods to 
detect recombination from nucleotide sequences (Bruen et al., 2006). However, neither of 
these programs detected recombination in any group except for Newport-II and Newport-
III. Only limited incompatibilities were observed in Newport-III by Reticulate, indicating a 
lower frequency of recombination than in Newport-II. A very low nucleotide diversity and 
the limited number of informative sites within each group might explain why only 
negligible incompatibilities was observed in the other groups. 
An alternative allele-based approach (Feil et al., 2000) was used to assess the relative role 
of recombination and mutation in the clonal diversification of each group. Alleles derived 
by mutation or recombinational events were identified based on the nucleotide differences 
between the variant alleles and those in their putative ancestral genotypes. This approach 
has previously been used to estimate mutation and recombination events within groups of 
closely related isolates for various pathogenic bacteria (Feil et al., 1999; Feil et al., 2000; 
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Feil et al., 2001; Feil et al., 2003). Although traditionally such events were only scored 
between putative ancestors and their descendents SLVs, I also included DLVs or TLVs 
within each group because these were closely related by all the methods that were used to 
identify genealogies. 
Recombination is more likely to introduce new alleles in Newport-II than Newport-III 
(Table 3.7). The exact per allele R/M value could not be determined for Newport-I because 
both variant alleles resulted by recombination, leading to an R/M ratio of > 2.0. The relative 
frequencies of recombination to mutation (per allele R/M) also varied markedly among the 
groups and between serovars. Point mutations have been the main source of new alleles 
within Enteritidis and Typhimurium whereas most variant alleles were imported from 
elsewhere within Paratyphi B-II and Paratyphi B-III (Table 3.7). An allele in Kentucky-II, 
Newport-I, Newport-II, Newport-III and Paratyphi B-IV is also more likely to change by 
recombination but the frequencies were intermediate i.e. higher than Enteritidis and 
Typhimurium and lower than Paratyphi B-II and Paratyphi B-III.  
The average numbers of nucleotide sites changed by recombination than mutation (per site 
R/M) in Enteritidis and Typhimurium correlated with their low nucleotide diversity and low 
R/M per allele (Table 3.7). This correlation was also observed for Newport-II and Newport-
III. The values of π, per allele R/M as well as per site R/M were higher in Newport-II than 
for Enteritidis, Typhimurium or Newport-III. All three values were intermediate in 
Newport-III, i.e., higher than for Enteritidis and Typhimurium but lower than for Newport-
II. However, any correlation between per site R/M and the π values or per allele R/M was 
not observed for the remaining groups. I could not estimate an exact per site R/M value for 
Newport-I, for the same reasons as for per allele R/M values. 
Although nucleotide diversity in Paratyphi B-II was comparable to Newport-II, the 
likelihood of generating new alleles by recombination (per allele R/M) was much higher 
but the likelihood of a polymorphic nucleotide to be introduced by a recombinational event 
(per site R/M) was lower than for Newport-II. These observations suggest that a 
recombinational event in Paratyphi B-II introduced comparatively low number of 
polymorphic nucleotides than in Newport-II. Similarly, per site R/M was much higher in 
Kentucky-II and Paratyphi B-IV than Paratyphi B-II despite the 2fold lower per allele R/M 
values and significantly lower nucleotide diversities in both the groups. Therefore, a 
recombination event in Kentucky-II and Paratyphi B-IV introduced alleles with more 
polymorphic nucleotides than in Paratyphi B-II. The value of per site R/M has been used as 
an indicator of sequence divergence in different bacterial species, e.g. a high per site R/M 
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correlated with the high nucleotide diversity in Neisseria meningitidis whereas the lower 
per site R/M values correlated with the low nucleotide diversity in Streptococcus 
pneumoniae and Staphylococcus aureus (Feil et al., 2001). The average number of 
polymorphic nucleotides introduced by recombination has been highly variable between the 
groups of subspecies enterica serovars. Perhaps such an approach is not as suitable for 
analyses within groups of closely related genotypes within a species. 
In agreement with previous observations (Brown et al., 2003; Octavia and Lan, 2006; 
Falush et al., 2006), recombination was quite frequent among housekeeping genes within 
subspecies enterica. However, the relative role of recombination and mutation in the clonal 
diversification has been markedly variable not only between serovars but also between the 
groups within a serovar. Subspecies enterica represents a pool of diverse strains that have 
been assigned to > 1500 serovars based on the antigenic profiles of the surface antigens 
(Popoff et al., 2004). However, a serovar does not necessarily indicate a group of 
genetically identical isolates and genes encoding surface antigens are probably exchanged 
quite frequently within the subspecies giving rise to multiple lineages within a serovar. 
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4. Comparison of carried and disease associated salmonellae 
4.1 Introduction 
Non-typhoidal salmonellosis generally results in a self limiting diarrhea in humans but can 
also lead to a life-threatening bacteremia in immunocompromised patients (Hohmann, 
2001; Gordon, 2008). The enteric invasion of salmonellae triggers immune responses to 
limit the spread of infection (Uzzau et al., 2000; Srinivasan and McSorley, 2006). The 
bacteria that survive the immune responses can be disseminated to systemic organs, e.g., 
the liver, gallbladder and spleen causing bacteremia in patients (Worley et al., 2006; Ly and 
Casanova, 2007). 
After clinical recovery from Salmonella infection, 1-5% of patients continue to harbour 
these bacteria in their hepatobiliary system and are designated as chronic carriers (D'Aoust, 
1991; Gupta et al., 2006). Asymptomatic human carriers of Salmonella shed bacteria in 
their stools for years and impose a potential threat to the healthy community. Healthy 
carriers may be the major source of Salmonella infection, especially carriers that are 
associated with food handling (Dryden et al., 1994; Ollinger-Snyder and Matthews, 1996; 
Kariuki et al., 2006). However, it has not yet been determined whether salmonellae from 
chronic human carriers are the same as those isolated from non-carrier hosts. 
In this study, I analyzed subspecies enterica isolates that had been isolated from chronic 
human carriers in the 1980s in Germany. In order to determine the prevalence of carrier 
genotypes among human clinical and animal isolates, I focused on carried isolates from 
serovars where MLST data were also available from non-carrier humans or animals (other 
mammals, birds and reptiles). 
4.2 Methods 
4.2.1 Bacterial isolates 
Forty-five strains isolated from chronic human carriers in the 1980s in Germany were 
obtained from Dr. Roy Curtiss, Center for Infectious Diseases and Vaccinology, Arizona 
State University, Tempe, U.S.A. These isolates belonged to 20 serovars of subspecies 
enterica. I also included one Newport isolate from a human carrier from chapter 3 and one 
carrier isolate of serovar Abony from the Salmonella MLST website, resulting in 47 
isolates in 22 serovars. These results were compared with MLST data of the same serovars 
for 686 isolates from non-carrier humans and 329 isolates from animals, including the 
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Newport data from chapter 3 and reptile data from chapter 5. These MLST data were 
downloaded from the Salmonella MLST website (http://web.mpiib-
berlin.mpg.de/mlst/dbs/Senterica). The numbers of isolates are summarized in Table 4.1. 
Table 4.1. List of isolates from different hosts 
No. of isolates 
Serovar; mnemonic 
 
Human 
carriers 
Non-carrier 
humans 
Animals 
 
Abony; Ab 1 1 0 
Agona;, Ag 1 10 1 
Anatum; An 3 1 3 
Bovismorbificans; Bv 2 2 7 
Braenderup; Bu 1 4 5 
Brandenburg; Ba 1 6 1 
Bredeney; Bd 1 2 0 
Derby; De 1 4 3 
Enteritidis; En 1 123 24 
Hadar; Hd 3 11 9 
Heidelberg; He 2 11 4 
Infantis; In 4 11 4 
Manhattan; Mn 2 4 1 
Montevideo; Mo 1 9 4 
Newport; Np 1 267 91 
Ohio; Oh 3 0 1 
Panama; Pn 2 4 5 
Paratyphi B1;Pb 1 24 18 
Schwarzengrund; Sc 1 2 0 
Thompson; Th 1 7 3 
Typhimurium; Tm 13 164 141 
Virchow; Vi 1 19 4 
Total 47 686 329 
1Including Paratyphi B var. Java 
 
The cultivation and storage of isolates, isolation of DNA, PCR amplification, sequencing 
and MLST analyses were carried out as previously described (Chapter 3). An MSTREE was 
generated in Bionumerics 4.5 based on the allelic profiles of isolates. 
4.2.2 Characteristics of housekeeping genes 
Nucleotide diversity (π) with Jukes-Cantor correction was calculated using MEGA 4.0 
(Tamura et al., 2007) separately for concatenated sequence alignments of isolates from 
carrier humans, non-carrier humans and non-carrier humans plus animals (ncHA). The 
average pairwise distance at non-synonymous (Ka) and synonymous (Ks) sites was 
calculated for alignments of gene fragments for isolates from human carriers and ncHA 
using DnaSP 4.0 (Rozas et al., 2003). 
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4.2.3 Statistical analyses 
To compare the genotypic diversity within salmonellae from human carriers, the expected 
numbers of STs were estimated for 47 isolates from non-carrier humans as well as from 
ncHA by rarefaction analysis using PAST 1.73 (Hammer et al., 2001). Fisher’s exact tests 
and χ2 tests were computed using the statistical package STATISTICA (StatSoft, Inc., 
Tulsa, U.S.A.). 
4.3 Results 
4.3.1 Properties of housekeeping genes 
The genetic diversity (π) of concatenated sequence alignments of MLST housekeeping 
genes was compared between carried isolates and isolates from non-carrier humans as well 
as ncHA. The π value for carried isolates was not significantly different from the value for 
ncHA isolates (Table 4.2). It also did not differ from isolates from non-carrier humans. 
Therefore, there does not seem to be any difference in overall selection pressure on 
housekeeping gene diversity between salmonellae from human carriers and other hosts. 
 
Table 4.2. Diversity among isolates in different host categories 
Host No. of Isolates No. of STs π Rarefied STs1 
Carrier humans 47 23 0.011 ± 0.001 23 
Non-carrier humans 686 101 0.010 ± 0.001 22.1 ± 2.7 
ncHA 1015 137 0.009 ± 0.001 22.7 ± 2.7 
1Number of STs estimated by rarefaction analysis for 47 isolates 
 
 
The ratio of non-synonymous substitutions per non-synonymous site to synonymous 
substitutions per synonymous site (Ka/Ks) was also calculated on alignments of individual 
gene fragments to test whether any of these housekeeping genes experienced different 
selection pressures. The Ka/Ks value was < 1.0 for all the gene fragments in both carried 
and ncHA isolates, indicating the presence of purifying selection (Table 4.3). 
The Ka/Ks was much higher for hemD than for other gene fragments (as described in 
chapter 3). This observation indicates that non-synonymous substitutions are fixed at higher 
frequency in hemD than in other gene fragments, although not frequently enough to suggest 
diversifying selection. 
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Table 4.3. Average pairwise distances at non-synonymous and synonymous sites among carried and ncHA 
isolates 
Carrier Isolates    ncHA isolates 
Genes  Ka Ks Ka/Ks   Ka Ks Ka/Ks 
aroC 0.00077 0.02808 0.027  0.00010 0.02318 0.004 
dnaN 0.00122 0.03543 0.034  0.00137 0.02256 0.061 
hemD 0.00540 0.02415 0.224  0.00518 0.02120 0.244 
hisD 0.00242 0.05839 0.041  0.00209 0.04613 0.045 
purE 0.00057 0.04149 0.014  0.00083 0.03197 0.026 
sucA < 0.00011 0.03241 < 0.003  0.00009 0.03042 0.003 
thrA < 0.00011 0.05603 < 0.002   0.00004 0.06551 0.001 
 
4.3.2 Diversity between carried and ncHA isolates 
The 47 isolates from chronic human carriers fell into 23 STs. All carried isolates within a 
serovar possessed an identical MLST profile, except for serovar Hadar where two STs were 
identified among three carried isolates. In contrast, multiple STs were identified for isolates 
from non-carrier humans and animals for all serovars except Abony, Anatum, Heidelberg, 
Panama, Schwarzengrund and Thompson. 
Rarefaction curves are often used to compare the number of taxa between samples of 
different sizes because this approach allows estimating the number of taxa that would be 
expected for a smaller sample from the data for larger populations (Gotelli and Colwell, 
2001). Rarefaction curves were computed on ncHA isolates and also separately for isolates 
from non-carrier humans to predict diversity in samples of the same size as that of the 
isolates from human carriers. The predictions for 47 isolates were similar to those observed 
for isolates from carrier humans, both for non-carrier humans as well as ncHA, indicating 
similar levels of genotype richness between these classes (Table 4.2, Fig. 4.1). 
4.3.3 Prevalence of carrier-STs among ncHA isolates 
An MSTREE revealed that the STs present among carried isolates were generally the most 
common ST for that serovar among isolates from non-carrier humans and animals (Fig 4.2). 
STs of all ncHA isolates were identical to carried isolates within serovars Abony, Anatum, 
Heidelberg, Panama, Schwarzengrund and Thompson (Table 4.4a). However, the 
proportion of ncHA isolates in carrier STs varied from 0.06-0.91 for the remaining serovars 
(Table 4.4b). For two serovars, the proportions can not be readily evaluated because only 
few ncHA isolates were available. Only two ncHA isolates were available for serovar 
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Bredeney, both from non-carrier humans. One of these ncHA isolates possessed the same 
ST as the sole carried isolate while the second possessed a different ST. For serovar Ohio, 
the sole animal isolate available was of a different ST than the three carried isolates. These 
are not discussed further below. 
 
 
Figure 4.1. Rarefaction curve on isolates from non-carrier humans and ncHA. Number of STs observed 
among 47 isolates is marked by a dashed arrow. 
 
Table 4.4a. Serovars where all ncHA isolates were the carrier STs 
Serovar 
Carrier ST 
(carried isolates) 
No. of ncHA 
isolates 
Abony ST273 (1) 1 
Anatum ST64 (3) 4 
Heidelberg ST15 (2) 15 
Panama ST48 (2) 9 
Schwarzengrund ST96 (1) 2 
Thompson ST26 (1) 10 
 
 
The STs associated with carriers were the same as for ≥ 50% ncHA isolates within 16 of the 
remaining 20 serovars (Table 4.4a & b). The exceptions were serovars Derby, Montevideo, 
Newport and Paratyphi B, where the proportions of ncHA isolates in carrier STs were 
<40%. Two STs, 33 and 368, were observed among carried isolates of serovar Hadar. ST33 
was present in 90% of ncHA isolates but ST368 was not found. Fisher’s exact tests were 
computed for serovars where ≥ 5 ncHA isolates were available to test whether the 
proportions of carried and ncHA isolates in identical STs were significantly different within 
each serovar. 
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The proportions of isolates in the same STs were not significantly different between human 
carriers and ncHA hosts for any serovar other than Typhimurium (Table 4.4b). All 13 
carried isolates of serovar Typhimurium were ST19 whereas only 52% (160/305) of ncHA 
isolates were in ST19. Other ncHA Typhimurium isolates fell into multiple other STs. 
Although only 6-31% ncHA isolates shared STs with carried isolates within serovars 
Derby, Montevideo, Newport and Paratyphi B, the proportions of isolates in shared STs 
were not significantly different between the two categories for any of these serovars. Only 
< 5 carried isolates were available for each serovar other than Typhimurium within which 
13 carried isolates had been analyzed. And only a single carried isolate was analyzed from 
13 of the 22 serovars. These very low numbers of carried isolates may have been 
responsible for the lack of significance of most comparisons. 
 
Fig 4.2. An MSTREE of the allelic profiles of isolates. Isolates from carrier humans are shown in red, from non-
carrier humans in green, from other mammals in blue and from reptiles in white. Abbreviations used are the 
mnemonic from Table 4.1 with a suffix that indicates group designation assigned by Prof. Mark Achtman, 
e.g., Hd-22 is serovar Heidelberg of ST grouping 22. 
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Table 4.4b. Distribution of ncHA isolates in carrier STs/groups for the remaining serovars 
Serovar 
 
Carrier ST 
(Carried 
isolates) 
Mnemonic- 
group 
 
No. of 
ncHA 
isolates 
Proportion1 
 
P-value2 
 
Proportion3 
 
Agona ST13 (1) Ag-54 11 0.91 (10) 0.92 1.00 (11) 
Bovismorbificans ST142 (2) Bv-34 9 0.56 (5) 0.38 0.78 (7) 
Braenderup ST22 (1) Bu-24 9 0.78 (7) 0.80 1.00 (9) 
Brandenburg ST20 (1) Ba-12 7 0.57 (4) 0.63 1.00 (7) 
Bredeney ST241 (1) Bd-33 2 0.50 (1) n.d. 0.50 (1) 
Derby ST39 (1) De-57 7 0.14 (1) 0.25 0.71 (5) 
Enteritidis ST11 (1) En-4 147 0.88 (130) 0.89 1.00 (147) 
Hadar 
 
ST33 (2), 
ST368 (1) 
Hd-22 
 
20 
 
0.90 (18) 
 
0.09 
 
1.00 (20) 
 
Infantis ST32 (4) In-31 15 0.73 (11) 0.35 0.80 (12) 
Manhattan ST18 (2) Mn-27 5 0.60 (3) 0.48 1.00 (5) 
Montevideo ST138 (1) Mo-39 13 0.31 (4) 0.36 0.31 (4) 
Newport ST166 (1) Np-35 358 0.06 (21) 0.06 0.08 (28) 
Ohio ST329 (3) Oh-72 1 < 1.00 (0) n.d. 1.00 (1) 
Paratyphi B ST88 (1) Pb-19 42 0.26 (11) 0.28 0.29 (12) 
Typhimurium ST19 (13) Tm-1 305 0.52 (160) < 0.01 0.99 (301) 
Virchow ST16 (1) Vi-9 23 0.70 (16) 0.71 0.91 (21) 
1Proportion of ncHA isolates that were the same ST as carried isolates for respective serovar 
2Fisher’s exact test comparing the proportions of carried and ncHA isolates in the same STs 
3Proportion of ncHA isolates that shared the groups with carried isolates 
n.d., note done where ncHA isolates were < 5 or all isolates shared the group with carried isolates 
Note: ST33 and ST368 were observed among carried isolates. The proportions ncHA isolates were 
independently compared with carried isolates in STs 33 and 368. Both the values were multiplied followed by 
another multiplication by two. 
 
To further compare the frequencies of occurrence of ncHA isolates in carrier-STs within 
each serovar, I restricted the analyses to common STs for which at least five ncHA isolates 
had been identified, thus excluding serovars Abony, Anatum Brandenburg, Derby, 
Montevideo and Schwarzengrund. Serovars Heidelberg and Panama were also excluded 
because all ncHA isolates of these serovars were of the same STs as carried isolates. After 
excluding these serovars, the carrier-ST was the same as an ST containing most of ncHA 
isolates of the same serovar (Table 4.5). The only exceptions were Newport and Paratyphi 
B, where carrier-STs were common but not the most common among ncHA isolates. 
4.3.4 Prevalence of carrier-STs among ncHA isolates from Europe 
Most ncHA isolates had been isolated in Europe except for serovars Newport and 
Typhimurium where 66% (237/358) and 57% (175/305) of ncHA isolates were from non-
European countries. Most ncHA Newport isolates from outside Europe were from the 
North America (Chapter 3) whereas most non-European Typhimurium were from North 
America or Africa. The carried serovar Newport isolate was ST166, which is part of lineage 
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Newport-I that is prevalent among humans in Europe (Chapter 3). Most ST166 isolates 
were also isolated from European humans. Similarly, ST19, the ST of all carried isolates of 
serovar Typhimurium was more common among ncHA isolates from Europe than those 
from outside of Europe (P < 0.001). These results suggest that carrier genotypes of serovars 
Newport and Typhimurium were relatively more prevalent in Europe than other geographic 
regions. 
Table 4.5. Distribution of ncHA isolates in common (≥ 5 isolates) and rare STs (< 5 isolates) 
Serovar 
 
Carrier 
ST 
Common STs 
(isolates) 
Rare STs (isolates) 
 
Geo. 
mean1 
Agona 13 13 (10) 37 (1) 1.0 
Bovismorbificans 142 142 (5) 148 (1), 150 (2), 377 (1) 1.3 
Braenderup 22 22 (7) 194 (1), 311 (1) 1.0 
Brandenburg  20  20 (4), 65 (1), 249 (2) 2.0 
Derby  39  39 (1), 40 (4), 71 (1), 72 (1) 1.4 
Enteritidis 
 
11 
 
11 (130), 183 (10) 
 
136 (1), 168(1), 172 (1), 180 (1), 310 (2), 
366 (1) 
1.1 
 
Hadar 33, 368 33 (18) 12 (1), 123 (1) 1.0 
Infantis 32 32 (11) 41(1), 141 (1), 361 (1), 493 (1) 1.0 
Montevideo  
 
138 
  
138 (4), 4 (4), 81 (1), 195 (2), 305 (1), 316 
(1) 
1.8 
 
Newport 
 
 
 
 
 
 
166 
 
 
 
 
 
 
166 (21), 5 (17), 
31 (42), 45(102), 
46 (34), 115 (6), 
118 (71), 132 (9), 
156 (6), 164 (6) 
 
 
116 (4), 117 (1), 119 (1), 120 (1), 121 (1), 
122 (1), 123 (1), 125 (1), 158 (1), 163 (1), 
167 (2), 184 (1), 187 (1), 188 (1), 189 (2), 
190 (1), 191 (2), 193 (1), 199 (1), 200 (1), 
211 (1), 223 (2), 345 (1), 346 (1), 347 (1), 
348 (1), 349 (1), 350 (3), 351 (1), 352 (1), 
353 (1), 354 (1), 355 (1), 360 (1) 
1.2 
 
 
 
 
 
 
Paratyphi B 
 
88 
 
88 (11), 28 (12), 
86 (7) 
42 (2), 43 (4), 110 (2), 127 (1), 149 (1), 
307 (1), 570 (1) 
1.5 
 
Typhimurium 
 
 
 
19 
 
 
 
19 (160), 34 (6), 
128 (14), 213 
(37), 302 (6), 313 
(55) 
35 (1), 36 (3), 98 (3), 99 (1), 137 (1), 153 
(1), 204 (1), 205 (1), 207(1), 209 (1), 323 
(2), 328 (1), 332 (2), 376 (2), 394 (1), 429 
(1), 568 (3), 569 (1) 
1.3 
 
 
 
Virchow 
 
16 
 
16 (16) 
 
38 (1), 181 (1), 197 (1), 303 (1), 326 (1), 
333 (1), 359 (1) 
1.0 
 
1Geometric mean of the isolates in rare STs 
 
4.3.5 Carrier-STs in groups with ncHA isolates 
The MLST scheme used in this study has been widely accepted by the Salmonella 
community, leading to MLST data for > 2350 Salmonella isolates on the website 
(http://web.mpiib-berlin.mpg.de/mlst/dbs/Senterica) (June 2008). Ninety groups were 
identified among these isolates by Prof. Mark Achtman on the basis of phylogenetic 
analyses of nucleotide sequences and an MSTREE of allelic profiles (unpublished data). Each 
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phylogenetic group of ≥ 2 STs and all distinct STs with ≥ 4 isolates were assigned a unique 
group designation and represents a distinct cluster of genetically closely related isolates. 
For most serovars, multiple isolates possessed STs that differed from the carrier-STs (Table 
4.4b, Table 4.5). However, it was not clear whether isolates in those STs were genetically 
distant from carried isolates. Therefore, I used the groups assigned by Prof. Achtman to 
calculate the proportion of ncHA isolates that was genetically related to the carried isolates 
within each serovar. 
For six serovars, all ncHA isolates were of the same ST as the carrier-STs (Table 4.4a). 
Furthermore, all ncHA isolates of serovars Agona, Braenderup, Brandenburg, Enteritidis, 
Hadar and Manhattan were in the same groups as carried isolates of those serovars (Table 
4.4b). A high proportion of other isolates were also in the same groups as carrier-STs and 
only 1-29% isolates were genetically distinct. However, for serovars Montevideo, Newport 
and Paratyphi B, the groups containing carrier STs were rarely found among ncHA isolates, 
indicating that most isolates in these serovars are genetically distinct from carried isolates 
(Table 4.4b). In serovar Typhimurium, only 52% of ncHA isolates were in ST19 but 99% 
of ncHA isolates were in the same group (Group 1) as carrier isolates. These results 
indicate that most of ncHA isolates were genetically closely related to the carried isolates in 
most serovars. 
4.4 Discussion 
4.4.1 Diversity between isolates from asymptomatic human carriers and non-carrier 
humans and animals 
The genetic diversity was higher among Neisseria meningitidis isolates from asymptomatic 
carriers than clinical isolates, both by MLEE and MLST analyses (Caugant et al., 1988; 
Yazdankhah et al., 2004). In contrast, Salmonella isolates from asymptomatic human 
carriers showed similar levels of nucleotide diversity and genotype richness as non-carrier 
isolates of the same serovars from humans and animals (Fig 4.1, Table 4.2). These 
observations possibly reflect a difference in the biology of carrier and non-carrier isolates 
between the two species. Multiple unique alleles were found that distinguished carried from 
invasive N. meningitidis (Jolley et al., 2000) but all the alleles in carried salmonellae were 
common among ncHA isolates. Furthermore, several groups of STs were preferentially 
associated with disease in N. meningitidis, indicating a differential association between 
clonal lineages of meningococci and disease (Yazdankhah et al., 2004). In contrast, most 
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Salmonella STs found among isolates from carriers were common to ncHA isolates within 
each serovar and with similar frequencies (Table 4.4a & b). The proportions of ncHA 
isolates in the groups with carried isolates were even higher than those in carrier-STs for 
most serovars (Table 4.4b). These observations indicate that Salmonella isolates from 
human carriers probably belong to the same population as isolates from non-carrier humans 
and animals. However, only few isolates from human carriers were tested except for 
serovar Typhimurium, which may be responsible for the lack of significance of most 
comparisons. 
The results of my study are in general agreement with the previous study that found a 
comparable overall genotypic diversity among Typhimurium DT104 isolates from 
asymptomatic and sick pigs by pulsed-field gel electrophoresis (Perron et al., 2007). 
However, isolates from asymptomatic pigs were more diverse within individual herds, 
leading to the suggestion that selection bias was followed by selective sweep of adaptive 
genotypes that resulted in lower genotypic diversity in disease associated populations 
within herds (Perron et al., 2007). 
4.4.2 Prevalence of carrier genotypes among non-carrier isolates 
The carrier-STs were generally the most common among ncHA isolates for most serovars 
(Table 4.4a & 4.4b and Table 4.5). >50% ncHA isolates were the same STs as carried 
isolates of most serovars, except for serovars Derby, Montevideo, Newport and Paratyphi B 
where only 6-31% of ncHA isolates shared STs with carried isolates. The proportions of 
carried and ncHA isolates in the same ST were similar for all serovars except for 
Typhimurium (Table 4.4b), where only 52% ncHA isolates were the same ST as carried 
isolates. These results indicate the existence of common genotypes for most serovars that 
can asymptomatically inhabit the hepatobiliary system in human carriers as well as can 
cause disease in other individuals. 
All carried isolates and a high proportion of ncHA isolates were from Europe, except for 
serovars Newport and Typhimurium where ncHA isolates from outside Europe were most 
frequent. The carrier-ST of serovar Newport was more prevalent within Europe because 
only one of the 21 ncHA isolates in this ST was from outside Europe (Chapter 3). 
Similarly, the carrier genotype was more frequent among ncHA isolates of serovar 
Typhimurium from Europe than other geographic regions (P < 0.001). Possibly these 
carrier genotypes are more prevalent in Europe than elsewhere. However, more ncHA 
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isolates from other geographic regions would need to be analyzed for the remaining 
serovars to confirm this observation. 
The carrier-ST was the common ST for most serovars (Table 4.5). For 12 serovars, all 
ncHA isolates either shared the carrier-STs or were in the same groups as the carried 
isolates (Fig 4.2, Table 4.4a & 4.4b). The proportion of ncHA isolates in the same groups 
as carried isolates was higher (71-99%) than in other groups or STs for the remaining 
serovars, except for Montevideo, Newport and Paratyphi B where most isolates were 
genetically distinct from carrier-STs. These results suggest that Salmonella isolates from 
chronic human carriers are genetically identical to isolates from non-carrier humans and 
animals within most serovar. However, all ncHA isolates of a serovar are not necessarily 
the same as carried isolates. 
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5. Clonal diversity and host association in subspecies enterica 
5.1 Introduction 
Serovars of S. enterica vary greatly in their host range (Kingsley and Baumler, 2000). Most 
serovars are generalists and have a broad host range, e.g. Enteritidis and Typhimurium 
(Uzzau et al., 2000). In contrast, some serovars are host restricted and only infect specific 
hosts, e.g., Typhi that can only infect humans and higher primates (Kingsley and Baumler, 
2000; Uzzau et al., 2000). Still other serovars are adapted to particular hosts but are 
occasionally isolated from other sources, e.g. Choleraesuis and Dublin that are adapted to 
pigs and cattle, respectively (Kingsley and Baumler, 2000; Uzzau et al., 2000). These are 
called host adapted. 
Host restricted and host adapted variants have also been identified within some generalist 
serovars. Phage typing has identified some host associated subtypes within serovars 
Typhimurium and Enteritidis (Hickman-Brenner et al., 1991; Rabsch et al., 2002; van 
Duijkeren et al., 2002). DT2 and DT99 are two Typhimurium phage types that are 
restricted to pigeons (Rabsch et al., 2002). Enteritidis phage types, PT4 and PT11, are 
associated with poultry and hedgehogs, respectively (Coyle et al., 1988; Nauerby et al., 
2000; Riley and Chomel, 2005). Host associated lineages have also been identified for 
some S. enterica serovars by other approaches that are based on selectively neutral loci and 
which have been extensively used in population genetic studies. Based on the relative 
frequencies of isolates from various hosts, MLEE analysis has identified bird and mammal 
associated lineages of Derby as well as human and animal associated lineages of Newport 
(Beltran et al., 1988). The occurrence of host associated subtypes has also been 
demonstrated within subspecies enterica by MLST (Alcaine et al., 2006). A collection of 
156 bovine and 179 human isolates belonging to 52 serovars was analyzed by a three gene 
MLST scheme and STs that were unique to bovine or human isolates were observed in 
addition to STs present in diverse hosts (Alcaine et al., 2006). Human and bovine 
associated lineages were also identified within Newport by this scheme (Alcaine et al., 
2006; Sukhnanand et al., 2005). Finally, host associated subtypes were identified within 
serovar Enteritidis when a diverse collection of 34 isolates was analyzed by MLVA (Cho et 
al., 2007). 
Although reptiles are the primary reservoir for Salmonella, and reptile-associated 
salmonellosis is a global problem (Ebani et al., 2005; Geue and Loschner, 2002; Nakadai et 
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al., 2005; Centers for Disease Control and Prevention, 2007c; Woodward et al., 1997), 
most studies have been focused on isolates from human and animals. In this study, reptile 
isolates of subspecies enterica were analyzed by an MLST scheme that is based on seven 
housekeeping genes (Torpdahl et al., 2005). In order to compare their host associations 
within serovars, I only tested reptile isolates from serovars where MLST data were 
available for isolates from humans or non-human warm blooded animals (NhWBA). 137 
reptile isolates from 23 serovars matched these criteria and were tested by MLST. 
 
5.2 Methods 
5.2.1 Bacterial isolates 
109 isolates that had been isolated from reptiles in different parts of Germany were 
obtained from Dr. Reiner Helmuth, National Salmonella Reference Laboratory, Federal 
Institute for Risk Assessment (BFR), Berlin, Germany. 28 reptile isolates of serovar 
Newport from Chapter 3 were also included. In total, these 137 isolates belonged to 23 
serovars of subspecies enterica. 
MLST data were available for 748 isolates for the same 23 serovars from humans and 269 
isolates from NhWBA (birds and other mammals) on the Salmonella MLST website. This 
dataset includes 268 Newport isolates from humans and 69 isolates from NhWBA from 
Chapter 3. MLST data for host adapted serovar Choleraesuis (74 isolates) and host 
restricted serovars Paratyphi A (41 isolates), Paratyphi C (48 isolates) and Typhi (27 
isolates) were also downloaded for comparison with any host adapted variants of these 
generalist serovars. Details are summarized in Table 5.1. 
 
The cultivation and storage of isolates, isolation of DNA, PCR amplification, sequencing 
and MLST analyses were carried out as previously described (Chapter 3). An MSTREE was 
generated in Bionumerics 4.5 based on the allelic profiles of isolates. 
 
5.2.2 Characteristics of housekeeping genes 
The average pairwise nucleotide diversity (π) with Jukes-Cantor correction was calculated 
on concatenated sequence alignments of isolates from reptiles, humans and NhWBA using 
MEGA 4.0 (Tamura et al., 2007). The mean of non-synonymous substitutions per non-
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synonymous site (Ka) and synonymous substitutions per synonymous site (Ks) was 
calculated for alignments of gene fragments in each host category using DnaSP 4.0 (Rozas 
et al., 2003). Unique sequences from each of the seven gene fragments present in any host 
category were tested for positive selection using the codon substitution models 
implemented in PAML 4.0 (Yang, 2007). Likelihood ratio tests were computed between the 
codon substitution models to find the model with the best fit (Yang et al., 2000). Only sites 
that were inferred to be under positive selection with a posterior probability of > 95% were 
considered. 
Table 5.1. Details of isolates from each host category 
Number of isolates Serovars; Mnemonic 
 Reptiles Humans NhWBA1 
Anatum; An 2 4 1 
Bovismorbificans; Bv 2 4 5 
Braenderup; Bu 5 5  
Brandenburg; Ba     1 7  
Choleraesuis2; Cs  37 37 
Decatur; Dc 1  2 
Dublin; Du 2 11 9 
Enteritidis; En 8 124 16 
Hadar; Hd 1 13 8 
Infantis; In     2 15 2 
Javiana3; Jv 4 6  
Miami; Mi 2 5  
Montevideo; Mo 4 10  
Muenchen; Mu 15 7  
Newport; Np      28 268 62 
Oranienburg; Or 30 5  
Panama; Pn 5 6  
Paratyphi A; Pa  41  
Paratyphi B4; Pb 8 25 10 
Paratyphi C5; Pc  48  
Saintpaul; Sp 2 12 14 
Senftenberg; Sf 3 10 2 
Stanley; St 1 4  
Thompson; Th 3 8  
Typhi; Ty  27  
Typhimurium; Tm 5 179 137 
Virchow; Vi 3 20 1 
Total 137 901 306 
1Isolates from non-human warm blooded animals (NhWBA) 
2Including Choleraesuis var. Kunzendorf 
3Including two z28 negative (H1 antigen) isolates from reptiles 
4Including Paratyphi B var. Java from humans and NhWBA 
5Including Paratyphi C var. Hirschfeld, Orient and Orientalis 
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5.2.3 Rarefaction curves 
Rarefaction is one of the best methods to compare the number of taxa between samples of 
different sizes because it allows estimating the number of taxa to be expected for a smaller 
sample from the data for larger populations. Individual based rarefaction curves were 
computed on isolates from reptiles, humans and NhWBA using the paleontological 
statistics software package PAST, version 1.73 (Hammer et al., 2001). 
Isolates of serovars Enteritidis, Newport and Typhimurium from humans and NhWBA and 
serovar Oranienburg from reptiles were overrepresented in the dataset. Therefore, I re-
computed rarefaction curves on isolates from each host category after excluding these 
serovars. 
5.2.4 Simpson’s diversity index (1-D) 
Simpson’s diversity index (SID) is often used to quantify the species diversity within a 
habitat. SID (1-D) indicates the probability that two randomly selected individuals from a 
sample will be from different species, where D = Σ (n / N)2. In this formula, n is the number 
of individuals of a particular species and N is the total number of individuals in the sample. 
SID was calculated using PAST version 1.73 (Hammer et al., 2001) for isolates from 
reptiles, humans and NhWBA. SID was also calculated for these host categories after 
excluding serovars Enteritidis, Newport, Oranienburg and Typhimurium. 
5.2.5 The UniFrac test of significance and the P-test 
Given a phylogenetic tree and environmental information for each sequence, the UniFrac 
test of significance computes differences between communities as a fraction of the branch 
lengths that are unique to each environment i.e. that leads to the descendents of either of 
environment but not from both (Lozupone and Knight, 2005). The program calculates a 
probability, P, that corresponds to the fraction of permutations where more branch lengths 
are unique in the original tree than in a tree where environment assignments were 
randomized (Lozupone et al., 2006). 
The program UniFrac also computes a P-test that compares communities by counting the 
numbers of changes responsible for the distribution of sequences from different 
environments in a phylogenetic tree (Martin, 2002). The probability is calculated as the 
fraction of permutated trees with randomized environments that needed fewer changes to 
describe the distribution than the original tree. 
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PAUP package 4.0 (Swofford, 1998) was used to generate a Neighbor-joining (NJ) tree on 
a concatenated sequence alignment for the seven housekeeping genes using only unique 
sequences from each host category. The UniFrac tests of significance were computed with 
1,000 permutations without weight abundance on all environments together and on each 
pair of environments. The P-tests were also computed with 1,000 permutations on all 
environments together and on each pair of environments. 
5.2.6 Other statistical tests 
Fisher’s exact tests and χ2 tests were computed using the statistical package STATISTICA 
(StatSoft, Inc., Tulsa, U.S.A.). 
5.3 Results 
5.3.1 Characteristics of housekeeping genes 
An adaptation to a particular ecological niche may involve evolutionary pressure which 
might possibly be reflected by variable nucleotide diversity between the individuals of a 
species from different environments. Therefore, I compared nucleotide diversity (π) of 
concatenated sequences between isolates from each host category. Serovars Choleraesuis, 
Paratyphi A, Paratyphi C and Typhi were not included because isolates of these serovars 
were not available from reptiles. The π values were comparable between reptile and human 
isolates but π was lower among isolates from NhWBA (Table 5.2). Hence, nucleotide 
diversity did not indicate any difference in selection pressure between isolates from reptiles 
and humans. A difference between the π values of isolates from reptiles and NhWBA might 
indicate a difference in the selection pressure or a selective advantage of particular 
sequence types in NhWBA hosts. 
To test whether housekeeping genes in any host category have experienced positive 
selection, ω, the ratio of nonsynonymous substitutions per non-synonymous site (Ka) to 
synonymous substitution per synonymous site (Ks) was calculated for sequence alignments 
of gene fragments (Table 5.3). The ω (Ka/Ks) values were < 1.0, as expected for purifying 
selection (Perez-Losada et al., 2006), indicating that none of the gene fragments was under 
positive selection in any of the three host categories. However, ω was 4-10fold higher for 
the hemD gene fragment than for other gene fragments, indicating that non-synonymous 
substitutions were fixed at higher frequencies in hemD than other fragments in all host 
categories. 
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Table 5.2. Diversity within each host category 
Host category 
Nucleotide 
diversity 
Rarefied 
STs1 
SID 
(1-D)2 
Rarefied 
STs3 
SID 
(1-D)4 
Reptile 0.012 ± 0.001 47 0.96 28.3 ± 1.4 0.94 
Human 0.010 ± 0.001 45.2 ± 3.8 0.94 30.6 ± 2.5 0.96 
NhWBA 0.007 ± 0.001 33.7 ± 2.7 0.84 18 0.87 
Note: isolates of serovars Choleraesuis, Paratyphi A, Paratyphi C and Typhi were not included because these 
serovars are not isolated from reptiles. 
1Number of STs identified by rarefaction analysis for 137 isolates against 47 STs of reptile isolates 
2SID on all isolates in each host category 
3Number of STs identified by rarefaction analysis for 54 isolates against 18 STs of NhWBA isolates after 
excluding isolates of serovars Enteritidis, Newport, Oranienburg and Typhimurium 
4SID in each host category after excluding isolates of serovars Enteritidis, Newport, Oranienburg and 
Typhimurium. 
Table 5.3. Average pairwise distance at non-synonymous (Ka) and synonymous (Ks) sites among gene 
fragments in different host categories 
Reptile  Human  NhWBA Gene 
fragments Ka Ks ω  Ka Ks ω  Ka Ks ω 
aroC 0.00016 0.02712 0.0059  0.00014 0.02610 0.0054  <0.00002 0.01509 <0.0013 
dnaN 0.00081 0.04208 0.0192  0.00129 0.02539 0.0508  0.00122 0.01705 0.0716 
hemD 0.00434 0.02259 0.1921  0.00488 0.02195 0.2223  0.00481 0.01610 0.2987 
hisD 0.00101 0.05847 0.0173  0.00223 0.04854 0.0459  0.00197 0.02979 0.0661 
purE 0.00034 0.05120 0.0066  0.00101 0.03323 0.0304  0.00022 0.02319 0.0095 
sucA 0.00008 0.04397 0.0018  0.00002 0.03364 0.0006  0.00028 0.02519 0.0111 
thrA 0.00004 0.06469 0.0006  0.00004 0.06722 0.0006  0.00004 0.05517 0.0007 
Note: Isolates of serovars Choleraesuis, Paratyphi A, Paratyphi C and Typhi were not included. 
 
To confirm that the seven gene fragments were not under positive selection, alignments of 
all unique fragments for each gene from all three host categories were also tested using 
various codon substitution models implemented in PAML 4.0. In agreement to the ω 
values, none of the gene fragments is under overall positive selection. At the single codon 
level, only one codon in aroC (position 110), four in hemD (positions 33, 34, 114 and 115) 
and one in hisD (position 6) are under diversifying selection at the > 95% level according to 
the M2 (positive selection), M3 (discrete site) or M8 (β and ω) models. None of the models 
differ significantly from the others according to the likelihood ratio test for any gene 
fragment. The only exception was model M1 (nearly neutral) for the purE gene fragment 
where the likelihood was marginally lower than M2 and M3. 
5.3.2 Diversity between different host categories 
A total of 47 STs were observed among the 137 reptile isolates. Since more isolates had 
been tested from humans and NhWBA, the numbers of STs that would be expected for 137 
isolates from humans and NhWBA were estimated using individual rarefaction. Again, 
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isolates of serovars Choleraesuis, Paratyphi A, Paratyphi C and Typhi were not included. 
The expected value for the number of STs among human isolates was comparable to the 
number of STs observed among reptile isolates (Fig. 5.1, Table 5.2). The genotypic 
diversity among isolates from NhWBA was much lower because only 33.7 ± 2.7 STs would 
be expected for 137 isolates. 
The Simpson’s Index of Diversity (SID) was also comparable between reptile and human 
isolates. Similar to the rarefaction analysis, SID was lower for isolates from NhWBA 
(Table 5.2). Isolates of serovars Enteritidis, Newport and Typhimurium from humans and 
NhWBA were overrepresented in the dataset because other projects had focussed on these 
serovars. Isolates of serovar Oranienburg from reptiles (n = 30) were also 6fold higher in 
numbers than from other hosts (n = 5). I therefore calculated rarefaction and SID values 
again, but after excluding isolates of these four serovars from all host categories. Now the 
smallest category was NhWBA (54 isolates, 18 STs), and therefore rarefaction values were 
estimated for 54 isolates each from reptiles and humans. The results were consistent with 
the previous observations. The rarefied STs and SID values were comparable between 
reptile and human isolates but higher than for isolates from NhWBA (Table 5.2). A lower 
diversity among NhWBA isolates possibly indicates selective advantages for a limited 
number of genotypes in the host environment. 
 
Fig 5.1. Rarefaction curves on isolates from humans and NhWBA. STs for 137 isolates are marked with a star 
sign. 
5.3.3 Host-unique sequence types (STs) among generalist salmonellae 
An MSTREE generated from the allelic profile of isolates (Fig. 5.2) defined STs that were 
common between the host categories (multi-coloured pie-charts) as well as STs that were 
specific to a particular host type (uni-coloured) within generalist serovars. Of the 47 STs 
observed among reptile isolates, 12 were present in all three host categories (Fig. 5.3A). An 
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additional 12 STs were shared by reptile and human isolates. Reptile and NhWBA isolates 
did not share any unique STs. Approximately 49%, 68% and 51% of the STs were specific 
for reptile, human and NhWBA isolates, respectively. Isolates of host restricted and host 
adapted serovars (Choleraesuis, Paratyphi A, Paratyphi C and Typhi) were excluded from 
these comparisons. 
 
 
Fig. 5.2. An MSTREE of allelic profiles of isolates. Reptile isolates are shown in red, human isolates in green 
and NhWBA in blue. Abbreviations used as mentioned in Table 5.1, followed by group designation assigned 
by Prof. Mark Achtman. Host specific groups or STs are marked with arrows. ST193, a Newport ST, is a 
DLV to ST45 of group 3 and ST31 of group 7. 
 
The proportion of reptile isolates in host-specific STs was slightly but insignificantly (p = 
0.08) higher than for human isolates and significantly higher than for NhWBA isolates (p < 
0.01). The proportion of NhWBA isolates in host-specific STs was also significantly lower 
than human isolates in human-specific STs (p < 0.01). These results indicate that isolates 
from reptiles are more often host-specific than isolates from humans or NhWBA. However, 
a high proportion of Oranienburg isolates from reptiles might partially be responsible for 
such a phenomenon. 67% of reptile isolates of serovar Oranienburg were present in host-
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specific STs. A significantly lower proportion of NhWBA isolates in host-specific STs 
possibly indicates that NhWBA-specific isolates are rare. 
Table 5.4. Distribution of STs observed for the isolates in different host-categories 
 Host 
 
No. of observed STs 
(Total isolates) 
Common STs
(% isolates) 
Host specific 
STs (% isolates) 
Host specific groups 
(% isolates) 
Reptile 47 (137) 24 (67.9) 23 (32.1) 6 (19.0) 
Human 114 (748) 36 (75.1) 78 (24.9) 10 (3.0) 
NhWBA 49 (269) 24 (83.6) 25 (16.4) 3 (1.5)  
Note Isolates of serovans Choleraesuis, Paratyphi A, Paratyphi C and Typhi were not included. 
 
 
 
Fig 5.3. Proportional Venn-diagrams A). the number of STs shared between the three host categories, and B). 
the numbers of groups shared between the host categories. 
 
5.3.4 Host restricted groups among generalist salmonellae 
My analyses of salmonellae from human carriers revealed that most STs found among 
carried isolates were also found among isolates from human non-carriers and from animals 
(Chapter 4). Only one ST in serovar Hadar was specific to carriage. Other STs were only 
observed among isolates from non-carrier humans and from animals but most were 
genetically closely related to carrier isolates. In contrast, approximately half (23/47) of the 
STs among reptile isolates were specific to reptiles. To test whether STs unique to reptile 
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hosts represent genetically distinct populations, the groups defined by Prof. Mark Achtman 
were used (Fig. 5.1, Fig. 5.3B, Table 5.5). 
Table 5.5. Distribution of groups according to serovar and host specificity 
Serovar 
 
Shared groups [Hosts (ST designation)] 
 
Host specific groups [Hosts (ST 
designation)] or singleton 
Anatum 65 [R-H-N (64)]  
Bovismorbificans 34 [H-N (142), N (148, 377)] [R (150)] 
Braenderup 24 [R-H (22), R (194), H (311)]  
Brandenburg 12 [R (65), H (20, 249)]  
Choleraesuis 6 [H-N (66, 68, 145), H (133)]  
Decatur  50 [N (70)]; [R (186)] 
Dublin 
 
32 [R (74)1]; 53 [H-N (10), N (73)]; 4 [R 
(180)2]  
Enteritidis 
 
4 [R-H-N (11), H-N (183), R (168), H (310, 
366), N (136), R (172, 180)2]  
Hadar 22 [R-H-N (33), N (12), H (368, 473)]  
Infantis 31 [R-H-N (32), H (41)] [H (361)]; [H( 493)]; [N (141)] 
Javiana 17 [R-H (24), R (175), H (143)]  
Miami 42 [H (48)3] 66 [H (140)4]; [R (171)]; [H (80)] 
Montevideo 40 [R-H (4), R-H (195), H (81, 305, 316)] 39 [H (138)] 
Muenchen 
 
8 [R-H (112), R (170, 173, 176, 177), H (82, 
111)] 
[R (178)]; [H (83)]; [H( 84)] 
 
Newport 
 
 
 
 
 
 
2 [R-H-N (118), H-N (5, 115), H (117, 119, 
163, 164, 167, 187, 189, 190, 199, 223, 345, 
347, 350, 351, 352, 354), N (120, 122, 123)], 
3 [R-H-N (45, 46, ), H-N (116), H (353, 355, 
158, 201), N (121, 125), R (184, 211)], 7 [H-
N (31), H (132, 188, 191, 200, 346, 348, 
349)], 35 [H-N (166), H (156, 360)]; ST1935  
Oranienburg 41 [R-H (23, 47), H (91)] 44 [R (169, 174)]; 52 [R (179)] 
Panama 42 [R-H (48)3]  
Paratyphi A  11 [H (85, 129, 130, 479, 494, 495)] 
Paratyphi B 
(including var. java) 
 
5 [R-H (43), H-N (86), H (110,  307, 570), N 
(149)]; 19 [R-H (88), H (127)]; 32 [H (42)1]; 
59 [H-N (28)]  
Paratyphi C  20 [H (90, 114, 146)] 
Saintpaul 
 
14 [R-H-N (27), R-H (50), H-N (49), H 
(344)]; 21 [H (343)6] 
89 [H (95)] 
 
Senftenberg 55 [R-H-N (14)] 30 [H (185, 217)] 
Stanley 29 [R (182), H (29, 51)]  
Thompson 28 [R-H (26)]  
Typhi  13 [H (1, 2, 3, 8)] 
Typhimurium 
 
 
1 [R-H-N (19, 34), H-N (213), H (35, 137, 
302, 313, 328, 394, 568, 569), N (98, 99, 
128, 153, 204, 205, 209, 323, 332, 376, 429)] 
[H (36)]; [N (207)] 
 
 
Virchow 
 
9 [R-H-N (16), H (38, 326, 303, 359)]; 70 [H 
(333), R (197)]  
R, reptile host; H, human host; N, non-human warm blooded animal host  
Note: 1.Host categories separated by hyphens before an ST in parentheses indicate that that ST is common to 
them. 
2. The group designations are in bold face. 
3. The groups and/or the distinct STs in each category are separated by semicolons.  
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Table 5.5 continued… 
 
1Group 32 contained two STs, ST74 which was unique to a reptile isolate of serovar Dublin and ST42 which 
was specific to two human isolates of Paratyphi B. 
2ST180 is a part of group 4 and most group 4 isolates are Entertidis. ST180 was common to reptile isolates of 
serovar Dublin and Enteritidis. 
3Group 42, a single ST group, is common between serovars Miami and Panama. 
4Group 66 contained STs 140 and 410. The former is specific to a human isolate of serovar Miami whereas 
the latter was observed for an isolate of serovar Eastbourne of unknown origin. 
5ST193 is a DLV between ST45 of group 3 and ST31 of group 7. 
6ST343 was assigned to group 21. Group 21 has two other STs 126 and 412. Serovar of the sole isolate in 
ST126 was not determined whereas ST412 contained an isolate of serovar Reading. 
 
 
All isolates of serovars Anatum, Braenderup, Brandenburg, Enteritidis, Hadar, Javiana, 
Panama, Stanley and Thompson belonged to a single serovar-specific group (Fig. 5.2, Table 
5.5). Two or more distinct groups were identified within serovars Dublin, Newport, 
Paratyphi B and Virchow but none of them was specific to particular host. Host-specific 
groups or singleton STs were observed only in serovars Bovismorbificans, Decatur, 
Infantis, Miami, Montevideo, Muenchen, Oranienburg, Saintpaul, Senftenberg and 
Typhimurium (Table 5.5). 
Two group and four singletons that were specific to reptile isolates (Table 5.6) are marked 
with red arrows in Fig. 5.2. Four groups plus six singletons specific to isolates from humans 
(green arrows in Fig. 5.2) and one group plus two singletons were specific to NhWBA 
(blue arrows in Fig. 5.2). Host adapted and restricted serovars Choleraesuis, Paratyphi A, 
Paratyphi C and Typhi were also excluded from these comparisons. The proportion of 
reptile isolates in host-specific groups and singletons was significantly higher than for 
isolates from humans (p < 0.01) or NhWBA (p < 0.01). However, host-specific groups and 
singletons for human and NhWBA isolates contained similar proportions of isolates (p = 
0.14). Therefore, in agreement with the previous observation, host specific salmonellae are 
relatively more common among reptiles than humans or NhWBA. 
To test whether reptiles represent a distinct host community from humans and NhWBA, the 
UniFrac significance test and the P-test were computed. The host categories did not 
differentiate the isolates as indicated by the UniFrac significance test (p = 0.72) or the P-
test (p = 0.22) when all host categories were compared together. Pairwise comparisons also 
did not resolve any significant differences between the host categories by either method 
(Table 5.7). These results indicate that generalist salmonellae from reptiles are not 
divergent from those isolated from humans or NhWBA and belong to the same population. 
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Table 5.6. Host specific groups and STs 
Host Serovar Group [ST] Number of isolates 
Reptile Bovismorbificans [150] 2 
 Decatur [186] 1 
 Miami [171] 2 
 Muenchen [178] 1 
 Oranienburg 44 [169, 174] 13 
 Oranienburg 52 [179] 7 
Human Infantis [361] 1 
 Infantis [493] 1 
 Miami 66 [140] 1 
 Miami [80] 2 
 Montevideo 39 [138] 5 
 Muenchen [83] 2 
 Muenchen [84] 2 
 Paratyphi A 11 [85, 129, 130, 479, 494, 495] 41 
 Paratyphi C 20 [90, 114, 140] 48 
 Saintpaul 89 [95] 3 
 Senftenberg 30 [185, 217] 4 
 Typhi 13 [1, 2, 3, 8] 27 
 Typhimurium [36] 3 
NhWBA Decatur 50 [70] 2 
 Infantis [141] 1 
 Typhimurium [207] 1 
 
Table 5.7. Probability matrix of pairwise comparison of host categories 
   Reptile Human  NhWBA  
Reptile   1.0000 0.6600 
Human  1.0000  1.0000 
NhWBA  0.0660 0.6600   
Note: 1. Probabilities of the UniFrac test of significance are shown in the upper half and the P-test 
probabilities in the lower half of the matrix. 2. Isolates of serovars Choleraesuis, Paratyphi A, Paratyphi C and 
Typhi were not included in the analysis. 
 
5.3.5 Host-adapted serovars/variants and host specific genotypes 
All human and cattle isolates of cattle adapted serovar Dublin clustered together in group 
53 (Fig. 5.2, Table 5.5, Table 5.8). Similar results were obtained for the swine adapted 
serovar Choleraesuis, where all human and swine isolates were in group 6. Thus, human 
cases of Dublin and Choleraesuis infections probably originate from cattle and swine, 
respectively. 
I also analyzed poultry-associated phage type PT4 and hedgehog-associated PT11 of 
serovar Enteritidis and pigeon-restricted phage types DT2 and DT99 of serovar 
Typhimurium. All isolates of each phage type were confined to a single ST within groups 
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that were common to isolates from reptiles, humans as well as other animals (Table 5.8). 
One Typhimurium DT99 isolate was the exception that was in ST128 whereas the 
remaining 10 DT99 isolates were in ST19. None of these STs was host specific. These 
patterns are different from those of host restricted serovars Paratyphi A, Paratyphi C and 
Typhi in which all isolates of these serovars were assigned to a single host- and serovar-
specific group of STs (Fig. 5.2, Table 5.6). Thus, Typhimurium DT2 and DT99 are 
apparently not totally host-restricted. Enteritidis PT4 and PT11 are not host-restricted. All 
13 Enteritidis PT4 isolates that were analyzed in this study were from humans whereas 
PT11 isolates were available both from hedgehogs (n = 5) and humans (n = 4). All human 
as well as hedgehog isolates of Enteritidis PT11 were the same ST (ST183). Therefore, 
similar to the host adapted serovars, Enteritidis PT11 infections in humans are probably 
derived from hedgehogs. 
Table 5.8. Host-specificity among host-associated serovars/variants 
Isolates from other hosts in the same group Serovar (Phage type) 
 
Primary host 
(isolates) 
Group [STs] 
 Reptile Human Other 
Choleraesuis Swine (37) 6 [66, 68, 145] 0 37 0 
Dublin Cattle (6) 53 [10, 73] 0 11 3 
Enteritidis (PT4, 4b) Poultry (0) 4 [11] 8 124 16 
Enteritidis (PT11) Hedgehogs (5) 4 [183] 8 124 7 
Typhimurium (DT2) Pigeon (12) 1 [128] 4 176 114 
Typhimurium (DT99) Pigeon (11) 1 [19, 128] 4 176 114 
Note: A total of 11 Enteritidis PT4 and 2 PT4b isolates were analyzed but all were isolated from humans. 
 
5.4 Discussion 
5.4.1 Genetic and genotypic diversity 
Asymptomatic isolates of Neisseria meningitidis were more diverse than clinical isolates 
(Caugant et al., 2007). In contrast, genetic diversity was comparable between salmonellae 
from asymptomatic human carriers and non-carrier humans plus animals (Chapter 4). 
Similarly, overall genotypic diversity was comparable between Typhimurium DT104 
isolates from asymptomatic and disease associated animal populations (Perron et al., 2007). 
Reptiles are a natural reservoir for Salmonella and carry them asymptomatically in the 
intestinal tract (Ebani et al., 2005; Geue and Loschner, 2002; Woodward et al., 1997). In 
agreement with previous observations, similar levels of genotypic and genetic diversity 
were observed between salmonellae from reptiles and human. However, isolates from 
NhWBA were less diverse (Table 5.2). This observation is consistent with a previous study 
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where bovine isolates were found to be less diverse than human isolates (Alcaine et al., 
2006). The lower diversity possibly indicates that prevalent genotypes of generalist 
serovars among NhWBA eliminate others by competitive inhibition. However, competitive 
inhibition has not yet been described among Salmonella isolates. Alternatively, the host 
environment may provide a selective advantage for particular genotypes in NhWBA hosts. 
For example, antibiotics are often used to supplement animal feeds (Threlfall et al., 2000; 
Angulo et al., 2004), which will select for  isolates with resistance to those particular 
antimicrobials, possibly resulting in limited nucleotide and genotypic diversity among 
animal isolates. 
5.4.2 Clonal diversity and host association 
Common and host-specific STs were observed within most serovars (Fig. 5.2, Fig 5.3 and 
Table 5.4). However, most of the specific STs belonged to the same groups as isolates from 
other hosts (Table 5.5). Only two groups plus four singletons were restricted to isolates 
from reptiles whereas four groups plus six singletons were specific to human isolates and 
one group plus two singletons were specific to NhWBA isolates (Fig. 5.2, Table 5.6). The 
proportion of reptile isolates in host specific groups and singletons was significantly higher 
than for human or NhWBA isolates. Therefore, host specificity is more frequently exhibited 
by reptile isolates than isolates from other hosts. 
22% (30/137) of all reptile isolates belonged to serovar Oranienburg and most of these were 
in two host-specific groups. Only five Oranienburg isolates were available from other hosts, 
all from humans. These isolates shared group 41 with ten Oranienburg isolates from 
reptiles. The proportion of reptile isolates in host specific groups or singletons (5.6%) was 
only slightly higher than that of human (3.0%) or NhWBA isolates (1.5%), when 
Oranienburg isolates were excluded. Therefore, more isolates of serovar Oranienburg from 
non-reptile hosts are required to be analyzed to determine whether reptile isolates of this 
serovar are host associated. 
None of the host categories represented genetically distinct populations as suggested by the 
UniFrac significance tests and the P-tests (Table 5.7). This observation might indicate that 
most genotypes can cross-infect individuals from different host categories. Approximately 
half of the STs observed among isolates from reptiles as well as NhWBA were shared with 
human isolates (Fig. 5.3A). This observation suggests that both reptiles and NhWBA are 
potential reservoirs for Salmonella infection in human. 
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As expected for host adapted serovars, human and cattle isolates of serovar Dublin were 
identical as were human and swine isolates of serovar Choleraesuis (Fig 3.2, Table 5.5). 
This observation supports an argument that human infection by serovars Dublin and 
Choleraesuis probably originate from cattle and pigs, respectively (Kingsley and Baumler, 
2000; Uzzau et al., 2000). Most isolates of a host adapted phage type of generalist serovars 
were confined to a single ST. The only exception was one Typhimurium DT99 isolate 
whose ST differed from the remaining DT99 isolates. But unlike the host-restricted 
serovars Paratyphi A, Paratyphi C and Typhi where all isolates were in serovar- and host-
specific groups, none of the STs was host specific among host adapted variants of 
generalist serovars. Enteritidis PT4 and PT11 which are associated to poultry and 
hedgehogs, respectively, were isolated from other hosts as well. Although Typhimurium 
DT2 and DT99 are considered to be restricted to pigeons, a reduced ability of isolates of 
these phage types in murine organs has been reported (Andrews-Polymenis et al., 2004). 
Since these phage types can infect individuals of other host categories, they do not seem to 
reflect host specific STs. Furthermore, host adaptation usually involve insertions, deletions 
and genomic rearrangements (Wu et al., 2005; Helm et al., 2004) that do not necessarily 
have any impact on housekeeping genes. Genomic rearrangements at rrn operon, insertions 
that potentially contribute to the increased virulence in certain hosts, and genome 
degradation have been characterized within serovars Typhi and Paratyphi A (Liu et al., 
2006; McClelland et al., 2004). The genomes of Typhimurium phage types DT2 and DT99 
were similar to Typhimurium LT2 and the only differences were Fels-1 and Fels-2 
prophages that were absent in DT2 and DT99 (Andrews-Polymenis et al., 2004). However, 
these differences did not correlate with the host association when isolates of different phage 
types were tested (Andrews-Polymenis et al., 2004). 
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